Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Inflamm Bowel Dis

Retrieve available abstracts of 878 articles:
HTML format



Single Articles


    June 2022
  1. SEDANO R, Hogan M, Zou G, Narula N, et al
    Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis Trials.
    Inflamm Bowel Dis. 2022 Jun 24. pii: 6617565. doi: 10.1093.
    PubMed    


  2. INNOCENTI T, Bigagli E, Lynch EN, Galli A, et al
    MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing?
    Inflamm Bowel Dis. 2022 Jun 24. pii: 6617564. doi: 10.1093.
    PubMed     Abstract available


  3. ARJOMAND FARD N, Armstrong H, Perry T, Wine E, et al
    Appendix and Ulcerative Colitis: a Key to Explaining the Pathogenesis and Directing Novel Therapies?
    Inflamm Bowel Dis. 2022 Jun 24. pii: 6617562. doi: 10.1093.
    PubMed     Abstract available


  4. LIU E, Laube R, Leong RW, Fraser A, et al
    Managing Inflammatory Bowel Disease in Pregnancy: Health Care Professionals' Involvement, Knowledge, and Decision Making.
    Inflamm Bowel Dis. 2022 Jun 17. pii: 6609865. doi: 10.1093.
    PubMed     Abstract available


  5. JORDAN A, Maraj B, Kinnucan J
    Is it a Flare? Acute Appendicitis in Ulcerative Colitis Patient Found on Routine Screening Colonoscopy.
    Inflamm Bowel Dis. 2022 Jun 14. pii: 6608386. doi: 10.1093.
    PubMed    


  6. LONG MD, Afzali A, Fischer M, Hudesman D, et al
    Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting.
    Inflamm Bowel Dis. 2022 Jun 14. pii: 6608417. doi: 10.1093.
    PubMed     Abstract available


  7. KAWAMOTO A, Fujii T, Mitani R, Suzuki Y, et al
    Serum Levels of Infliximab Biosimilar in a Child Delivered From a Mother Treated for Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Jun 14. pii: 6608379. doi: 10.1093.
    PubMed    


  8. STAFFORD IS, Gosink MM, Mossotto E, Ennis S, et al
    A Systematic Review of Artificial Intelligence and Machine Learning Applications to Inflammatory Bowel Disease, with Practical Guidelines for Interpretation.
    Inflamm Bowel Dis. 2022 Jun 14. pii: 6608231. doi: 10.1093.
    PubMed     Abstract available


  9. TIAN WN, Huang YH, Dai C
    Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: A Survey From China.
    Inflamm Bowel Dis. 2022 Jun 6. pii: 6603234. doi: 10.1093.
    PubMed    


  10. JEDEL S, Beck T, Swanson G, Hood MM, et al
    Mindfulness Intervention Decreases Frequency and Severity of Flares in Inactive Ulcerative Colitis Patients: Results of a Phase II, Randomized, Placebo-Controlled Trial.
    Inflamm Bowel Dis. 2022 Jun 4. pii: 6602039. doi: 10.1093.
    PubMed     Abstract available


  11. TURSI A, Nenna R
    COVID-19 as a Trigger for De Novo Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e76-e77.
    PubMed    


  12. ZHANG Y, Tian F, Li H
    Pulmonary Infection Due to Reactivation of Latent Epstein-Barr Virus in a Patient With Crohn's Disease Treated With Infliximab.
    Inflamm Bowel Dis. 2022;28:e80-e81.
    PubMed    


  13. STIDHAM RW, Yu D, Zhao X, Bishu S, et al
    Identifying the Presence, Activity, and Status of Extraintestinal Manifestations of Inflammatory Bowel Disease Using Natural Language Processing of Clinical Notes.
    Inflamm Bowel Dis. 2022 Jun 3. pii: 6601382. doi: 10.1093.
    PubMed     Abstract available


  14. YU M, Zhu W, Wang J, Chen X, et al
    Caveolin-1 Alleviates Crohn's Disease-induced Intestinal Fibrosis by Inhibiting Fibroblasts Autophagy Through Modulating Sequestosome 1.
    Inflamm Bowel Dis. 2022;28:923-935.
    PubMed     Abstract available


  15. WANG B, Li R, Zhang S, Zhao Q, et al
    A Case of Behcet's Disease With Hepatic Lesions Misdiagnosed as Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e86-e87.
    PubMed    


  16. DONG G, Yang Y, Zhang H, Yu W, et al
    Protein Kinase CK2 Maintains Reciprocal Balance Between Th17 and Treg Cells in the Pathogenesis of UC.
    Inflamm Bowel Dis. 2022;28:830-842.
    PubMed     Abstract available


  17. WANG X, Tang J, Zheng JW, Huang WF, et al
    Granulomatous Pneumonia and Liver Lesions Associated With Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e78-e79.
    PubMed    


  18. SORENSEN KM, Jensen CH, Sheikh SP, Qvist N, et al
    Treatment of Fistulizing Perianal Crohn's Disease by Autologous Microfat Enriched With Adipose-Derived Regenerative Cells.
    Inflamm Bowel Dis. 2022;28:967-970.
    PubMed    


  19. FRADKOV E, Sheehan J, Cushing K, Higgins PDR, et al
    Efficacy of Ustekinumab in Crohn's Disease With and Without Concurrent Autoimmune Skin Disease.
    Inflamm Bowel Dis. 2022;28:895-904.
    PubMed     Abstract available


  20. CHEN G, Pedarla V, Null KD, Cazzetta SE, et al
    Health Care Costs and Resource Utilization Among Patients With Crohn's Disease With and Without Perianal Fistula.
    Inflamm Bowel Dis. 2022;28:870-877.
    PubMed     Abstract available


  21. JAVAID A, Shahab O, Adorno W, Fernandes P, et al
    Machine Learning Predictive Outcomes Modeling in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2022;28:819-829.
    PubMed     Abstract available


  22. NOORIAN S, Jeon Y, Nguyen MT, Sauk J, et al
    The Impact of NAFLD on Hospitalization Outcomes in Patients With Inflammatory Bowel Diseases: Nationwide Analysis.
    Inflamm Bowel Dis. 2022;28:878-887.
    PubMed     Abstract available


  23. WITGES K, Sexton K, Graff LA, Targownik LE, et al
    What Is a Flare? The Manitoba Living With IBD Study.
    Inflamm Bowel Dis. 2022;28:862-869.
    PubMed     Abstract available


  24. BROMS G
    IBD in the Postpartum Period: Spotlight on Maternal Outcomes.
    Inflamm Bowel Dis. 2022;28:980-981.
    PubMed    


  25. ABOUBAKR A, Gottlieb ZS, Riggs AR, Johnson SO, et al
    Peripartum Exposure to Biologic Therapy Does Not Impact Postpartum Wound Healing in Women With IBD.
    Inflamm Bowel Dis. 2022;28:843-849.
    PubMed     Abstract available


  26. RANGEL PANIZ G, Lebow J, Sim L, Lacy BE, et al
    Eating Disorders: Diagnosis and Management Considerations for the IBD Practice.
    Inflamm Bowel Dis. 2022;28:936-946.
    PubMed    


  27. CAO Q, Chen C, Gao X, Chen Y, et al
    Real-world Short-term Effectiveness of Ustekinumab in Crohn's Disease: Results from a Multicenter, Prospective Study in China.
    Inflamm Bowel Dis. 2022;28.
    PubMed    


  28. PENG L, Hu S, Yu Q, Chen Y, et al
    Challenging the Surge of Inflammatory Bowel Disease: The Role of the China Crohn's and Colitis Foundation in the Healthcare Landscape of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022;28.
    PubMed     Abstract available


  29. CHEN YJ, Chen BL, Liang MJ, Chen SL, et al
    Longitudinal Bowel Behavior Assessed by Bowel Ultrasound to Predict Early Response to Anti-TNF Therapy in Patients With Crohn's Disease: A Pilot Study.
    Inflamm Bowel Dis. 2022;28.
    PubMed     Abstract available


  30. ARKENBOSCH JHC, Mak JWY, Ho JCL, Beelen EMJ, et al
    Indications, Postoperative Management, and Long-term Prognosis of Crohn's Disease After Ileocecal Resection: A Multicenter Study Comparing the East and West.
    Inflamm Bowel Dis. 2022;28.
    PubMed     Abstract available


  31. YAO L, Chen H, Shao B, Liu J, et al
    Temporal Changes in the Treatment Paradigm and Long-term Prognosis of Patients With Crohn's Disease: A Hospital-Based Cohort Study in China.
    Inflamm Bowel Dis. 2022;28.
    PubMed     Abstract available


  32. BAI X, Zhang H, Ruan G, Lv H, et al
    Long-term Disease Behavior and Surgical Intervention Analysis in Hospitalized Patients With Crohn's Disease in China: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2022;28.
    PubMed     Abstract available


  33. WINTHROP KL, Vermeire S, Long MD, Panes J, et al
    Long-term Risk of Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.
    Inflamm Bowel Dis. 2022 Jun 1. pii: 6596831. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  34. TSE CS, Melmed GY, Siegel CA, Weng CH, et al
    Bidirectional Correlations Between Health Confidence and Inflammatory Bowel Disease Activity: A Nationwide Longitudinal Cohort Study.
    Inflamm Bowel Dis. 2022 May 28. pii: 6594471. doi: 10.1093.
    PubMed    


  35. WINTER RW, Boyd T, Chan WW, Levy AN, et al
    Risk Factors for Voluntary Childlessness in Men and Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 May 28. pii: 6594473. doi: 10.1093.
    PubMed    


  36. WU S, Xie S, Yuan C, Yang Z, et al
    Inflammatory Bowel Disease and Long-term Risk of Cancer: A Prospective Cohort Study Among Half a Million Adults in UK Biobank.
    Inflamm Bowel Dis. 2022 May 27. pii: 6594105. doi: 10.1093.
    PubMed     Abstract available


  37. SOOKAROMDEE P, Wiwanitkit V
    Correspondence on "Immunogenicity of COVID-19 Vaccine Doses in Patients With Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2022 May 27. pii: 6594100. doi: 10.1093.
    PubMed    


  38. GOLD SL, Rabinowitz LG, Manning L, Keefer L, et al
    High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease Course.
    Inflamm Bowel Dis. 2022 May 19. pii: 6589577. doi: 10.1093.
    PubMed     Abstract available


  39. GOODYEAR BG, Heidari F, Ingram RJM, Cortese F, et al
    Multimodal Brain MRI of Deep Gray Matter Changes Associated With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 May 19. pii: 6589553. doi: 10.1093.
    PubMed     Abstract available


  40. SLEUTJES JAM, Roeters van Lennep JE, van der Woude CJ, de Vries AC, et al
    Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease: Effect of Different Drug Classes and Inflammation.
    Inflamm Bowel Dis. 2022 May 19. pii: 6589576. doi: 10.1093.
    PubMed     Abstract available


  41. KAWASHIMA K, Oshima N, Kishimoto K, Kataoka M, et al
    Low Fecal Calprotectin Predicts Histological Healing in Patients with Ulcerative Colitis with Endoscopic Remission and Leads to Prolonged Clinical Remission.
    Inflamm Bowel Dis. 2022 May 18. pii: 6588003. doi: 10.1093.
    PubMed     Abstract available


  42. MADSEN GR, Bertl K, Pandis N, Stavropoulos A, et al
    The Impact of Periodontitis on Inflammatory Bowel Disease Activity.
    Inflamm Bowel Dis. 2022 May 12. pii: 6584926. doi: 10.1093.
    PubMed     Abstract available


  43. DE KRIJGER M, Carvalho B, Rausch C, Bolijn AS, et al
    Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 May 11. pii: 6584483. doi: 10.1093.
    PubMed     Abstract available


  44. RIZVI A, Trivedi P, Bar-Mashiah A, Plietz M, et al
    Vitamin D Deficiency is Common in Patients with Ulcerative Colitis After Total Proctocolectomy with Ileal Pouch Anal Anastomosis.
    Inflamm Bowel Dis. 2022 May 11. pii: 6584485. doi: 10.1093.
    PubMed    


  45. DE SIRE R, Rispo A, Compare D, Tortora F, et al
    Wernicke Encephalopathy in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022;28:e70-e71.
    PubMed    


  46. BATTAT R
    Authors' Reply to "Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2022;28:e61.
    PubMed    


  47. MC GETTIGAN N, Boland K, O'Toole A
    Letter to the Editor in Response to "Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2022;28:e59-e60.
    PubMed    


  48. PEREZ K, Ngollo M, Rabinowitz K, Hammoudi N, et al
    Meta-Analysis of IBD Gut Samples Gene Expression Identifies Specific Markers of Ileal and Colonic Diseases.
    Inflamm Bowel Dis. 2022;28:775-782.
    PubMed     Abstract available


  49. ETWEBI Z, Goldsmith JR, Bou-Dargham M, Tian Y, et al
    TIPE2 Promotes Tumor Initiation But Inhibits Tumor Progression in Murine Colitis-Associated Colon Cancer.
    Inflamm Bowel Dis. 2022;28:764-774.
    PubMed     Abstract available


  50. NIGAM GB, Patel RN, Lakhtakia S, Desai D, et al
    A Survey of Endoscopists' Views on Dysplasia Surveillance and Chromoendoscopy in IBD from India.
    Inflamm Bowel Dis. 2022;28:e64-e65.
    PubMed    


  51. GOLUSDA L, Kuhl AA, Siegmund B, Paclik D, et al
    Reducing Pain in Experimental Models of Intestinal Inflammation Affects the Immune Response.
    Inflamm Bowel Dis. 2022;28:801-807.
    PubMed     Abstract available


  52. ZHAO QF, Wang S
    Crohn's Disease Complicated by an Ileo-urachal Fistula.
    Inflamm Bowel Dis. 2022;28:e62-e63.
    PubMed    


  53. HUANG JS, Definis M, Cruz R, Parker J, et al
    Patient Portal Usage: An Objective Target for Transition Interventions Among Youth with IBD?
    Inflamm Bowel Dis. 2022;28:808-810.
    PubMed    


  54. ROBLIN X, Genin C, Nancey S, Williet N, et al
    Swapping Versus Dose Optimization in Patients Losing Response to Adalimumab With Adequate Drug Levels.
    Inflamm Bowel Dis. 2022;28:720-727.
    PubMed     Abstract available


  55. GU P, Chhabra A, Chittajallu P, Chang C, et al
    Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy.
    Inflamm Bowel Dis. 2022;28:657-666.
    PubMed     Abstract available


  56. BRENNER EJ, Long MD, Mann CM, Lin L, et al
    Anxiety and Depressive Symptoms Are Not Associated With Future Pediatric Crohn's Disease Activity.
    Inflamm Bowel Dis. 2022;28:728-733.
    PubMed     Abstract available


  57. DE CRUZ P, Hamilton AL, Burrell KJ, Gorelik A, et al
    Endoscopic Prediction of Crohn's Disease Postoperative Recurrence.
    Inflamm Bowel Dis. 2022;28:680-688.
    PubMed     Abstract available


    April 2022
  58. LEBER A, Hontecillas R, Tubau-Juni N, Lichtiger S, et al
    Correction to: Efficacy, Safety, and Tolerability of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Apr 30. pii: 6576383. doi: 10.1093.
    PubMed    


  59. NELSON AD, Elkins JR, Stocchi L, Farraye FA, et al
    Use and Misuse of Parenteral Nutrition in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 26. pii: 6574514. doi: 10.1093.
    PubMed     Abstract available


  60. TORTORA C, Di Paola A, Creoli M, Argenziano M, et al
    Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 26. pii: 6574513. doi: 10.1093.
    PubMed     Abstract available


  61. FRIEDMAN S, Zegers FD, Jolving LR, Nielsen J, et al
    Increased Risk of Postpartum Infections After Caesarian and Vaginal Delivery in Women With Inflammatory Bowel Disease: A Danish Nationwide Cohort Study.
    Inflamm Bowel Dis. 2022 Apr 26. pii: 6574515. doi: 10.1093.
    PubMed     Abstract available


  62. KWON JY, Daoud ND, Hashash JG, Picco MF, et al
    Efficacy of Hepatitis B Vaccination with a Novel Immunostimulatory Sequence Adjuvant (Heplisav-B) in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 25. pii: 6573907. doi: 10.1093.
    PubMed     Abstract available


  63. VELOSO FT
    Are Ulcerative Colitis and Diverticulitis Connected by the Same Hub?
    Inflamm Bowel Dis. 2022 Apr 23. pii: 6573214. doi: 10.1093.
    PubMed    


  64. HASAN B, Ur Rahman A
    Ulcerative Colitis and Diverticulitis Are Possibly Connected to the Same Hub.
    Inflamm Bowel Dis. 2022 Apr 23. pii: 6573283. doi: 10.1093.
    PubMed    


  65. MAO R, Ng SC, Chen M
    Network Clinical Collaboration to Improve Quality of Care of Patients with Inflammatory Bowel Disease in China.
    Inflamm Bowel Dis. 2022 Apr 20. pii: 6571486. doi: 10.1093.
    PubMed    


  66. MIKOLAJCZYK AE, Cohen NA, Watson S, Ackerman M, et al
    Assessment of the Degree of Variation of Histologic Inflammation in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Apr 18. pii: 6569959. doi: 10.1093.
    PubMed     Abstract available


  67. ZIV Y, Swaminath A, Sultan K
    Patient With Ulcerative Colitis and Failure of Ustekinumab Responds to Risankizumab: Similar Is Not Identical.
    Inflamm Bowel Dis. 2022 Apr 13. pii: 6568039. doi: 10.1093.
    PubMed    


  68. LI D, Xu A, Mengesha E, Elyanow R, et al
    The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy.
    Inflamm Bowel Dis. 2022 Apr 9. pii: 6565880. doi: 10.1093.
    PubMed    


  69. SEONG G, Song JH, Kim JE, Kim TJ, et al
    Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1.
    Inflamm Bowel Dis. 2022 Apr 9. pii: 6565877. doi: 10.1093.
    PubMed     Abstract available


  70. SCHELL TL, Knutson KL, Saha S, Wald A, et al
    Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 9. pii: 6565876. doi: 10.1093.
    PubMed    


  71. MASUTA Y, Watanabe T, Minaga K, Kudo M, et al
    Reply to Response to "'A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses After COVID-19 Vaccination'" by Mungmunpuntipantip and Wiwanitkiton.
    Inflamm Bowel Dis. 2022 Apr 8. pii: 6565439. doi: 10.1093.
    PubMed    


  72. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    Ulcerative Colitis Relapse After COVID-19 Vaccination: Correspondence.
    Inflamm Bowel Dis. 2022 Apr 8. pii: 6565438. doi: 10.1093.
    PubMed    


  73. VALENTIN S, Renel B, Manneville F, Caron B, et al
    Prevalence of and Factors Associated with Respiratory Symptoms Among Patients with Inflammatory Bowel Disease: A Prospective Study.
    Inflamm Bowel Dis. 2022 Apr 8. pii: 6565436. doi: 10.1093.
    PubMed     Abstract available


  74. MACALUSO FS, Giuliano A, Fries W, Viola A, et al
    Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
    Inflamm Bowel Dis. 2022 Apr 6. pii: 6564282. doi: 10.1093.
    PubMed     Abstract available


  75. KUANG R, O'Keefe SJD, Ramos Del Aguila de Rivers C, Koutroumpakis F, et al
    Is Salt at Fault? Dietary Salt Consumption and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 5. pii: 6563753. doi: 10.1093.
    PubMed     Abstract available


  76. DUBINSKY MC, Magro F, Steinwurz F, Hudesman DP, et al
    Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program.
    Inflamm Bowel Dis. 2022 Apr 5. pii: 6563756. doi: 10.1093.
    PubMed     Abstract available


  77. AGRAWAL M, Petralia F, Tepler A, Durbin L, et al
    Gender-Based Differences in Response to Tumor Necrosis Factor Inhibitor Therapies for Ulcerative Colitis: Individual Participant Data Meta-Analyses of Clinical Trials.
    Inflamm Bowel Dis. 2022 Apr 2. pii: 6562696. doi: 10.1093.
    PubMed     Abstract available


  78. BERGAMASCHI G, Castiglione F, D'Inca R, Astegiano M, et al
    Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study.
    Inflamm Bowel Dis. 2022 Apr 2. pii: 6562695. doi: 10.1093.
    PubMed     Abstract available


  79. ZHANG W, Scalori A, Fuh F, McBride J, et al
    Correction to: Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized Trial.
    Inflamm Bowel Dis. 2022 Apr 2. pii: 6562694. doi: 10.1093.
    PubMed    


  80. FAYE AS, Dodson JA, Shaukat A
    Sarcopenia as a Risk Prediction Tool in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Apr 2. pii: 6562699. doi: 10.1093.
    PubMed    


    March 2022
  81. COATES MD, Ba DM, Liu G, Dalessio S, et al
    Response to the Letter to the Editor: "Re-Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease".
    Inflamm Bowel Dis. 2022 Mar 31. pii: 6561784. doi: 10.1093.
    PubMed    


  82. PATIL SA, Bhat S, Limdi JK, Farraye FA, et al
    The Sincerest Form of Flattery? Biosimilars in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Mar 30. pii: 6556005. doi: 10.1093.
    PubMed    


  83. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    Response to: COVID-19 Vaccination, Willingness, Hesitancy, and Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2022;28:e45.
    PubMed    


  84. COSTANTINO A, Noviello D, Costantino C, Vecchi M, et al
    Letter of Reply to "Response to: COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association".
    Inflamm Bowel Dis. 2022;28:e57-e58.
    PubMed    


  85. SCHRODER AL, Chami B, Liu Y, Doyle CM, et al
    Neutrophil Extracellular Trap Density Increases With Increasing Histopathological Severity of Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:586-598.
    PubMed     Abstract available


  86. CHANDRASEKHARAN B, Boyer D, Owens JA, Wolfarth AA, et al
    Intracolonic Neuropeptide Y Y1 Receptor Inhibition Attenuates Intestinal Inflammation in Murine Colitis and Cytokine Release in IBD Biopsies.
    Inflamm Bowel Dis. 2022;28:502-513.
    PubMed     Abstract available


  87. LIGHTNER AL, Buhulaigah H, Zaghiyan K, Holubar SD, et al
    Is Intestinal Diversion an Effective Treatment for Distal Crohn's Disease?
    Inflamm Bowel Dis. 2022;28:547-552.
    PubMed     Abstract available


  88. LAWRENCE LS, Heider A, Singer AAM, Neef HC, et al
    Granulomas in Diagnostic Biopsies Associated With High Risk of Crohn's Complications-But May Be Preventable.
    Inflamm Bowel Dis. 2022;28:523-530.
    PubMed     Abstract available


  89. GANDHI S, Zelman S, De Armas RE, Hemond C, et al
    Natural History of New-onset Inflammatory Bowel Disease Among Patients With Multiple Sclerosis.
    Inflamm Bowel Dis. 2022 Mar 26. pii: 6554576. doi: 10.1093.
    PubMed    


  90. DASHARATHY SS, Long MD, Lackner JM, Ben-Ami Shor D, et al
    Psychological Factors Associated With Adherence to Oral Treatment in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Mar 24. pii: 6553867. doi: 10.1093.
    PubMed     Abstract available


  91. GREYWOODE R, Ullman T, Keefer L
    National Prevalence of Psychological Distress and Use of Mental Health Care in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Mar 24. pii: 6553591. doi: 10.1093.
    PubMed     Abstract available


  92. RANA T
    Influence and Implications of the Molecular Paradigm of Nitric Oxide Underlying Inflammatory Reactions of the Gastrointestinal Tract of Dog: A Major Hallmark of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Mar 21. pii: 6551624. doi: 10.1093.
    PubMed     Abstract available


  93. PETERSON AR, Srinivasan A, Proud D, Jackett L, et al
    Synchronous Multifocal Adenomatous Dysplasia and Post-transplant Lymphoproliferative Disorder Confined to the Colon in a Patient with Ulcerative Colitis After Liver Transplant.
    Inflamm Bowel Dis. 2022 Mar 15. pii: 6548883. doi: 10.1093.
    PubMed    


  94. CHRISTENSEN B, Prentice RE, Al-Ani AH, Zhang E, et al
    Self-Reported Failure to Address Sexual Function in Patients With Inflammatory Bowel Disease by Gastroenterologists: Barriers and Areas for Improvement.
    Inflamm Bowel Dis. 2022 Mar 14. pii: 6548311. doi: 10.1093.
    PubMed    


  95. NOGUCHI T, Ando T, Emoto S, Nozawa H, et al
    Artificial Intelligence Program to Predict p53 Mutations in Ulcerative Colitis-Associated Cancer or Dysplasia.
    Inflamm Bowel Dis. 2022 Mar 12. pii: 6547691. doi: 10.1093.
    PubMed     Abstract available


  96. HAASNOOT ML, Mookhoek A, Duijvestein M, D'Haens GRAM, et al
    Prognostic Value of Colonic Tissue and Blood Eosinophils in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Mar 11. pii: 6547139. doi: 10.1093.
    PubMed     Abstract available


  97. PETER I, Dubinsky M, Xuan S, Chen N, et al
    Letter to the Editor: Re-Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease.
    Inflamm Bowel Dis. 2022 Mar 10. pii: 6546455. doi: 10.1093.
    PubMed    


  98. SHEN J, Liang J, Mao R, Ran Z, et al
    Secondary Indicators for an Evaluation and Guidance System for Quality of Care in Inflammatory Bowel Disease Centers: A Critical Review of the Inflammatory Bowel Disease Quality of Care Center.
    Inflamm Bowel Dis. 2022 Mar 5. pii: 6542945. doi: 10.1093.
    PubMed     Abstract available


  99. OZSOY M, Stummer N, Zimmermann FA, Feichtinger RG, et al
    Role of Energy Metabolism and Mitochondrial Function in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Mar 5. pii: 6542923. doi: 10.1093.
    PubMed     Abstract available


  100. SPIERA E, Ganjian DY, Zhang X, Brenner EJ, et al
    Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry.
    Inflamm Bowel Dis. 2022 Mar 3. pii: 6541762. doi: 10.1093.
    PubMed    


  101. HUDHUD D, Caldera F, Cross RK
    Addressing COVID-19 Vaccine Hesitancy in Patients with IBD.
    Inflamm Bowel Dis. 2022;28:492-493.
    PubMed    


  102. COSTANTINO A, Noviello D, Conforti FS, Aloi M, et al
    COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.
    Inflamm Bowel Dis. 2022;28:474-478.
    PubMed    


  103. YU B, Lin C, Yang Y, Yang YF, et al
    Spontaneous Perforation in Crohn's Disease: A Report of Two Cases.
    Inflamm Bowel Dis. 2022;28:e40-e42.
    PubMed    


  104. RAGHAVA RG, Sharma V, Malegaonkar SK, Dhooria S, et al
    Tracheobronchial Crohn's Disease: Case Report and Systematic Review of the Literature.
    Inflamm Bowel Dis. 2022;28:e33-e35.
    PubMed    


  105. SOFIA C, Adiletta V, Iovene B, Sgalla G, et al
    Acute Respiratory Distress Syndrome and Lung Fibrosis Complicating Surgery in a Patient With Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e31-e32.
    PubMed    


  106. DULANEY D, Dave P, Walsh S, Mehandru S, et al
    Noninfectious Pulmonary Complications Associated With Anti-Integrin Therapy: A Case Report and Systematic Review of the Literature.
    Inflamm Bowel Dis. 2022;28:479-483.
    PubMed    


  107. NICOLETTI F, Hammer L, Furtado S, Mangano K, et al
    Oral Delivery of Encapsulated All-Trans Retinoic Acid Ameliorates Disease in Rodent Models of Colitis.
    Inflamm Bowel Dis. 2022;28:455-465.
    PubMed     Abstract available


  108. BISCAGLIA G, Latiano A, Castellana S, Fontana R, et al
    Germline Alterations in Patients With IBD-associated Colorectal Cancer.
    Inflamm Bowel Dis. 2022;28:447-454.
    PubMed     Abstract available


  109. MARK-CHRISTENSEN A, Lange A, Erichsen R, Froslev T, et al
    Early-Life Exposure to Antibiotics and Risk for Crohn's Disease: A Nationwide Danish Birth Cohort Study.
    Inflamm Bowel Dis. 2022;28:415-422.
    PubMed     Abstract available


  110. BENNETT A, Mamunes A, Kim M, Duley C, et al
    The Importance of Monitoring the Postpartum Period in Moderate to Severe Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:409-414.
    PubMed     Abstract available


  111. SINGH S, Qian AS, Nguyen NH, Ho SKM, et al
    Trends in U.S. Health Care Spending on Inflammatory Bowel Diseases, 1996-2016.
    Inflamm Bowel Dis. 2022;28:364-372.
    PubMed     Abstract available


  112. WHITE BA, Ramos GP, Kane S
    The Impact of Alcohol in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2022;28:466-473.
    PubMed     Abstract available


  113. YADAV A, Jena A, Arpitha K, Shah J, et al
    Colon Cancer in Ulcerative Colitis: A Mimicker of a Flare of Disease.
    Inflamm Bowel Dis. 2022 Mar 1. pii: 6540315. doi: 10.1093.
    PubMed    


  114. SHEEHAN JL, Jacob J, Berinstein EM, Greene-Higgs L, et al
    The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2022 Mar 1. pii: 6540317. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  115. MASUTA Y, Watanabe T, Minaga K, Kudo M, et al
    A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses after COVID-19 Vaccination.
    Inflamm Bowel Dis. 2022 Feb 26. pii: 6537472. doi: 10.1093.
    PubMed    


  116. LAMERS CR, de Roos NM, Heerink HH, van de Worp-Kalter LA, et al
    Lower Impact of Disease on Daily Life and Less Fatigue in Patients With Inflammatory Bowel Disease Following a Lifestyle Intervention.
    Inflamm Bowel Dis. 2022 Feb 25. pii: 6536898. doi: 10.1093.
    PubMed     Abstract available


  117. GROSEN A, Bellaguarda E, Liljeqvist-Soltic I, Mejlby Hansen M, et al
    Normal Sperm DNA Integrity in Patients With Inflammatory Bowel Disease on Ustekinumab Maintenance Therapy.
    Inflamm Bowel Dis. 2022 Feb 25. pii: 6536901. doi: 10.1093.
    PubMed    


  118. QUERA R, Nunez F P, Flores L
    SARS-CoV-2 Infection in the Follow-Up of a Population With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Feb 22. pii: 6534444. doi: 10.1093.
    PubMed    


  119. VALDES DELGADO T, Barranco Castro D, Arguelles Arias F
    Cap-Polyposis: A Cause of Treatment Failure in Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Feb 22. pii: 6534443. doi: 10.1093.
    PubMed    


  120. PHILIPPOU A, Birhanu B, Biello A, Keefer L, et al
    A Mixed-methods Assessment of the Impact of Insurance Issues on the Emotional and Physical Health of Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Feb 22. pii: 6534445. doi: 10.1093.
    PubMed     Abstract available


  121. KAYAL M, Kohler D, Plietz M, Khaitov S, et al
    Early Pouchitis Is Associated With Crohn's Disease-like Pouch Inflammation in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Feb 21. pii: 6533541. doi: 10.1093.
    PubMed     Abstract available


  122. CAMPBELL JP, Teigen L, Manski S, Blumhof B, et al
    Sarcopenia Is More Prevalent Among Inflammatory Bowel Disease Patients Undergoing Surgery and Predicts Progression to Surgery Among Medically Treated Patients.
    Inflamm Bowel Dis. 2022 Feb 15. pii: 6528831. doi: 10.1093.
    PubMed     Abstract available


  123. BOYD T, Winter RW, Winter HS, Kissous-Hunt M, et al
    Provider Knowledge and Recommendations Regarding Ileoanal Pouch Surgery and Fertility in Women with Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Feb 15. pii: 6528828. doi: 10.1093.
    PubMed    


  124. BERBISA MAF, Nielsen KR, Ingham AC, Midjord J, et al
    Similar Gut Bacterial Composition Between Patients With Ulcerative Colitis and Healthy Controls in a High Incidence Population: A Cross-sectional Study of the Faroe Islands IBD Cohort.
    Inflamm Bowel Dis. 2022 Feb 9. pii: 6524838. doi: 10.1093.
    PubMed     Abstract available


  125. XIE Y, Li H, Zhou L, Tian F, et al
    A Case of Vedolizumab-induced Acute Allergic Reaction in a Patient With Refractory Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Feb 4. pii: 6522051. doi: 10.1093.
    PubMed    


  126. CHONGSRISAWAT V, Suratannon N, Chatchatee P, Ittiwut R, et al
    Novel CD55 Mutation Associated With Severe Small Bowel Ulceration Mimicking Inflammatory Bowel Disease in a Pair of Siblings.
    Inflamm Bowel Dis. 2022 Feb 4. pii: 6522222. doi: 10.1093.
    PubMed    


  127. THOMAS PWA, den Broeder N, Derikx M, Kievit W, et al
    Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study.
    Inflamm Bowel Dis. 2022 Feb 4. pii: 6522042. doi: 10.1093.
    PubMed     Abstract available


  128. BOKEMEYER B, Picker N, Wilke T, Rosin L, et al
    Inadequate Response, Treatment Patterns, Health Care Utilization, and Associated Costs in Patients With Ulcerative Colitis: Retrospective Cohort Study Based on German Claims Data.
    Inflamm Bowel Dis. 2022 Feb 4. pii: 6522041. doi: 10.1093.
    PubMed     Abstract available


  129. MOGHADAM P, Dumas M, Blum L, Gimenez I, et al
    Atypical Orofacial Granulomatosis Associated With Bowel Relapse in an Adult With Crohn's Disease Under Anti-TNF Therapy.
    Inflamm Bowel Dis. 2022;28:e25-e26.
    PubMed    


  130. JOHNSON S, Ko J, Halabi WJ, Stondell J, et al
    Fistula Healing Is Low After Fecal Diversion Surgery in Perianal Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e17.
    PubMed    


  131. UENO A, Jijon HB, Peng R, Sparksman S, et al
    Association of Circulating Fibrocytes With Fibrostenotic Small Bowel Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:246-258.
    PubMed     Abstract available


  132. LEE SD, Singla A, Harper J, Barahimi M, et al
    Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:309-313.
    PubMed     Abstract available


  133. WIEGHARD NEK
    The Difficulty of Distal Crohn's Disease and the Utility of Diverting Stomas.
    Inflamm Bowel Dis. 2022;28:325-326.
    PubMed    


  134. ALRIC H, Amiot A, Kirchgesner J, Treton X, et al
    Vedolizumab Clinical Decision Support Tool Predicts Efficacy of Vedolizumab But Not Ustekinumab in Refractory Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:218-225.
    PubMed     Abstract available


  135. ADLER J, Lee GJ, Singer AAM
    Do Not Stop Anti-TNF Medications in Children With IBD When They Are Working.
    Inflamm Bowel Dis. 2022;28:322-324.
    PubMed    


  136. LIEFFERINCKX C, Bottieau J, Toubeau JF, Thomas D, et al
    Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2022;28:208-217.
    PubMed     Abstract available


    January 2022
  137. TANDON P, Lee E, Jogendran R, Kroeker KI, et al
    Breastfeeding Patterns in Mothers with Inflammatory Bowel Disease: A Pilot Prospective Longitudinal Study.
    Inflamm Bowel Dis. 2022 Jan 31. pii: 6517873. doi: 10.1093.
    PubMed     Abstract available


  138. GUZZO GL, Andrews JM, Weyrich LS
    The Neglected Gut Microbiome: Fungi, Protozoa, and Bacteriophages in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jan 29. pii: 6517341. doi: 10.1093.
    PubMed     Abstract available


  139. HE ZX, Wang SL, Zhao SB, Li ZS, et al
    An Unusual Case of Hypernatremia in Patient With Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Jan 29. pii: 6517203. doi: 10.1093.
    PubMed    


  140. DA LUZ MOREIRA A, de Campos Lobato LF, de Lima Moreira JP, Luiz RR, et al
    Geosocial Features and Loss of Biodiversity Underlie Variable Rates of Inflammatory Bowel Disease in a Large Developing Country: A Population-Based Study.
    Inflamm Bowel Dis. 2022 Jan 28. pii: 6516702. doi: 10.1093.
    PubMed     Abstract available


  141. TARABAR D, El Jurdi K, Traboulsi C, Yvellez O, et al
    A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab.
    Inflamm Bowel Dis. 2022 Jan 25. pii: 6515101. doi: 10.1093.
    PubMed     Abstract available


  142. SEDANO R, Hogan M, McDonald C, Aswani-Omprakash T, et al
    Underrepresentation of Minorities and Lack of Race Reporting in Ulcerative Colitis Drug Development Clinical Trials.
    Inflamm Bowel Dis. 2022 Jan 25. pii: 6515239. doi: 10.1093.
    PubMed    


  143. LEBER A, Hontecillas R, Tubau-Juni N, Lichtiger S, et al
    WITHDRAWN: EFFICACY, SAFETY, AND TOLERABILITY OF OMILANCOR IN A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PATIENTS WITH ULCERATIVE COLITIS.
    Inflamm Bowel Dis. 2022;28.
    PubMed     Abstract available


  144. PETERSON AR, Hilley P, De Cruz P
    Combination Tofacitinib and Calcineurin Inhibitor in the Management of Treatment-Refractory Ulcerative Colitis May Be Effective, But Is It Necessary?
    Inflamm Bowel Dis. 2022 Jan 19. pii: 6511711. doi: 10.1093.
    PubMed    


  145. COWHERD E, Egberg MD, Kappelman MD, Zhang X, et al
    The Cumulative Incidence of Pouchitis in Pediatric Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Jan 18. pii: 6510907. doi: 10.1093.
    PubMed     Abstract available


  146. RUNDE J, Erondu A, Akiyama S, Traboulsi C, et al
    Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Jan 18. pii: 6510906. doi: 10.1093.
    PubMed     Abstract available


  147. MASSIMINO L, Spano S, Lamparelli LA, Fuggetta D, et al
    Tofacitinib Inhibits Leukocyte Trafficking Across the Intestinal Endothelial Barrier in a Specific Cohort of Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2022 Jan 15. pii: 6507842. doi: 10.1093.
    PubMed    


  148. KAPLAN GG, Underwood FE, Coward S, Agrawal M, et al
    The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis.
    Inflamm Bowel Dis. 2022 Jan 15. pii: 6507839. doi: 10.1093.
    PubMed     Abstract available


  149. LEWIS JD, Cross RK, Long M, Singh S, et al
    High Degree of Practice Variability in Colonic Dysplasia Surveillance for Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jan 11. pii: 6503739. doi: 10.1093.
    PubMed    


  150. KIM SC
    Sudden-Onset Polyposis in Pediatric Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2022 Jan 11. pii: 6503738. doi: 10.1093.
    PubMed    


  151. CUSHING KC, Du X, Chen Y, Stetson LC, et al
    Inflammatory Bowel Disease Risk Variants Are Associated with an Increased Risk of Skin Cancer.
    Inflamm Bowel Dis. 2022 Jan 8. pii: 6501204. doi: 10.1093.
    PubMed     Abstract available


  152. PARK J, Kang SJ, Yoon H, Park J, et al
    Histologic Evaluation Using the Robarts Histopathology Index in Patients With Ulcerative Colitis in Deep Remission and the Association of Histologic Remission With Risk of Relapse.
    Inflamm Bowel Dis. 2022 Jan 7. pii: 6500768. doi: 10.1093.
    PubMed     Abstract available


  153. PRENTICE R, Wright EK, Flanagan E, Ross AL, et al
    The Use of Fecal Calprotectin and Intestinal Ultrasound in the Evaluation and Management of Stricturing Crohn's Disease in Pregnancy.
    Inflamm Bowel Dis. 2022;28:e13-e16.
    PubMed    


  154. WEI Y, Yang W, Mei Q
    Detection of a Novel Antigen for Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e5-e6.
    PubMed    


  155. WEN HZ, He ZH, Li PH, Zhao QF, et al
    Gluteal Sinus Presenting as the Initial Symptom in a Patient With Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:e11-e12.
    PubMed    


  156. NAZARI H, Naei VY, Tabasi AH, Badripour A, et al
    Advanced Regenerative Medicine Strategies for Treatment of Perianal Fistula in Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:133-142.
    PubMed     Abstract available


  157. DALAL RS, Gupta S, Goodrick H, Mitri J, et al
    Outcomes of Standard and Intensified Dosing of Ustekinumab for Chronic Pouch Disorders.
    Inflamm Bowel Dis. 2022;28:146-149.
    PubMed    


  158. BOUCHER G, Paradis A, Chabot-Roy G, Coderre L, et al
    Serum Analyte Profiles Associated With Crohn's Disease and Disease Location.
    Inflamm Bowel Dis. 2022;28:9-20.
    PubMed     Abstract available


  159. FAYE AS, Colombel JF
    Aging and IBD: A New Challenge for Clinicians and Researchers.
    Inflamm Bowel Dis. 2022;28:126-132.
    PubMed     Abstract available


  160. JOUSTRA V, Duijvestein M, Mookhoek A, Bemelman W, et al
    Natural History and Risk Stratification of Recurrent Crohn's Disease After Ileocolonic Resection: A Multicenter Retrospective Cohort Study.
    Inflamm Bowel Dis. 2022;28:1-8.
    PubMed     Abstract available


  161. TAPETE G, Bertani L, Pieraccini A, Lynch EN, et al
    Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry.
    Inflamm Bowel Dis. 2022;28:62-69.
    PubMed     Abstract available


  162. BERMEJO F, Jimenez L, Algaba A, Vela M, et al
    Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.
    Inflamm Bowel Dis. 2022;28:41-47.
    PubMed     Abstract available


  163. LIU J, Ge X, Ouyang C, Wang D, et al
    Prevalence of Malnutrition, Its Risk Factors, and the Use of Nutrition Support in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jan 4. pii: 6497520. doi: 10.1093.
    PubMed     Abstract available


  164. YANG H, Qian J
    Current status of cytomegalovirus colitis among patients with inflammatory bowel disease in China: A questionnaire-based multi-center study.
    Inflamm Bowel Dis. 2022 Jan 4. pii: 6497521. doi: 10.1093.
    PubMed     Abstract available


  165. ASHTON JJ, Boukas K, Stafford IS, Cheng G, et al
    Deleterious Genetic Variation Across the NOD Signaling Pathway Is Associated With Reduced NFKB Signaling Transcription and Upregulation of Alternative Inflammatory Transcripts in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Jan 3. pii: 6492639. doi: 10.1093.
    PubMed     Abstract available


  166. LARSEN MD, Norgard BM, Kjeldsen J
    Does Disease Activity After Induction Treatment With Biologics Predict Short-Term Outcome in Crohn's Disease and Ulcerative Colitis?
    Inflamm Bowel Dis. 2022 Jan 3. pii: 6491898. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  167. FANG L, Gao H, Gao X, Wu W, et al
    Risks of Cardiovascular Events in Patients with Inflammatory Bowel Disease in China: A Retrospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2021 Dec 30. pii: 6490203. doi: 10.1093.
    PubMed     Abstract available


  168. DULAI PS, Wong ECL, Reinisch W, Colombel JF, et al
    Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab.
    Inflamm Bowel Dis. 2021 Dec 30. pii: 6490022. doi: 10.1093.
    PubMed     Abstract available


  169. MEISINGER C, Freuer D
    Causal Association Between Atopic Dermatitis and Inflammatory Bowel Disease: A 2-Sample Bidirectional Mendelian Randomization Study.
    Inflamm Bowel Dis. 2021 Dec 29. pii: 6488545. doi: 10.1093.
    PubMed     Abstract available


  170. SANDBORN WJ, Armuzzi A, Liguori G, Irving PM, et al
    Predictors of Sustained Response With Tofacitinib Therapy in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Dec 27. pii: 6484790. doi: 10.1093.
    PubMed     Abstract available


  171. SHAH R, Elangovan A, Jordan DW, Katz J, et al
    10-Year Trend of Abdominal Magnetic Resonance Imaging Compared With Abdominal Computed Tomography Scans in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Dec 22. pii: 6479634. doi: 10.1093.
    PubMed     Abstract available


  172. SINGH AK, Sasani A, Dhamor D, Jena A, et al
    Surgical Management of Medical Refractory Acute Severe Ulcerative Colitis in Immune Thrombocytopenic Purpura: Killing Two Birds With One Stone.
    Inflamm Bowel Dis. 2021 Dec 20. pii: 6470737. doi: 10.1093.
    PubMed    


  173. ELIA JR, Beck KR
    The Importance of Physical Activity and Structured Exercise Distinction and Analysis-Response to "Physical Activity in Patients with Inflammatory Bowel Disease: A Narrative Review".
    Inflamm Bowel Dis. 2021 Dec 18. pii: 6469656. doi: 10.1093.
    PubMed    


  174. SHIMODAIRA Y, Watanabe K, Takahashi S, Koizumi S, et al
    Inflammatory Bowel Disease Triggered by BNT162b2 mRNA Vaccination for SARS-CoV-2.
    Inflamm Bowel Dis. 2021 Dec 18. pii: 6469651. doi: 10.1093.
    PubMed    


  175. HILL JE, Pena-Sanchez JN, Fernando C, Freitas AC, et al
    Composition and Stability of the Vaginal Microbiota of Pregnant Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Dec 17. pii: 6468817. doi: 10.1093.
    PubMed     Abstract available


  176. RAMAN M, Reimer RA, Ghosh S, Vallance J, et al
    The Importance of Physical Activity in Patients With Inflammatory Bowel Disease: A Narrative Review.
    Inflamm Bowel Dis. 2021 Dec 17. pii: 6468793. doi: 10.1093.
    PubMed    


  177. BAMIAS G, Pizarro TT, Cominelli F
    Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Dec 14. pii: 6460699. doi: 10.1093.
    PubMed     Abstract available


  178. YANG L, Song X, Chen Y, Li Y, et al
    Treatment Decision-making in Chinese Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 Dec 11. pii: 6459488. doi: 10.1093.
    PubMed     Abstract available


  179. TSE CS, Siegel CA, Weaver SA, Oliver BJ, et al
    Health Confidence Is Associated With Disease Outcomes and Health Care Utilization in Inflammatory Bowel Disease: A Nationwide Cross-sectional Study.
    Inflamm Bowel Dis. 2021 Dec 10. pii: 6459204. doi: 10.1093.
    PubMed     Abstract available


  180. JENA A, Sachan A, Singh AK, Sharma V, et al
    Multifocal Pyoderma Gangrenosum at Presentation in a Patient With Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Dec 10. pii: 6459194. doi: 10.1093.
    PubMed    


  181. WAN Y, Yang L, Jiang S, Qian D, et al
    Excessive Apoptosis in Ulcerative Colitis: Crosstalk Between Apoptosis, ROS, ER Stress, and Intestinal Homeostasis.
    Inflamm Bowel Dis. 2021 Dec 6. pii: 6454294. doi: 10.1093.
    PubMed     Abstract available


  182. WEAVER KN, Zhang X, Dai X, Watkins R, et al
    Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
    Inflamm Bowel Dis. 2021 Dec 6. pii: 6454297. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  183. LEITE-GOMES E, Dias AM, Azevedo CM, Santos-Pereira B, et al
    Bringing to Light the Risk of Colorectal Cancer in Inflammatory Bowel Disease: Mucosal Glycosylation as a Key Player.
    Inflamm Bowel Dis. 2021 Nov 29. pii: 6446097. doi: 10.1093.
    PubMed     Abstract available


  184. SUN Y, Geng J, Chen X, Chen H, et al
    Association Between Inflammatory Bowel Disease and Dementia: A Longitudinal Cohort Study.
    Inflamm Bowel Dis. 2021 Nov 29. pii: 6445975. doi: 10.1093.
    PubMed     Abstract available


  185. CERNA K, Duricova D, Lukas M, Machkova N, et al
    Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study.
    Inflamm Bowel Dis. 2021 Nov 29. pii: 6445976. doi: 10.1093.
    PubMed     Abstract available


  186. ZHANG W, Scalori A, Fuh F, McBride J, et al
    Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized Trial.
    Inflamm Bowel Dis. 2021 Nov 29. pii: 6446094. doi: 10.1093.
    PubMed     Abstract available


  187. BIRDA CL, Agarwal A, Goyal A
    A Rare Case of Hearing Loss in a Patient With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Nov 24. pii: 6438178. doi: 10.1093.
    PubMed    


  188. DESALERMOS A, Pimienta M, Kalligeros M, Shehadeh F, et al
    Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2021 Nov 24. pii: 6438176. doi: 10.1093.
    PubMed     Abstract available


  189. KJELDSEN S, Nielsen J, Mertz Norgard B, Kjeldsen J, et al
    Mesalazine in Inflammatory Bowel Disease and COVID-19: Hospitalization and Adverse In-Hospital Outcomes Based on Nationwide Data.
    Inflamm Bowel Dis. 2021 Nov 24. pii: 6438420. doi: 10.1093.
    PubMed     Abstract available


  190. WESTBERG K, Olen O, Soderling J, Bengtsson J, et al
    Primary Versus Staged Reconstruction and Risk of Surgical Failure in Patients With Ulcerative Colitis: a Nation-wide Cohort Study.
    Inflamm Bowel Dis. 2021 Nov 18. pii: 6430979. doi: 10.1093.
    PubMed     Abstract available


  191. SACHAN A, Singh AK
    Reply to Response to "Strongyloides stercoralis in Acute Severe Ulcerative Colitis-A Triggering Nuisance or an Opportunistic Bystander?" by Hokama et al.
    Inflamm Bowel Dis. 2021 Nov 15. pii: 6428578. doi: 10.1093.
    PubMed    


  192. PAPALIA I, Tjandra D, Quah S, Tan C, et al
    Colon Capsule Endoscopy in the Assessment of Mucosal Healing in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  193. LI Y, Chen J, Bolinger AA, Chen H, et al
    Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  194. HONIG G, Larkin PB, Heller C, Hurtado-Lorenzo A, et al
    Research-Based Product Innovation to Address Critical Unmet Needs of Patients with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  195. MOTTA JP, Deraison C, Le Grand S, Le Grand B, et al
    PAR-1 Antagonism to Promote Gut Mucosa Healing in Crohn's Disease Patients: A New Avenue for CVT120165.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  196. YAU YY, Wasinger VC, Hirten RP, Chuang E, et al
    Current Trends in IBD-Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  197. BUSQUETS D, Oliver L, Amoedo J, Ramio-Pujol S, et al
    RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment.
    Inflamm Bowel Dis. 2021;27.
    PubMed     Abstract available


  198. TANG J, Huang Z, Guo H, Chao K, et al
    Unexpected Liver Lesions in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e161-e162.
    PubMed    


  199. BORGHINI R, Villanacci V, Oberti A, Caronna R, et al
    Long-term Effects of Teduglutide on Intestinal Mucosa in a Patient With Crohn's Disease and Short Bowel Syndrome: Clinical, Endoscopic and Histological Data Compared.
    Inflamm Bowel Dis. 2021;27:e152-e153.
    PubMed    


  200. DAR ANTAKI L, Volkov A, Ben-Horin S
    Cytomegalovirus Limited to the Rectum in an Immunosuppressed IBD Patient.
    Inflamm Bowel Dis. 2021;27:e154-e155.
    PubMed    


  201. ALLEGRETTI JR, Canakis A, McClure E, Marcus J, et al
    Infliximab De-escalation in Patients With Crohn's Disease in Clinical Remission Is Safe and Well-tolerated.
    Inflamm Bowel Dis. 2021;27:2031-2033.
    PubMed    


  202. AGUILAR D, Revilla L, Garrido-Trigo A, Panes J, et al
    Randomized Controlled Trial Substudy of Cell-specific Mechanisms of Janus Kinase 1 Inhibition With Upadacitinib in the Crohn's Disease Intestinal Mucosa: Analysis From the CELEST Study.
    Inflamm Bowel Dis. 2021;27:1999-2009.
    PubMed     Abstract available


  203. GHAFARI-SARAVI A, Rabizadeh S, Dubovsky A, Miller S, et al
    Technical Issues Are a Major Determinant of Patient Satisfaction in Virtual Visits for Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:2034-2037.
    PubMed    


  204. SOMINENI HK, Weitzner JH, Venkateswaran S, Dodd A, et al
    Site- and Taxa-Specific Disease-Associated Oral Microbial Structures Distinguish Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:1889-1900.
    PubMed     Abstract available


  205. MANZINI R, Schwarzfischer M, Atrott K, Laimbacher A, et al
    Combination of Vedolizumab With Tacrolimus Is More Efficient Than Vedolizumab Alone in the Treatment of Experimental Colitis.
    Inflamm Bowel Dis. 2021;27:1986-1998.
    PubMed     Abstract available


  206. WANG MH, Friton JJ, Raffals LE, Leighton JA, et al
    Novel Genetic Variant Predicts Surgical Recurrence Risk in Crohn's Disease Patients.
    Inflamm Bowel Dis. 2021;27:1968-1974.
    PubMed     Abstract available


  207. FLANAGAN E, Wright EK, Sparrow MP, Moore GT, et al
    A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive.
    Inflamm Bowel Dis. 2021;27:1909-1918.
    PubMed     Abstract available


  208. KIM J, Yoon H, Kim N, Lee KM, et al
    Clinical Outcomes and Response Predictors of Vedolizumab Induction Treatment for Korean Patients With Inflammatory Bowel Diseases Who Failed Anti-TNF Therapy: A KASID Prospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2021;27:1931-1941.
    PubMed     Abstract available


  209. TRIPODI A, Spina L, Pisani LF, Padovan L, et al
    Anti-TNF-alpha Treatment Reduces the Baseline Procoagulant Imbalance of Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:1901-1908.
    PubMed     Abstract available


  210. HANZEL J, Dreesen E, Vermeire S, Lowenberg M, et al
    Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study.
    Inflamm Bowel Dis. 2021 Nov 12. pii: 6426108. doi: 10.1093.
    PubMed    


  211. HOKAMA A, Fujita J
    Response to "Strongyloides stercoralis in Acute Severe Ulcerative Colitis-A Triggering Nuisance or an Opportunistic Bystander?"
    Inflamm Bowel Dis. 2021 Nov 12. pii: 6426022. doi: 10.1093.
    PubMed    


  212. LUTZ MK, Matthews LA, Tuan WJ, Caldera F, et al
    Did You Get My Message? Trends and Predictors of Inflammatory Bowel Disease Patient-to-Provider Electronic Messaging.
    Inflamm Bowel Dis. 2021 Nov 10. pii: 6425060. doi: 10.1093.
    PubMed    


  213. JAGT JZ, Struys EA, Ayada I, Bakkali A, et al
    Fecal Amino Acid Analysis in Newly Diagnosed Pediatric Inflammatory Bowel Disease: A Multicenter Case-Control Study.
    Inflamm Bowel Dis. 2021 Nov 10. pii: 6425057. doi: 10.1093.
    PubMed     Abstract available


  214. JENA A, Singh AK, Siddharda BV, Panda P, et al
    Mesalamine-Induced Perimyocarditis: Rare Adverse Event in a Patient With Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Nov 9. pii: 6425058. doi: 10.1093.
    PubMed    


  215. ZHANG S, Chen F, Wu J, Liu C, et al
    Regional Gray Matter Volume Changes in Brains of Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Nov 3. pii: 6420319. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  216. TRIPATHI K, Godoy Brewer G, Thu Nguyen M, Singh Y, et al
    COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2021 Oct 27. pii: 6412576. doi: 10.1093.
    PubMed     Abstract available


  217. DAI C, Huang YH, Jiang M
    Successful Treatment of Ulcerative Colitis, Rectovaginal Fistula, and Skin Erythema Nodule With Adalimumab.
    Inflamm Bowel Dis. 2021 Oct 27. pii: 6412248. doi: 10.1093.
    PubMed    


  218. KING D, Chandan JS, Thomas T, Nirantharakumar K, et al
    The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021;27:1731-1739.
    PubMed     Abstract available


  219. SPENCER EA, Klang E, Dolinger M, Pittman N, et al
    Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients.
    Inflamm Bowel Dis. 2021;27:1862-1864.
    PubMed    


  220. CRISPINO F, Brinch D, Carrozza L, Cappello M, et al
    Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey.
    Inflamm Bowel Dis. 2021;27:e134-e135.
    PubMed    


  221. DALAL RS, Allegretti JR
    Fecal Microbiota Transplantation for Chronic Pouchitis: Promising Novel Therapeutic or Lost Cause?
    Inflamm Bowel Dis. 2021;27:1873-1875.
    PubMed    


  222. CEBALLOS D
    Predictors: How to Approach the Individualization of Treatment.
    Inflamm Bowel Dis. 2021;27:1876-1877.
    PubMed     Abstract available


  223. ARTHUR S, Palaniappan B, Afroz S, Sundaram U, et al
    Unique Regulation of Coupled NaCl Absorption by Inducible Nitric Oxide in a Spontaneous SAMP1/YitFc Mouse Model of Chronic Intestinal Inflammation.
    Inflamm Bowel Dis. 2021;27:1804-1812.
    PubMed     Abstract available


  224. KARJALAINEN EK, Renkonen-Sinisalo L, Satokari R, Mustonen H, et al
    Fecal Microbiota Transplantation in Chronic Pouchitis: A Randomized, Parallel, Double-Blinded Clinical Trial.
    Inflamm Bowel Dis. 2021;27:1766-1772.
    PubMed     Abstract available


  225. STULMAN MY, Asayag N, Focht G, Brufman I, et al
    Epidemiology of Inflammatory Bowel Diseases in Israel: A Nationwide Epi-Israeli IBD Research Nucleus Study.
    Inflamm Bowel Dis. 2021;27:1784-1794.
    PubMed     Abstract available


  226. CALDERA F, Balzora S, Hayney MS, Farraye FA, et al
    Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD.
    Inflamm Bowel Dis. 2021;27:1703-1705.
    PubMed     Abstract available


  227. KANG MJ, Kim HW, Park SB, Kang DH, et al
    A Case of Iliopsoas Abscess and Ileitis With Enterocutaneous Fistula Caused by a Toothpick Mimicking Small Bowel Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e121-e122.
    PubMed    


  228. VALDES DELGADO T, Arguelles Arias F, Gastearena Idoate MA
    Mixed Adenocarcinoma in a 44-Year-Old Male with Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e119-e120.
    PubMed    


  229. PATEL BM, Ramos Rivers C, Koutroumpakis F, Ahsan M, et al
    Ustekinumab-Induced Remission of Two Cases of Refractory Cutaneous Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e124.
    PubMed    


  230. LOU Y, Li Z
    Is It Crohn's Disease?
    Inflamm Bowel Dis. 2021;27:e116-e117.
    PubMed    


  231. ALAYO QA, Khatiwada A, Patel A, Zulfiqar M, et al
    Effectiveness and Safety of Combining Tofacitinib With a Biologic in Patients With Refractory Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:1698-1702.
    PubMed    


  232. ADLER J, Eder SJ, Gebremariam A, French KR, et al
    Development and Testing of a New Simplified Endoscopic Mucosal Assessment for Crohn's Disease: The SEMA-CD.
    Inflamm Bowel Dis. 2021;27:1585-1592.
    PubMed     Abstract available


  233. SINGH S, Heien HC, Sangaralingham L, Shah ND, et al
    Frailty and Risk of Serious Infections in Biologic-treated Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:1626-1633.
    PubMed     Abstract available


  234. KULKARNI C, Murag S, Cholankeril G, Fardeen T, et al
    Association of Anti-TNF Therapy With Increased Risk of Acute Cholangitis in Patients With Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2021;27:1602-1609.
    PubMed     Abstract available


  235. PATEL DB, van Deen WK, Almario CV, Khalil C, et al
    Assessing Patient Decision-Making on Biologic and Small-Molecule Therapies in Inflammatory Bowel Diseases: Insights From a Conjoint Analysis in the United States, Canada, and the United Kingdom.
    Inflamm Bowel Dis. 2021;27:1593-1601.
    PubMed     Abstract available


  236. PIPPIS EJ, Yacyshyn BR
    Clinical and Mechanistic Characteristics of Current JAK Inhibitors in IBD.
    Inflamm Bowel Dis. 2021;27:1674-1683.
    PubMed     Abstract available


  237. REENAERS C, de Roover A, Kohnen L, Nachury M, et al
    Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID.
    Inflamm Bowel Dis. 2021 Oct 12. pii: 6391132. doi: 10.1093.
    PubMed     Abstract available


  238. ANNE SHAFER L, Shaffer S, Witt J, Nugent Z, et al
    IBD Disability Index Is Associated With Both Direct and Indirect Costs of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Oct 12. pii: 6390721. doi: 10.1093.
    PubMed     Abstract available


  239. YU N, Basnayake C, Connell W, Ding NS, et al
    Interventions to Improve Adherence to Preventive Care in Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2021 Oct 7. pii: 6383125. doi: 10.1093.
    PubMed     Abstract available


  240. HOWALDT S, Domenech E, Martinez N, Schmidt C, et al
    Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.
    Inflamm Bowel Dis. 2021 Oct 6. pii: 6382159. doi: 10.1093.
    PubMed    


  241. RAMAN M, Rajagopalan V, Kaur S, Reimer RA, et al
    Physical Activity in Patients With Inflammatory Bowel Disease: A Narrative Review.
    Inflamm Bowel Dis. 2021 Oct 4. pii: 6380888. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  242. LEE KE, Lim F, Colombel JF, Hur C, et al
    Cost-effectiveness of Venous Thromboembolism Prophylaxis After Hospitalization in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 30. pii: 6378418. doi: 10.1093.
    PubMed     Abstract available


  243. GU X, Ke X, Shen M, Zhang M, et al
    Association Between Inflammatory Bowel Disease and Atopic Dermatitis: A Two-Sample Mendelian Randomization Study.
    Inflamm Bowel Dis. 2021 Sep 30. pii: 6378417. doi: 10.1093.
    PubMed    


  244. MICHEL HK, Boyle B, David J, Donegan A, et al
    The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model.
    Inflamm Bowel Dis. 2021 Sep 25. pii: 6375326. doi: 10.1093.
    PubMed     Abstract available


  245. BOOTH A, Ford W, Brennan E, Magwood G, et al
    Towards Equitable Surgical Management of Inflammatory Bowel Disease: A Systematic Review of Disparities in Surgery for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 23. pii: 6374390. doi: 10.1093.
    PubMed     Abstract available


  246. MACISAAC MB, Julsgaard M, Flanagan E, Rowe S, et al
    Anti-TNFalpha Induction Therapy for Patients With Active Inflammatory Bowel Disease During Pregnancy: A Case Series.
    Inflamm Bowel Dis. 2021 Sep 18. pii: 6372251. doi: 10.1093.
    PubMed    


  247. LAWTON RC
    "The Tough Get Going": Understanding the Role of Resilience and a Multidimensional Conceptualization of Mental Health Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 17. pii: 6371841. doi: 10.1093.
    PubMed    


  248. DAILEY J, Kozhaya L, Dogan M, Hopkins D, et al
    Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 16. pii: 6371006. doi: 10.1093.
    PubMed     Abstract available


  249. OUAHED J
    Expanding Contributions of Monogenic Very Early Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370827. doi: 10.1093.
    PubMed     Abstract available


  250. BADER-MEUNIER B, Martins AL, Charbit-Henrion F, Meinzer U, et al
    Mevalonate Kinase Deficiency: A Cause of Severe Very-Early-Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370829. doi: 10.1093.
    PubMed     Abstract available


  251. VAHIDNEZHAD H, Youssefian L, Anbardar MH, Zeinali S, et al
    Very-Early-Onset Inflammatory Bowel Disease in a Patient With Junctional Epidermolysis Bullosa With a Homozygous Mutation in the alpha6 Integrin Gene (ITGA6).
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370826. doi: 10.1093.
    PubMed    


  252. MISHRA S, Kumar Singh A, Kopp C, Jena A, et al
    Tubercular Pleural Effusion in a Patient of Ulcerative Colitis Treated With Tofacitinib.
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370835. doi: 10.1093.
    PubMed    


  253. DE VOOGD F, Joshi H, Van Wassenaer E, Bots S, et al
    Intestinal Ultrasound to Evaluate Treatment Response During Pregnancy in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Sep 15. pii: 6370832. doi: 10.1093.
    PubMed     Abstract available


  254. WU N, Li H, Zhang J, Huang W, et al
    Herpes Zoster in a Patient With Ulcerative Colitis After Vedolizumab Initiation-Causal Link or Only Temporal Coincidence?
    Inflamm Bowel Dis. 2021 Sep 4. pii: 6364140. doi: 10.1093.
    PubMed    


  255. HERMAN SM, Zaborniak K, Bernstein CN
    Insight into Inflammatory Bowel Disease Pathogenesis: Is the Answer Blowing in the Wind?
    Inflamm Bowel Dis. 2021 Sep 2. pii: 6362805. doi: 10.1093.
    PubMed     Abstract available


  256. BARNES EL, Nowell WB, Venkatachalam S, Dobes A, et al
    Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States.
    Inflamm Bowel Dis. 2021 Sep 2. pii: 6362806. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  257. PHILIPPOU A, Sehgal P, Ungaro RC, Wang K, et al
    High Levels of Psychological Resilience Are Associated With Decreased Anxiety in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Aug 27. pii: 6358608. doi: 10.1093.
    PubMed     Abstract available


  258. XERFAN EMS, Andersen ML, Tomimori J, Tufik S, et al
    Inflammatory Bowel Disease, Skin, and Sleep: An Overview of This Complex Interaction and Associated Issues.
    Inflamm Bowel Dis. 2021 Aug 27. pii: 6358561. doi: 10.1093.
    PubMed    


  259. RAFFALS LE, Saha S, Bewtra M, Norris C, et al
    The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD).
    Inflamm Bowel Dis. 2021 Aug 26. pii: 6358125. doi: 10.1093.
    PubMed     Abstract available


  260. MATSUNE Y, Yaguchi K, Saito S, Sakakibara H, et al
    Simultaneous Development of Ulcerative Colitis in the Sigmoidocolon Autotransplant Neovagina and the Residual Colorectum.
    Inflamm Bowel Dis. 2021 Aug 26. pii: 6358126. doi: 10.1093.
    PubMed    


  261. HASSAN-ZAHRAEE M, Ye Z, Xi L, Baniecki ML, et al
    Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Aug 24. pii: 6357022. doi: 10.1093.
    PubMed     Abstract available


  262. MALHI G, Tandon P, Perlmutter JW, Nguyen G, et al
    Risk Factors for Postpartum Disease Activity in Women With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2021 Aug 24. pii: 6357024. doi: 10.1093.
    PubMed     Abstract available


  263. XU Y, Tian Y, Li F, Wang Y, et al
    Circular RNA HECTD1 Mitigates Ulcerative Colitis by Promoting Enterocyte Autophagy Via miR-182-5p/HuR Axis.
    Inflamm Bowel Dis. 2021 Aug 24. pii: 6357021. doi: 10.1093.
    PubMed     Abstract available


  264. SABERZADEH-ARDESTANI B, Anushiravani A, Mansour-Ghanaei F, Fakheri H, et al
    Clinical Phenotype and Disease Course of Inflammatory Bowel Disease: A Comparison Between Sporadic and Familial Cases.
    Inflamm Bowel Dis. 2021 Aug 21. pii: 6356100. doi: 10.1093.
    PubMed     Abstract available


  265. BARNHOORN MC, Storm BN, de Boer NK, van der Voorn MMPJA, et al
    Azathioprine-induced Myelotoxicity After Switching Mesalazine Compound.
    Inflamm Bowel Dis. 2021;27:e114-e115.
    PubMed    


  266. KOCHAR B, Kalasapudi L, Ufere NN, Nipp RD, et al
    Systematic Review of Inclusion and Analysis of Older Adults in Randomized Controlled Trials of Medications Used to Treat Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:1541-1543.
    PubMed    


  267. WITTE M, Reiner J, Bannert K, Jaster R, et al
    Ileocolonic Healing After Extended Small Bowel Resection in Mice: NOD2 Deficiency Impairs Anastomotic Healing and Postoperative Outcome.
    Inflamm Bowel Dis. 2021;27:1503-1512.
    PubMed     Abstract available


  268. GEISMAN T, Chen L, Gray-Swain MR, Hiatt-Jensen D, et al
    Delivery Outcomes of Pregnant Patients With Inflammatory Bowel Diseases Compared With the General Population and With Women With Other Autoimmune Diseases at a Tertiary Care Center.
    Inflamm Bowel Dis. 2021;27:1418-1426.
    PubMed     Abstract available


  269. YANG Q, Chen L, Feng L, Liu C, et al
    Success of Cyclosporin and Tofacitinib Combination Therapy in a Patient With Severe Steroid-refractory Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Aug 16. pii: 6352953. doi: 10.1093.
    PubMed     Abstract available


  270. DEL SORDO R, Lupinacci G, Tanzi G, Bassotti G, et al
    Imatinib and Dasatinib-induced Ulcerative Colitis: Case Report.
    Inflamm Bowel Dis. 2021 Aug 10. pii: 6347487. doi: 10.1093.
    PubMed    


    July 2021
  271. UNGARO RC, Agrawal M, Brenner EJ, Zhang X, et al
    New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International Registry.
    Inflamm Bowel Dis. 2021 Jul 28. pii: 6329562. doi: 10.1093.
    PubMed    


  272. FALSEY A, Jo D, Sirak H, Moya D, et al
    Corticosteroids Can Be Used to Decrease Antidrug Antibodies in Pediatric Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 28. pii: 6329558. doi: 10.1093.
    PubMed    


  273. AXELRAD JE, Faye A, Slaughter JC, Harpaz N, et al
    Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia.
    Inflamm Bowel Dis. 2021 Jul 28. pii: 6329560. doi: 10.1093.
    PubMed     Abstract available


  274. MARKOVIC S, Ivanovski TK, Zogovic B, Kalaba A, et al
    The Effect of COVID-19 Resurgence on Morbidity and Mortality in Patients With IBD on Biologic Therapy.
    Inflamm Bowel Dis. 2021;27:e90.
    PubMed    


  275. WINTER MW, Levy LC
    Maybe Age Isn't Just a Number: Elderly-onset IBD Is a Demographic Deserving of Specific Considerations.
    Inflamm Bowel Dis. 2021;27:1363-1364.
    PubMed    


  276. PRIVITERA G, Pugliese D, Armuzzi A, Guidi L, et al
    Dual Targeted Therapy in Patient With Extensive Crohn's Disease: Different Response at Distinct Location.
    Inflamm Bowel Dis. 2021;27:e93-e94.
    PubMed    


  277. NEYAZI M, Bharadwaj SS, Bullers S, Varenyiova Z, et al
    Overexpression of Cancer-Associated Stem Cell Gene OLFM4 in the Colonic Epithelium of Patients With Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2021;27:1316-1327.
    PubMed     Abstract available


  278. SANTORU ML, Piras C, Murgia F, Leoni VP, et al
    Metabolic Alteration in Plasma and Biopsies From Patients With IBD.
    Inflamm Bowel Dis. 2021;27:1335-1345.
    PubMed     Abstract available


  279. MARRIE RA, Graff LA, Fisk JD, Patten SB, et al
    The Relationship Between Symptoms of Depression and Anxiety and Disease Activity in IBD Over Time.
    Inflamm Bowel Dis. 2021;27:1285-1293.
    PubMed     Abstract available


  280. ROZICH JJ, Luo J, Dulai PS, Collins AE, et al
    Disease- and Treatment-related Complications in Older Patients With Inflammatory Bowel Diseases: Comparison of Adult-onset vs Elderly-onset Disease.
    Inflamm Bowel Dis. 2021;27:1215-1223.
    PubMed     Abstract available


  281. DALAL RS, Njie C, Marcus J, Gupta S, et al
    Predictors of Ustekinumab Failure in Crohn's Disease After Dose Intensification.
    Inflamm Bowel Dis. 2021;27:1294-1301.
    PubMed     Abstract available


  282. CHIBA M, Ishii H, Sageshima M, Iwabuchi A, et al
    Appendiceal Orifice Inflammation in Severe Ulcerative Colitis and Its Resolution With Infliximab and Plant-based Diet as First-line Therapy.
    Inflamm Bowel Dis. 2021 Jul 22. pii: 6325475. doi: 10.1093.
    PubMed    


  283. SYAL G, Serrano M, Jain A, Cohen BL, et al
    Health Maintenance Consensus for Adults With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 19. pii: 6323888. doi: 10.1093.
    PubMed     Abstract available


  284. DAI C, Jiang M, Huang YH
    Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 14. pii: 6321215. doi: 10.1093.
    PubMed    


  285. COATES MD, Ba DM, Liu G, Dalessio S, et al
    Revisiting the Association Between Inflammatory Bowel Disease and Parkinson's Disease.
    Inflamm Bowel Dis. 2021 Jul 14. pii: 6321214. doi: 10.1093.
    PubMed     Abstract available


  286. SHIBUYA T, Nomura O, Nagahara A
    Safety and Efficacy of Ustekinumab for Ulcerative Colitis in a Liver Transplant Patient.
    Inflamm Bowel Dis. 2021 Jul 13. pii: 6320083. doi: 10.1093.
    PubMed    


  287. OJO BA, VanDussen KL, Rosen MJ
    The Promise of Patient-Derived Colon Organoids to Model Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jul 12. pii: 6319488. doi: 10.1093.
    PubMed     Abstract available


  288. WEISSMAN S, Systrom HK, Aziz M, El-Dallal M, et al
    Colorectal Cancer Prevention in Inflammatory Bowel Disease: A Systematic Analysis of the Overall Quality of Guideline Recommendations.
    Inflamm Bowel Dis. 2021 Jul 10. pii: 6318812. doi: 10.1093.
    PubMed     Abstract available


  289. KHAN N, Pernes T, Weiss A, Trivedi C, et al
    Efficacy of Vedolizumab in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 Jul 10. pii: 6318811. doi: 10.1093.
    PubMed     Abstract available


  290. TSE CS, Singh S, Sandborn WJ
    A Framework for Clinical Trials of Neurobiological Interventions That Target the Gut-Brain Axis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jul 9. pii: 6318240. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  291. WALLDORF J, von Arnim U, Schmelz R, Riesner-Wehner A, et al
    SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.
    Inflamm Bowel Dis. 2021 Jun 28. pii: 6310707. doi: 10.1093.
    PubMed    


  292. CHOSHEN S, Turner D, Pratt LT, Precel R, et al
    Development and Validation of a Pediatric MRI-Based Perianal Crohn Disease (PEMPAC) Index-A Report from the ImageKids Study.
    Inflamm Bowel Dis. 2021 Jun 21. pii: 6307118. doi: 10.1093.
    PubMed     Abstract available


  293. TAFT TH, Quinton S, Jedel S, Simons M, et al
    Posttraumatic Stress in Patients With Inflammatory Bowel Disease: Prevalence and Relationships to Patient-Reported Outcomes.
    Inflamm Bowel Dis. 2021 Jun 17. pii: 6301664. doi: 10.1093.
    PubMed     Abstract available


  294. HANZEL J, Dreesen E, Vermeire S, Lowenberg M, et al
    Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients With Crohn Disease: Posthoc Analysis of the LOVE-CD Study.
    Inflamm Bowel Dis. 2021 Jun 17. pii: 6301858. doi: 10.1093.
    PubMed     Abstract available


  295. MUTLU EA
    IBD Development After Diverticulitis May Hold Clues to IBD Pathogenesis.
    Inflamm Bowel Dis. 2021;27:1172-1173.
    PubMed    


  296. KARJALAINEN EK, Renkonen-Sinisalo L, Satokari R, Mustonen H, et al
    Author's Reply: Fecal Microbiota Transplantation for Chronic Pouchitis: Promising Novel Therapeutic or Lost Cause?
    Inflamm Bowel Dis. 2021;27:e79-e80.
    PubMed    


  297. ALKAISSI LY, Winberg ME, Heil SDS, Haapaniemi S, et al
    Antagonism of Adherent Invasive E. coli LF82 With Human alpha-defensin 5 in the Follicle-associated Epithelium of Patients With Ileal Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:1116-1127.
    PubMed     Abstract available


  298. ZHOU LY, Lin SN, Rieder F, Chen MH, et al
    Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn's Disease: The Path From Bench to Bedside.
    Inflamm Bowel Dis. 2021;27:971-982.
    PubMed     Abstract available


  299. MAZZURANA L, Bonfiglio F, Forkel M, D'Amato M, et al
    Crohn's Disease Is Associated With Activation of Circulating Innate Lymphoid Cells.
    Inflamm Bowel Dis. 2021;27:1128-1138.
    PubMed     Abstract available


  300. BUISSON A, Mak WY, Andersen MJ, Lei D, et al
    Fecal Calprotectin Is Highly Effective to Detect Endoscopic Ulcerations in Crohn's Disease Regardless of Disease Location.
    Inflamm Bowel Dis. 2021;27:1008-1016.
    PubMed     Abstract available


  301. NGUYEN NH, Khera R, Dulai PS, Boland BS, et al
    National Estimates of Financial Hardship From Medical Bills and Cost-related Medication Nonadherence in Patients With Inflammatory Bowel Diseases in the United States.
    Inflamm Bowel Dis. 2021;27:1068-1078.
    PubMed     Abstract available


  302. RINAWI F, Ricciuto A, Church PC, Frost K, et al
    Association of Early Postinduction Adalimumab Exposure With Subsequent Clinical and Biomarker Remission in Children with Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:1079-1087.
    PubMed     Abstract available


  303. COLMAN RJ, Tsai YT, Jackson K, Boyle BM, et al
    Achieving Target Infliximab Drug Concentrations Improves Blood and Fecal Neutrophil Biomarkers in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:1045-1051.
    PubMed     Abstract available


  304. HASAN B, Yim Y, Ur Rashid M, Khalid RA, et al
    Hyperbaric Oxygen Therapy in Chronic Inflammatory Conditions of the Pouch.
    Inflamm Bowel Dis. 2021;27:965-970.
    PubMed     Abstract available


  305. NGUYEN NH, Luo J, Ohno-Machado L, Sandborn WJ, et al
    Burden and Outcomes of Fragmentation of Care in Hospitalized Patients With Inflammatory Bowel Diseases: A Nationally Representative Cohort.
    Inflamm Bowel Dis. 2021;27:1026-1034.
    PubMed     Abstract available


  306. KUROWSKI JA, Milinovich A, Ji X, Bauman J, et al
    Differences in Biologic Utilization and Surgery Rates in Pediatric and Adult Crohn's Disease: Results From a Large Electronic Medical Record-derived Cohort.
    Inflamm Bowel Dis. 2021;27:1035-1044.
    PubMed     Abstract available


  307. QIN X
    High Fecal Proteolytic Activity That Precedes Ulcerative Colitis Likely Results From Impaired Inactivation of Pancreatic Proteases Rather Than Bacteria.
    Inflamm Bowel Dis. 2021 Jun 14. pii: 6298410. doi: 10.1093.
    PubMed    


  308. GALIPEAU HJ, Caminero A, Verdu EF
    Increased Bacterial Proteolytic Activity Detected Before Diagnosis of Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jun 14. pii: 6298409. doi: 10.1093.
    PubMed    


  309. LAMAZZA A, Fiori E, Carati MV, Pronio AM, et al
    Self-Expandable Metal Stents for Refractory Complete Rectal Obstruction in Patients With Crohn Disease.
    Inflamm Bowel Dis. 2021 Jun 10. pii: 6295865. doi: 10.1093.
    PubMed    


  310. GONG L, Xiao J, Yi J, Xiao J, et al
    Immunomodulatory Effect of Serum Exosomes From Crohn Disease on Macrophages via Let-7b-5p/TLR4 Signaling.
    Inflamm Bowel Dis. 2021 Jun 9. pii: 6295437. doi: 10.1093.
    PubMed     Abstract available


  311. VANDE CASTEELE N, Leighton JA, Pasha SF, Cusimano F, et al
    Utilizing Deep Learning to Analyze Whole Slide Images of Colonic Biopsies for Associations Between Eosinophil Density and Clinicopathologic Features in Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jun 9. pii: 6295436. doi: 10.1093.
    PubMed     Abstract available


  312. DAVID JG, Chute D, Reed B, Saeed S, et al
    Assessing the Prevalence of and Risk Factors for Disordered Eating Attitudes and Behaviors in Adolescents With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jun 9. pii: 6295433. doi: 10.1093.
    PubMed    


  313. JORDI SBU, Lang BM, Auschra B, von Kanel R, et al
    Depressive Symptoms Predict Clinical Recurrence of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jun 7. pii: 6294150. doi: 10.1093.
    PubMed     Abstract available


  314. DANESE S, Peyrin-Biroulet L
    Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise.
    Inflamm Bowel Dis. 2021 Jun 5. pii: 6293782. doi: 10.1093.
    PubMed     Abstract available


  315. MIKAIL M, Wilson A
    Low Serum Tumor Necrosis Factor-alpha Antagonist Concentrations in Patients With Inflammatory Bowel Disease Who Achieve Healing From Pyoderma Gangrenosum.
    Inflamm Bowel Dis. 2021 Jun 5. pii: 6293784. doi: 10.1093.
    PubMed    


    May 2021
  316. LUI J, Ramos GP, Codipilly DC, Katzka D, et al
    The Use of Biologics for the Treatment of Esophageal Crohn Disease.
    Inflamm Bowel Dis. 2021 May 29. pii: 6288092. doi: 10.1093.
    PubMed    


  317. LI H, Shu H, Tian F
    Distinct Entity of Inflammatory Bowel Disease in Autoimmune Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2021 May 27. pii: 6285983. doi: 10.1093.
    PubMed    


  318. GAZOULI M, Dovrolis N, Bourdakou MM, Gizis M, et al
    Response to Anti-alpha4beta7 Blockade in Patients With Ulcerative Colitis Is Associated With Distinct Mucosal Gene Expression Profiles at Baseline.
    Inflamm Bowel Dis. 2021 May 27. pii: 6285911. doi: 10.1093.
    PubMed     Abstract available


  319. LIU JJ
    Disparity in the Care of black Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284055. doi: 10.1093.
    PubMed    


  320. SHAFFER SR, Erondu AI, Traboulsi C, Rai V, et al
    Achieving Histologic Normalization in Ulcerative Colitis Is Associated With a Reduced Risk of Subsequent Dysplasia.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284061. doi: 10.1093.
    PubMed     Abstract available


  321. PENA-SANCHEZ JN, Osei JA, Marques Santos JD, Jennings D, et al
    Increasing Prevalence and Stable Incidence Rates of Inflammatory Bowel Disease Among First Nations: Population-Based Evidence From a Western Canadian Province.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284047. doi: 10.1093.
    PubMed     Abstract available


  322. MORRIS GA, McNicol M, Boyle B, Donegan A, et al
    Increasing Biosimilar Utilization at a Pediatric Inflammatory Bowel Disease Center and Associated Cost Savings: Show Me the Money.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284046. doi: 10.1093.
    PubMed     Abstract available


  323. OLIVER BJ, Kennedy AM, van Deen WK, Weaver SA, et al
    Development of Balanced Whole System Value Measures for Inflammatory Bowel Disease Care in the IBD Qorus Collaborative Using a Modified Delphi Process.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284056. doi: 10.1093.
    PubMed     Abstract available


  324. IACUCCI M, Jeffery L, Acharjee A, Nardone OM, et al
    Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis-An Exploratory Study to Define Deep Remission.
    Inflamm Bowel Dis. 2021 May 21. pii: 6279651. doi: 10.1093.
    PubMed     Abstract available


  325. SACHAN A, Srivastava S, Shah J, Singh AK, et al
    Strongyloides Stercoralis in Acute Severe Ulcerative Colitis-A Triggering Nuisance or An Opportunistic Bystander?
    Inflamm Bowel Dis. 2021 May 21. pii: 6279668. doi: 10.1093.
    PubMed    


  326. HUSSAMEDDIN A, Sedano R, Ramsewak D, Driman D, et al
    Vedolizumab-Induced Endoscopic and Histologic Improvement in Gastric Menetrier's Disease in a Patient With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 May 21. pii: 6279703. doi: 10.1093.
    PubMed    


  327. HANZEL J, Jansen JM, Ter Steege RWF, Gecse KB, et al
    Multiple Switches From the Originator Infliximab to Biosimilars Is Effective and Safe in Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2021 May 20. pii: 6278840. doi: 10.1093.
    PubMed     Abstract available


  328. VAN WASSENAER EA, Benninga MA, van Limbergen JL, D'Haens GR, et al
    Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease: Promising, but Work in Progress.
    Inflamm Bowel Dis. 2021 May 20. pii: 6278841. doi: 10.1093.
    PubMed     Abstract available


  329. MCCURDY J, Siw KCK, Kandel R, Larrigan S, et al
    The Effectiveness and Safety of Hyperbaric Oxygen Therapy in Various Phenotypes of Inflammatory Bowel Disease: Systematic Review With Meta-analysis.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277724. doi: 10.1093.
    PubMed     Abstract available


  330. CHEAH M, Wilson A, Solh Z, Khanna R, et al
    IgA-Mediated Warm Autoimmune Hemolytic Anemia as an Extraintestinal Manifestation in a Patient With Crohn Disease on Vedolizumab.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277765. doi: 10.1093.
    PubMed    


  331. VERDE A, Grammegna A, Petrone E, Mastrominico A, et al
    Crohn-Like Colitis in a Young Boy With Hirschsprung Disease.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277720. doi: 10.1093.
    PubMed    


  332. DOS SANTOS CHM, Koga GA
    Response to the Letter to the Editor: "Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine".
    Inflamm Bowel Dis. 2021 May 18. pii: 6277711. doi: 10.1093.
    PubMed    


  333. GRAZIANO F, Macaluso FS, Cassata N, Citrano M, et al
    Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine.
    Inflamm Bowel Dis. 2021 May 18. pii: 6277715. doi: 10.1093.
    PubMed    


  334. SQUIRE JD, Gonzalez-Estrada A, Caldera F, Farraye FA, et al
    COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276957. doi: 10.1093.
    PubMed    


  335. DE FRIAS GOMES CG, de Almeida ASR, Mendes CCL, Ellul P, et al
    Histological Inflammation in the Endoscopically Uninflamed Mucosa is Associated With Worse Outcomes in Limited Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276940. doi: 10.1093.
    PubMed     Abstract available


  336. HILLEY P, Gilmore R, Srinivasan A, Choy M, et al
    Combined Targeted Treatment Using Biologic-Tofacitinib Co-Therapy in Chronic Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276958. doi: 10.1093.
    PubMed    


  337. FASOULAS K, Stergiou E, Soufleris K
    Ustekinumab for Crohn Disease With Severe Gastroduodenal Involvement.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276944. doi: 10.1093.
    PubMed    


  338. SANTELLA C, Bitton A, Filliter C, Bessissow T, et al
    Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276941. doi: 10.1093.
    PubMed     Abstract available



  339. Corrigendum to: Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276866. doi: 10.1093.
    PubMed    



  340. Erratum to: Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 May 17. pii: 6276685. doi: 10.1093.
    PubMed    


  341. TAXONERA C, Alba C, Olivares D, Martin M, et al
    Innovation in IBD Care During the COVID-19 Pandemic: Results of a Cross-Sectional Survey on Patient-Reported Experience Measures.
    Inflamm Bowel Dis. 2021;27:864-869.
    PubMed     Abstract available


  342. GRAZIANO F, Buse M, Cassata N, Citrano M, et al
    Cerebral Venous Thrombosis in a Child With Very-Early-Onset IBD.
    Inflamm Bowel Dis. 2021;27:e71-e73.
    PubMed    


  343. SRINIVASAN A, van Langenberg D, De Cruz P
    Real-World Effectiveness of Ustekinumab Dose Intensification in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e69.
    PubMed    


  344. AHMED W, Lukin DJ
    Finding a Needle in the Haystack? Defining the Role of Random Biopsies in IBD Dysplasia Surveillance.
    Inflamm Bowel Dis. 2021;27:787-790.
    PubMed    


  345. FIOCCHI C, Iliopoulos D
    IBD Systems Biology Is Here to Stay.
    Inflamm Bowel Dis. 2021;27:760-770.
    PubMed     Abstract available


  346. KUROWSKI JA, Bewtra M, Kodish E, Lashner B, et al
    Reducing the Spread of Internet Misinformation in IBD: Ethics and Responsibility.
    Inflamm Bowel Dis. 2021;27:960-962.
    PubMed    


  347. SUDHAKAR P, Verstockt B, Cremer J, Verstockt S, et al
    Understanding the Molecular Drivers of Disease Heterogeneity in Crohn's Disease Using Multi-omic Data Integration and Network Analysis.
    Inflamm Bowel Dis. 2021;27:870-886.
    PubMed     Abstract available


  348. GUPTA N, Lustig RH, Andrews H, Gokhale R, et al
    Clinical Variables Associated With Statural Growth in Pediatric Crohn's Disease Differ by Sex (The Growth Study).
    Inflamm Bowel Dis. 2021;27:751-759.
    PubMed     Abstract available


  349. WONG ECL, Marshall JK, Reinisch W, Narula N, et al
    Body Mass Index Does Not Impact Clinical Efficacy of Ustekinumab in Crohn's Disease: A Post Hoc Analysis of the IM-UNITI Trial.
    Inflamm Bowel Dis. 2021;27:848-854.
    PubMed     Abstract available


  350. LEVINE I, Malik F, Castillo G, Jaros B, et al
    Prevalence, Predictors, and Disease Activity of Sacroiliitis Among Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:809-815.
    PubMed     Abstract available


  351. VARBOBITIS I, Kokkotis G, Gizis M, Perlepe N, et al
    The IBD-F Patient Self-Assessment Scale Accurately Depicts the Level of Fatigue and Predicts a Negative Effect on the Quality of Life of Patients With IBD in Clinical Remission.
    Inflamm Bowel Dis. 2021;27:826-835.
    PubMed     Abstract available


  352. ATTAUABI M, Zhao M, Bendtsen F, Burisch J, et al
    Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:927-939.
    PubMed     Abstract available


  353. TAXONERA C, Olivares D, Alba C
    Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review-Authors' Reply.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275622. doi: 10.1093.
    PubMed    


  354. JAIRATH V, Guizzetti L, Baker KA, Williamson LA, et al
    Impact of COVID-19 on Inflammatory Bowel Disease Clinical Trial Recruitment: A Global Survey of Principal Investigators.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275617. doi: 10.1093.
    PubMed    


  355. HOWALDT S, Domenech E, Martinez N, Schmidt C, et al
    Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275616. doi: 10.1093.
    PubMed     Abstract available


  356. DALAL RS, Mitri J, Goodrick H, Allegretti JR, et al
    Real-World Comparison of Tofacitinib vs Ustekinumab Among Bio-Exposed Patients With Ulcerative Colitis: A Propensity Score Analysis.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275620. doi: 10.1093.
    PubMed    


  357. CLICK B, Merchea A, Colibaseanu DT, Regueiro M, et al
    Ileocolic Resection for Crohn Disease: The Influence of Different Surgical Techniques on Perioperative Outcomes, Recurrence Rates, and Endoscopic Surveillance.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275618. doi: 10.1093.
    PubMed     Abstract available


  358. JENA A, Mishra S, Sachan A, Singh H, et al
    Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275623. doi: 10.1093.
    PubMed    


  359. MCCURDY JD, Reid J, Yanofsky R, Sinnathamby V, et al
    Fecal Diversion for Perianal Crohn Disease in the Era of Biologic Therapies: A Multicenter Study.
    Inflamm Bowel Dis. 2021 May 14. pii: 6275627. doi: 10.1093.
    PubMed     Abstract available


  360. ALKHAYYAT M, Abureesh M, Almomani A, Abou Saleh M, et al
    Patients With Inflammatory Bowel Disease on Treatment Have Lower Rates of Celiac Disease.
    Inflamm Bowel Dis. 2021 May 14. pii: 6277368. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  361. XU F, Carlson SA, Wheaton AG, Greenlund KJ, et al
    COVID-19 Hospitalizations Among U.S. Medicare Beneficiaries With Inflammatory Bowel Disease, April 1 to July 31, 2020.
    Inflamm Bowel Dis. 2021 Apr 27. pii: 6255240. doi: 10.1093.
    PubMed    


  362. HYAMS JS, Brimacombe M, Haberman Y, Walters T, et al
    Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Apr 27. pii: 6255234. doi: 10.1093.
    PubMed     Abstract available


  363. RODRIGUEZ-LAGO I, Barreiro-de Acosta M
    Risk of Depression During the Natural History of Inflammatory Bowel Disease: The Phantom Menace.
    Inflamm Bowel Dis. 2021 Apr 26. pii: 6179794. doi: 10.1093.
    PubMed    



  364. Corrigendum to: Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2021 Apr 20. pii: 6240061. doi: 10.1093.
    PubMed    


  365. ELTABBAKH M, Abd Alaty W, Sakr MA, Sherief AF, et al
    Commenting on the Letter (Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic").
    Inflamm Bowel Dis. 2021;27:e66.
    PubMed    


  366. FOTEINOGIANNOPOULOU K, Mala A, Koutroubakis IE
    Extra-pleural Solitary Fibrous Tumor of the Pelvis in a Patient with Crohn's Disease Under Anti-TNF: A Case Report.
    Inflamm Bowel Dis. 2021;27:e55-e56.
    PubMed    


  367. MAGEN-RIMON R, Garah J, Rosen I, Shaoul R, et al
    Postsurgical Treatment in Pediatric Patients With Crohn's Disease: Physician Practice.
    Inflamm Bowel Dis. 2021;27:e51-e54.
    PubMed    


  368. OSTERMAN MT, VanDussen KL, Gordon IO, Davis EM, et al
    Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:677-685.
    PubMed     Abstract available


  369. PAULIDES E, Boukema I, van der Woude CJ, de Boer NKH, et al
    The Effect of Psychotherapy on Quality of Life in IBD Patients: A Systematic Review.
    Inflamm Bowel Dis. 2021;27:711-724.
    PubMed     Abstract available


  370. CANNATELLI R, Bazarova A, Zardo D, Nardone OM, et al
    Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients.
    Inflamm Bowel Dis. 2021;27:647-654.
    PubMed     Abstract available


  371. GOREN G, Schwartz D, Friger M, Banai H, et al
    Randomized Controlled Trial of Cognitive-Behavioral and Mindfulness-Based Stress Reduction on the Quality of Life of Patients With Crohn Disease.
    Inflamm Bowel Dis. 2021 Apr 13. pii: 6224593. doi: 10.1093.
    PubMed     Abstract available


  372. ASONUMA K, Kobayashi T, Nakano M, Sagami S, et al
    Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relapse of Extensive Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Apr 13. pii: 6224886. doi: 10.1093.
    PubMed     Abstract available


  373. SCARALLO L, Bolasco G, Barp J, Bianconi M, et al
    Anti-Tumor Necrosis Factor-Alpha Withdrawal in Children With Inflammatory Bowel Disease in Endoscopic and Histologic Remission.
    Inflamm Bowel Dis. 2021 Apr 9. pii: 6218764. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  374. HERNANDEZ J, Rouille E, Chocteau F, Allard M, et al
    Nonhypoalbuminemic Inflammatory Bowel Disease in Dogs as Disease Model.
    Inflamm Bowel Dis. 2021 Mar 30. pii: 6203397. doi: 10.1093.
    PubMed     Abstract available


  375. FANG J, Wang H, Xue Z, Cheng Y, et al
    PPARgamma: The Central Mucus Barrier Coordinator in Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Mar 27. pii: 6192824. doi: 10.1093.
    PubMed     Abstract available


  376. SHAH KP, Triana AJ, Gusdorf RE, McCoy AB, et al
    Demographic Factors Associated With Successful Telehealth Visits in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 Mar 26. pii: 6188947. doi: 10.1093.
    PubMed     Abstract available


  377. KLUSMANN B, Fleer J, Tovote KA, Weersma RK, et al
    Trajectories of Fatigue in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 26. pii: 6188945. doi: 10.1093.
    PubMed     Abstract available


  378. STIDHAM RW, Liu Y, Enchakalody B, Van T, et al
    The Use of Readily Available Longitudinal Data to Predict the Likelihood of Surgery in Crohn Disease.
    Inflamm Bowel Dis. 2021 Mar 26. pii: 6188946. doi: 10.1093.
    PubMed     Abstract available


  379. ZHANG T, Xu Y, Yao Y, Jin L, et al
    Randomized Controlled Trial: Perioperative Dexamethasone Reduces Excessive Postoperative Inflammatory Response and Ileus After Surgery for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 22. pii: 6179795. doi: 10.1093.
    PubMed     Abstract available


  380. SANDS BE, Long MD, Reinisch W, Panes J, et al
    Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical Program.
    Inflamm Bowel Dis. 2021 Mar 20. pii: 6179119. doi: 10.1093.
    PubMed     Abstract available


  381. GARRIDO I, Lopes S, Macedo G
    Hit the Road JAK! The Role of New Oral Treatment in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 20. pii: 6179114. doi: 10.1093.
    PubMed     Abstract available


  382. KHORSHID M, AbdAllah M
    Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic".
    Inflamm Bowel Dis. 2021;27:e39.
    PubMed    


  383. WINTER RW, Ananthakrishnan A, Burke KE, Kochar B, et al
    Time to Negative SARS-CoV-2 PCR Should Not Delay Care Among Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:590-592.
    PubMed    


  384. AGRAWAL M, Brenner EJ, Zhang X, Modesto I, et al
    Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry.
    Inflamm Bowel Dis. 2021;27:585-589.
    PubMed    


  385. SANTANA GO, de Santana AC, Pfeilsticker VB
    Ileum Perforation in Crohn's Disease Patient During SARS-Cov-2 Infection.
    Inflamm Bowel Dis. 2021;27:e42.
    PubMed    


  386. SEDANO R, Dhaliwal I, Ramsewak D, Jairath V, et al
    Drug-induced Lupus Associated With Vedolizumab in a Patient with Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e47-e48.
    PubMed    


  387. FERNANDEZ ALVAREZ P, Maldonado Perez B, Castro Laria L, Arguelles-Arias F, et al
    Autoimmune Encephalitis During Treatment With Adalimumab: A Case Report in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e40-e41.
    PubMed    


  388. ZHOU G, Wu H, Lin J, Lin R, et al
    TRIM21 Is Decreased in Colitis-associated Cancer and Negatively Regulates Epithelial Carcinogenesis.
    Inflamm Bowel Dis. 2021;27:458-468.
    PubMed     Abstract available


  389. DALAL RS, Palchaudhuri S, Snider CK, Lewis JD, et al
    Preadmission Cannabis Use Is Positively Correlated With Inpatient Opioid Dose Exposure in Hospitalized Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:500-506.
    PubMed     Abstract available


  390. COLMAN RJ, Portocarrero-Castillo A, Chona D, Hellmann J, et al
    Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients.
    Inflamm Bowel Dis. 2021;27:507-515.
    PubMed     Abstract available


  391. PAUWELS RWM, Proietti E, van der Woude CJ, Oudijk L, et al
    Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 11. pii: 6168345. doi: 10.1093.
    PubMed     Abstract available


  392. BHAT S, Caldera F, Farraye FA
    Barriers to Administering Vaccines in Inflammatory Bowel Disease Centers.
    Inflamm Bowel Dis. 2021 Mar 11. pii: 6168341. doi: 10.1093.
    PubMed    


  393. ZAIATZ BITTENCOURT V, Jones F, Doherty G, Ryan EJ, et al
    Targeting Immune Cell Metabolism in the Treatment of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Mar 10. pii: 6166277. doi: 10.1093.
    PubMed     Abstract available


  394. XIANG BJ, Huang YH, Dai C
    A Rare Autoinflammatory Syndrome Involving Acute Severe Ulcerative Colitis Combined With Iritis.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163199. doi: 10.1093.
    PubMed    


  395. SCHMOYER CJ, Saidman J, Bohl JL, Bierly CL, et al
    The Pathogenesis and Clinical Management of Stricturing Crohn Disease.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163204. doi: 10.1093.
    PubMed     Abstract available


  396. ANDERSON A, Cherfane C, Click B, Ramos-Rivers C, et al
    Monocytosis Is a Biomarker of Severity in Inflammatory Bowel Disease: Analysis of a 6-Year Prospective Natural History Registry.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163208. doi: 10.1093.
    PubMed     Abstract available


  397. TAKAHASHI H, Ogawa M, Hoshina T, Kusuhara K, et al
    Multiple Nodules in the Kidney and Spleen Presenting as the Initial Manifestation of Crohn Disease.
    Inflamm Bowel Dis. 2021 Mar 9. pii: 6163180. doi: 10.1093.
    PubMed    


    February 2021
  398. VERSTOCKT S, Verstockt B, Machiels K, Vancamelbeke M, et al
    Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 24. pii: 6148910. doi: 10.1093.
    PubMed     Abstract available


  399. NASSANI N, Sweiss N, Berry JT, Calhoun C, et al
    Leukocytoclastic Vasculitis in Cutaneous Crohn Disease in the Setting of COVID-19.
    Inflamm Bowel Dis. 2021 Feb 22. pii: 6146239. doi: 10.1093.
    PubMed    


  400. IMPERATORE N, Bennato R, D'Avino A, Lombardi G, et al
    SARS-CoV-2 as a Trigger for De Novo Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Feb 22. pii: 6146240. doi: 10.1093.
    PubMed    


  401. BORGHINI R, Vescovo M, Giordano C, Donato G, et al
    Onset of Suspected Ulcerative Colitis After Treatment With Tocilizumab in Patient With Celiac Disease and Juvenile Idiopathic Arthritis.
    Inflamm Bowel Dis. 2021 Feb 22. pii: 6146241. doi: 10.1093.
    PubMed    


  402. MORILLA I, Uzzan M, Cazals-Hatem D, Colnot N, et al
    Computational Learning of microRNA-Based Prediction of Pouchitis Outcome After Restorative Proctocolectomy in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Feb 20. pii: 6145454. doi: 10.1093.
    PubMed     Abstract available


  403. CHIARELLA-REDFERN H, Lee S, Jubran B, Sharifi N, et al
    Suboptimal Vaccination Administration in Mothers With Inflammatory Bowel Disease and Their Biologic-Exposed Infants.
    Inflamm Bowel Dis. 2021 Feb 20. pii: 6145400. doi: 10.1093.
    PubMed     Abstract available


  404. MIRANDA-BAUTISTA J, Rodriguez-Feo JA, Puerto M, Lopez-Cauce B, et al
    Liver X Receptor Exerts Anti-Inflammatory Effects in Colonic Epithelial Cells via ABCA1 and Its Expression Is Decreased in Human and Experimental Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 20. pii: 6145399. doi: 10.1093.
    PubMed     Abstract available


  405. CHUGH R, Proctor DD, Little A, Myung P, et al
    Cutaneous Vasculitis After Ustekinumab Induction in Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:e30-e31.
    PubMed    


  406. SOFFER S, Dahan S, Maklakovski M, Dagan A, et al
    A Case of Aseptic Renal Abscesses Associated With IBD.
    Inflamm Bowel Dis. 2021;27:e28-e29.
    PubMed    


  407. LEON G, Hussey S, Walsh PT
    The Diverse Roles of the IL-36 Family in Gastrointestinal Inflammation and Resolution.
    Inflamm Bowel Dis. 2021;27:440-450.
    PubMed     Abstract available


  408. YANG Y, Zhang C, Jing D, He H, et al
    IRF5 Acts as a Potential Therapeutic Marker in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:407-417.
    PubMed     Abstract available


  409. STEINER CA, Rodansky ES, Johnson LA, Berinstein JA, et al
    AXL Is a Potential Target for the Treatment of Intestinal Fibrosis.
    Inflamm Bowel Dis. 2021;27:303-316.
    PubMed     Abstract available


  410. SCHARRER S, Lissner D, Primas C, Reinisch W, et al
    Passive Smoking Increases the Risk for Intestinal Surgeries in Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:379-385.
    PubMed     Abstract available


  411. BRENNER EJ, Long MD, Mann CM, Chen W, et al
    Responsiveness of the Patient-reported Outcomes Measurement Information System (PROMIS) Pediatric Measures to Changes in Disease Status and Quality of Life Among Children and Adolescents With Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:344-351.
    PubMed     Abstract available


  412. STONE JK, Shafer LA, Graff LA, Lix L, et al
    Utility of the MARS-5 in Assessing Medication Adherence in IBD.
    Inflamm Bowel Dis. 2021;27:317-324.
    PubMed     Abstract available


  413. TAXONERA C, Olivares D, Alba C
    Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis.
    Inflamm Bowel Dis. 2021 Feb 15. pii: 6136180. doi: 10.1093.
    PubMed     Abstract available


  414. PANES J, Lindsay JO, Teich N, Lindgren S, et al
    Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator Infliximab.
    Inflamm Bowel Dis. 2021 Feb 12. pii: 6134175. doi: 10.1093.
    PubMed     Abstract available


  415. DHARMASIRI S, Garrido-Martin EM, Harris RJ, Bateman AC, et al
    Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease.
    Inflamm Bowel Dis. 2021 Feb 11. pii: 6133075. doi: 10.1093.
    PubMed     Abstract available


  416. DALAL RS, Allegretti JR
    Ustekinumab Dose Optimization in Crohn Disease: One Size Does Not Fit All.
    Inflamm Bowel Dis. 2021 Feb 11. pii: 6133071. doi: 10.1093.
    PubMed    


  417. JUDGE C, Saeidi R, Sugrue K, Rabbitt L, et al
    Combining Therapies in Inflammatory Bowel Disease: End of the Line or a New Era?
    Inflamm Bowel Dis. 2021 Feb 5. pii: 6129139. doi: 10.1093.
    PubMed    


  418. MAHMMOD S, Schultheiss JPD, van Bodegraven AA, Dijkstra G, et al
    Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 4. pii: 6128461. doi: 10.1093.
    PubMed     Abstract available


  419. BHURWAL A, Minacapelli CD, Patel A, Mutneja H, et al
    Evaluation of a U.S. National Cohort to Determine Utilization in Colectomy Rates for Ulcerative Colitis Among Ethnicities.
    Inflamm Bowel Dis. 2021 Feb 3. pii: 6127293. doi: 10.1093.
    PubMed     Abstract available


  420. DUBINSKY MC, Watanabe K, Molander P, Peyrin-Biroulet L, et al
    Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis-Patients' and Physicians' View.
    Inflamm Bowel Dis. 2021 Feb 2. pii: 6126719. doi: 10.1093.
    PubMed     Abstract available


  421. BALDAN-MARTIN M, Chaparro M, Gisbert JP
    Tissue Proteomic Approaches to Understand the Pathogenesis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Feb 2. pii: 6126723. doi: 10.1093.
    PubMed     Abstract available


  422. GARG R, Mohammed A, Singh A, Regueiro M, et al
    Trends and Outcomes of Acute Diverticulitis in Inflammatory Bowel Disease: A Propensity-matched National Study.
    Inflamm Bowel Dis. 2021 Feb 2. pii: 6126191. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  423. RUBIN DT, Sninsky C, Siegmund B, Sans M, et al
    International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey.
    Inflamm Bowel Dis. 2021 Jan 29. pii: 6123676. doi: 10.1093.
    PubMed     Abstract available


  424. ROBERTSON AR, Arnott ID
    How Can We Predict Who Would Benefit From a Small-Bowel Capsule Endoscopy When Staging Crohn Disease?
    Inflamm Bowel Dis. 2021 Jan 29. pii: 6123688. doi: 10.1093.
    PubMed    



  425. Corrigendum to: Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies.
    Inflamm Bowel Dis. 2021 Jan 29. pii: 6123652. doi: 10.1093.
    PubMed    


  426. SHAH J, Shah A, Hassman L, Gutierrez A, et al
    Ocular Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121235. doi: 10.1093.
    PubMed     Abstract available


  427. CHUGH R, Kroner PT, Farraye FA, Ginsburg PM, et al
    Small-Bowel Lymphoma Mimicking Crohn Disease: A Case Series.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121236. doi: 10.1093.
    PubMed    


  428. DE SIRE R, Castiglione F, Picardi M, Mascolo M, et al
    Chemotherapy-Induced Remission of Steroid-Dependent Ulcerative Colitis Associated With Rectal Hodgkin Lymphoma.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121229. doi: 10.1093.
    PubMed    


  429. SORRENTINO D, Gray JM
    Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121238. doi: 10.1093.
    PubMed     Abstract available


  430. SUZUKI K, Kakuta Y, Naito T, Takagawa T, et al
    Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 27. pii: 6121230. doi: 10.1093.
    PubMed     Abstract available


  431. SEDANO R, Jairath V
    Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata.
    Inflamm Bowel Dis. 2021 Jan 23. pii: 6114619. doi: 10.1093.
    PubMed    


  432. SEDANO R, Jairath V
    High-Dose Rescue Tofacitinib Prevented Inpatient Colectomy in Acute Severe Ulcerative Colitis Refractory to Anti-TNF.
    Inflamm Bowel Dis. 2021 Jan 23. pii: 6114620. doi: 10.1093.
    PubMed    


  433. BURKE KE, Kochar B, Allegretti JR, Winter RW, et al
    Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:155-161.
    PubMed     Abstract available


  434. HASHASH JG, Jabak S, Francis FF, Regueiro M, et al
    Should We Be Screening for SARS-CoV-2 in IBD Patients Before Initiation of Biologic Therapy?
    Inflamm Bowel Dis. 2021;27:291-294.
    PubMed    


  435. LEE S, Clark-Snustad K
    Patient with Fistulizing Crohn's Disease with Nonresponse to Infliximab Subsequently Responds to Infliximab After Short-term Addition of Tacrolimus.
    Inflamm Bowel Dis. 2021;27:e20-e22.
    PubMed    


  436. DOS SANTOS CHM, Galindo ACA, da Silva BA, Dantas CR, et al
    Is There Really a Direct Relationship Between IBD and Anxiety/Depression, or Could Any Chronic Disease Have These Manifestations?
    Inflamm Bowel Dis. 2021;27:e18-e19.
    PubMed    


  437. NIGHOT P, Ma T
    Endocytosis of Intestinal Tight Junction Proteins: In Time and Space.
    Inflamm Bowel Dis. 2021;27:283-290.
    PubMed     Abstract available


  438. VAGIANOS K, Shafer LA, Witges K, Targownik LE, et al
    Association Between Change in Inflammatory Aspects of Diet and Change in IBD-related Inflammation and Symptoms Over 1 Year: The Manitoba Living With IBD Study.
    Inflamm Bowel Dis. 2021;27:190-202.
    PubMed     Abstract available


  439. SCHNELL A, Schwarz B, Wahlbuhl M, Allabauer I, et al
    Distribution and Cytokine Profile of Peripheral B Cell Subsets Is Perturbed in Pediatric IBD and Partially Restored During a Successful IFX Therapy.
    Inflamm Bowel Dis. 2021;27:224-235.
    PubMed     Abstract available


  440. DE CARVALHO LGF, Lima WG, Coelho LGV, Cardoso VN, et al
    Circulating Leptin Levels as a Potential Biomarker in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2021;27:169-181.
    PubMed     Abstract available


  441. MACALUSO FS, Fries W, Viola A, Centritto A, et al
    The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches.
    Inflamm Bowel Dis. 2021;27:182-189.
    PubMed     Abstract available


  442. BRAMUZZO M, Lionetti P, Miele E, Romano C, et al
    Phenotype and Natural History of Children With Coexistent Inflammatory Bowel Disease and Celiac Disease.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102415. doi: 10.1093.
    PubMed     Abstract available


  443. DI NARDO G, Quitadamo P, Quatrini M, Malfona F, et al
    Autoimmune Hemolitic Anemia in a Boy With Inactive Ulcerative Colitis.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102424. doi: 10.1093.
    PubMed    


  444. TA AD, Ollberding NJ, Karns R, Haberman Y, et al
    Association of Baseline Luminal Narrowing With Ileal Microbial Shifts and Gene Expression Programs and Subsequent Transmural Healing in Pediatric Crohn Disease.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102412. doi: 10.1093.
    PubMed     Abstract available


  445. ROY PALADHI U, Harb AH, Daniel SG, Dawwas GK, et al
    The Impact of Introducing Patient-Reported Inflammatory Bowel Disease Symptoms via Electronic Survey on Clinic Visit Length, Patient and Provider Satisfaction, and the Environment Microbiome.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102417. doi: 10.1093.
    PubMed    


  446. CHANDE N, Singh S, Narula N, Gordon M, et al
    Medical Management Following Surgical Therapy in Inflammatory Bowel Disease: Evidence from Cochrane Reviews.
    Inflamm Bowel Dis. 2021 Jan 16. pii: 6102409. doi: 10.1093.
    PubMed    


  447. WEIMERS P, Ankersen DV, Lokkegaard ECL, Burisch J, et al
    Occurrence of Colorectal Cancer and the Influence of Medical Treatment in Patients With Inflammatory Bowel Disease: A Danish Nationwide Cohort Study, 1997 to 2015.
    Inflamm Bowel Dis. 2021 Jan 7. pii: 6067198. doi: 10.1093.
    PubMed     Abstract available


  448. LI N, Zhan S, Tian Z, Liu C, et al
    Alterations in Bile Acid Metabolism Associated With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 5. pii: 6063290. doi: 10.1093.
    PubMed     Abstract available


  449. REGENSBURGER D, Tenkerian C, Purzer V, Schmid B, et al
    Matricellular Protein SPARCL1 Regulates Blood Vessel Integrity and Antagonizes Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061405. doi: 10.1093.
    PubMed     Abstract available


  450. FOULON A, Pichois R, Sabbagh C, Fumery M, et al
    Bowel Endometriosis Mimicking Crohn Disease.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061378. doi: 10.1093.
    PubMed    


  451. PUGLIESE D, Schepis T, Bove V, Privitera G, et al
    Morbidly Obese Patient With Ulcerative Colitis Treated With Endoscopic Gastroplasty: A Case Report.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061374. doi: 10.1093.
    PubMed    


  452. KOCHHAR GS, Mohan BP, Khan SR, Chandan S, et al
    Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2021 Jan 4. pii: 6061413. doi: 10.1093.
    PubMed     Abstract available


  453. HONG S, Zaki TA, Main M, Hine AM, et al
    Comparative Evaluation of Conventional Stool Testing and Multiplex Molecular Panel in Outpatients With Relapse of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021 Jan 2. pii: 6058972. doi: 10.1093.
    PubMed     Abstract available


  454. SCHARRER S, Primas C, Eichinger S, Tonko S, et al
    Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism.
    Inflamm Bowel Dis. 2021 Jan 2. pii: 6058971. doi: 10.1093.
    PubMed     Abstract available


  455. BAR-GIL SHITRIT A, Ben-Horin S, Mishael T, Hoyda A, et al
    Detection of Ustekinumab in Breast Milk of Nursing Mothers With Crohn Disease.
    Inflamm Bowel Dis. 2021 Jan 2. pii: 6058989. doi: 10.1093.
    PubMed    


  456. JEON Y, Limketkai BN
    Implications of Dietary Impact on Hepatic Steatosis and IBD.
    Inflamm Bowel Dis. 2021;27:10-11.
    PubMed    


  457. PENRICE DD, Kamboj AK, Simonetto DA
    Infliximab-induced Liver Injury: A Common Link Between Crohn's Disease and Acute Liver Injury.
    Inflamm Bowel Dis. 2021;27:e7-e8.
    PubMed    


  458. REINISCH W, Gecse K, Halfvarson J, Irving PM, et al
    Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:106-122.
    PubMed     Abstract available


  459. RIPOLLES T, Poza J, Suarez Ferrer C, Martinez-Perez MJ, et al
    Evaluation of Crohn's Disease Activity: Development of an Ultrasound Score in a Multicenter Study.
    Inflamm Bowel Dis. 2021;27:145-154.
    PubMed     Abstract available


  460. OLAISEN M, Flatberg A, Granlund AVB, Royset ES, et al
    Bacterial Mucosa-associated Microbiome in Inflamed and Proximal Noninflamed Ileum of Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2021;27:12-24.
    PubMed     Abstract available


  461. CHICCO F, Magri S, Cingolani A, Paduano D, et al
    Multidimensional Impact of Mediterranean Diet on IBD Patients.
    Inflamm Bowel Dis. 2021;27:1-9.
    PubMed     Abstract available


  462. CALDERA F, Ley D, Hayney MS, Farraye FA, et al
    Optimizing Immunization Strategies in Patients with IBD.
    Inflamm Bowel Dis. 2021;27:123-133.
    PubMed     Abstract available


  463. ARVANITIS M, Hart LC, DeWalt DA, Diaz-Gonzalez de Ferris ME, et al
    Transition Readiness Not Associated With Measures of Health in Youth With IBD.
    Inflamm Bowel Dis. 2021;27:49-57.
    PubMed     Abstract available


  464. SZIGETHY E, Murphy SM, Ehrlich OG, Engel-Nitz NM, et al
    Mental Health Costs of Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2021;27:40-48.
    PubMed     Abstract available


  465. SEGAL JP, Askari A, Clark SK, Hart AL, et al
    The Incidence and Prevalence of Human Papilloma Virus-associated Cancers in IBD.
    Inflamm Bowel Dis. 2021;27:34-39.
    PubMed     Abstract available


  466. VASSEUR P, Dugelay E, Benamouzig R, Savoye G, et al
    Dietary Patterns, Ultra-processed Food, and the Risk of Inflammatory Bowel Diseases in the NutriNet-Sante Cohort.
    Inflamm Bowel Dis. 2021;27:65-73.
    PubMed     Abstract available


    December 2020
  467. HIRTEN RP, Danieletto M, Scheel R, Shervey M, et al
    Longitudinal Autonomic Nervous System Measures Correlate With Stress and Ulcerative Colitis Disease Activity and Predict Flare.
    Inflamm Bowel Dis. 2020 Dec 31. pii: 6056323. doi: 10.1093.
    PubMed     Abstract available


  468. HASOSAH M, Alqahtani A, Almehaidib A, Qurashi M, et al
    Congenital Chloride Diarrhea and Childhood Inflammatory Bowel Disease: A Multicenter Case Series.
    Inflamm Bowel Dis. 2020 Dec 30. pii: 6055672. doi: 10.1093.
    PubMed    


  469. BORREN NZ, Long MD, Sandler RS, Ananthakrishnan AN, et al
    Longitudinal Trajectory of Fatigue in Patients With Inflammatory Bowel Disease: A Prospective Study.
    Inflamm Bowel Dis. 2020 Dec 25. pii: 6047698. doi: 10.1093.
    PubMed     Abstract available


  470. QIN X
    More Epidemiological Studies Warranted to Determine the Cause of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Dec 17. pii: 6040645. doi: 10.1093.
    PubMed    


  471. CURTIS JR, Regueiro M, Yun H, Su C, et al
    Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan(R) Administrative Claims Database With Tofacitinib Trial Data.
    Inflamm Bowel Dis. 2020 Dec 16. pii: 6039005. doi: 10.1093.
    PubMed     Abstract available


  472. DWADASI S, Zafer M, Goens D, Paknikar R, et al
    Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Dec 15. pii: 6034840. doi: 10.1093.
    PubMed     Abstract available


  473. PARIAN AM, Limketkai BN, Chowdhury R, Brewer GG, et al
    Serrated Epithelial Change Is Associated With High Rates of Neoplasia in Ulcerative Colitis Patients: A Case-controlled Study and Systematic Review With Meta-analysis.
    Inflamm Bowel Dis. 2020 Dec 9. pii: 6028664. doi: 10.1093.
    PubMed     Abstract available


  474. MELO FJ, Pinto-Lopes P, Estevinho MM, Magro F, et al
    The Role of Dipeptidyl Peptidase 4 as a Therapeutic Target and Serum Biomarker in Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2020 Dec 9. pii: 6028655. doi: 10.1093.
    PubMed     Abstract available


  475. LEE C, Hong SN, Kim ER, Chang DK, et al
    Depletion of Intestinal Stem Cell Niche Factors Contributes to the Alteration of Epithelial Differentiation in SAMP1/YitFcsJ Mice With Crohn Disease-Like Ileitis.
    Inflamm Bowel Dis. 2020 Dec 4. pii: 6020062. doi: 10.1093.
    PubMed     Abstract available


  476. BERNSTEIN CN, Hitchon CA, Walld R, Bolton JM, et al
    The Impact of Psychiatric Comorbidity on Health Care Utilization in Inflammatory Bowel Disease: A Population-based Study.
    Inflamm Bowel Dis. 2020 Dec 4. pii: 6020061. doi: 10.1093.
    PubMed     Abstract available


  477. LEE SH, Walshe M, Oh EH, Hwang SW, et al
    Early Changes in Serum Albumin Predict Clinical and Endoscopic Outcomes in Patients With Ulcerative Colitis Starting Anti-TNF Treatment.
    Inflamm Bowel Dis. 2020 Dec 3. pii: 6017554. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  478. BATTAT R, Lukin D, Scherl EJ, Pola S, et al
    Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 30. pii: 6012174. doi: 10.1093.
    PubMed     Abstract available


  479. BAMBA S, Inatomi O, Takahashi K, Morita Y, et al
    Assessment of Body Composition From CT Images at the Level of the Third Lumbar Vertebra in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 25. pii: 6000807. doi: 10.1093.
    PubMed     Abstract available


  480. YOON H, Jangi S, Dulai PS, Boland BS, et al
    Histologic Remission Is Associated With Lower Risk of Treatment Failure in Patients With Crohn Disease in Endoscopic Remission.
    Inflamm Bowel Dis. 2020 Nov 25. pii: 6000793. doi: 10.1093.
    PubMed     Abstract available


  481. DIMOPOULOS C, Al-Bawardy B
    SARS-CoV-2 Infection and Dual-Biologic Therapy for Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:e153-e154.
    PubMed    


  482. UR RAHMAN A, Hussain I, Hasan B, Ur Rashid M, et al
    Association of Complicated Diverticulitis With Development of De Novo Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 18. pii: 5987626. doi: 10.1093.
    PubMed     Abstract available


  483. BROMS G, Friedman S, Kim SC, Wood ME, et al
    The Patterns of Use of Medications for Inflammatory Bowel Disease During Pregnancy in the US and Sweden Are Changing.
    Inflamm Bowel Dis. 2020 Nov 18. pii: 5987622. doi: 10.1093.
    PubMed     Abstract available


  484. GEEM D, Kugathasan S
    It Takes Two to Make It Right: Dual Biologic and Small Molecule Therapy for Treatment-Refractory Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 17. pii: 5984956. doi: 10.1093.
    PubMed    


  485. SEDANO R, Jairath V
    Tofacitinib Induced Long-term Clinical, Endoscopic, and Histological Remission as a 6th Line Agent in Medically Refractory Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Nov 17. pii: 5985000. doi: 10.1093.
    PubMed    


  486. ATTAUABI M, Burisch J, Seidelin JB
    Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study.
    Inflamm Bowel Dis. 2020 Nov 17. pii: 5985019. doi: 10.1093.
    PubMed    


  487. GONZALEZ-BERNARDO O, Riestra S, Vivas S, de Francisco R, et al
    Chromoendoscopy With Indigo Carmine vs Virtual Chromoendoscopy (iSCAN 1) for Neoplasia Screening in Patients With Inflammatory Bowel Disease: A Prospective Randomized Study.
    Inflamm Bowel Dis. 2020 Nov 10. pii: 5970332. doi: 10.1093.
    PubMed     Abstract available


  488. BRETON J, Witmer CM, Zhang Y, Downing M, et al
    Utilization of an Electronic Medical Record-integrated Dashboard Improves Identification and Treatment of Anemia and Iron Deficiency in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962204. doi: 10.1093.
    PubMed     Abstract available


  489. SHIRWAIKAR THOMAS A, Criss ZK, Shroyer NF, Abraham BP, et al
    Vitamin D Receptor Gene Single Nucleotide Polymorphisms and Association With Vitamin D Levels and Endoscopic Disease Activity in Inflammatory Bowel Disease Patients: A Pilot Study.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962201. doi: 10.1093.
    PubMed     Abstract available


  490. RAMOS GP, Dimopoulos C, McDonald NM, Janssens LP, et al
    The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962203. doi: 10.1093.
    PubMed     Abstract available


  491. SIVASAILAM B, Manski S, Wentz A, Cross RK, et al
    Presence of Obstructive Symptoms and Absence of Perianal Crohn Disease Is Predictive of Surgery After Endoscopic Balloon Dilation.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962193. doi: 10.1093.
    PubMed     Abstract available


  492. CORDES F, Lenker E, Weinhage T, Spille LJ, et al
    Impaired IFN-gamma-dependent STAT3 Activation Is Associated With Dysregulation of Regulatory and Inflammatory Signaling in Monocytes of Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2020 Nov 9. pii: 5962195. doi: 10.1093.
    PubMed     Abstract available


  493. SLEUTJES JAM, de Vries AC, van der Woude CJ, Roeters van Lennep JE, et al
    Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.
    Inflamm Bowel Dis. 2020 Nov 6. pii: 5957728. doi: 10.1093.
    PubMed    


  494. HALLORAN BP, Jamil LH, Lo SK, Reeson M, et al
    Double-Balloon Endoscopy in Crohn Disease: A Tertiary Referral Center Experience.
    Inflamm Bowel Dis. 2020 Nov 6. pii: 5957726. doi: 10.1093.
    PubMed     Abstract available


  495. ALLEGRETTI JR, Kelly CR, Grinspan A, Mullish BH, et al
    Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection.
    Inflamm Bowel Dis. 2020 Nov 6. pii: 5957723. doi: 10.1093.
    PubMed     Abstract available


  496. BRUCKNER RS, Spalinger MR, Barnhoorn MC, Feakins R, et al
    Contribution of CD3+CD8- and CD3+CD8+ T Cells to TNF-alpha Overexpression in Crohn Disease-Associated Perianal Fistulas and Induction of Epithelial-Mesenchymal Transition in HT-29 Cells.
    Inflamm Bowel Dis. 2020 Nov 4. pii: 5955654. doi: 10.1093.
    PubMed     Abstract available


  497. BLOOMFELD RS, Bickston SJ
    Financial Toxicity in People With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Nov 4. pii: 5955755. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  498. DOLINGER MT, Spencer EA, Lai J, Dunkin D, et al
    Dual Biologic and Small Molecule Therapy for the Treatment of Refractory Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Oct 30. pii: 5944028. doi: 10.1093.
    PubMed     Abstract available


  499. RUBIN DT, Griffith J, Zhang Q, Hepp Z, et al
    The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor Therapies.
    Inflamm Bowel Dis. 2020 Oct 27. pii: 5940811. doi: 10.1093.
    PubMed     Abstract available


  500. BEHZAD C, Taheri H, Kashifard M
    Establishing Safe Out-of-Hospital Infusion Centers May Improve the Quality of Care in Patients With IBD During the COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020;26:e140.
    PubMed    


  501. HORRIGAN JM, Siegel CA, Tadros M
    Management of IBD Patients Who Are Unwilling or Unable to Receive Infusion Therapy During the COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020;26:e137.
    PubMed    


  502. ELTABBAKH MM, Shamkh MAA, Bassuny AN, Abd Alaty WH, et al
    Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020;26:1771-1778.
    PubMed    


  503. MATSUMOTO K, Urabe Y, Oka S, Inagaki K, et al
    Genomic Landscape of Early-stage Colorectal Neoplasia Developing From the Ulcerative Colitis Mucosa in the Japanese Population.
    Inflamm Bowel Dis. 2020 Oct 22. pii: 5934978. doi: 10.1093.
    PubMed     Abstract available


  504. FERREIRA-DUARTE M, Estevinho MM, Duarte-Araujo M, Magro F, et al
    Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Oct 16. pii: 5925264. doi: 10.1093.
    PubMed     Abstract available


  505. RUBIN DT, Hart A, Panaccione R, Armuzzi A, et al
    Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians.
    Inflamm Bowel Dis. 2020 Oct 15. pii: 5924202. doi: 10.1093.
    PubMed     Abstract available


  506. KE J, He R, Hou X
    Reply to the Letter: Gut Microbiota-mediated Pleiotropic Effects of Fucose Can Improve Inflammatory Bowel Disease by Modulating Bile Acid Metabolism and Enhancing Propionate Production.
    Inflamm Bowel Dis. 2020 Oct 14. pii: 5923156. doi: 10.1093.
    PubMed    


  507. ALKHAYYAT M, Abureesh M, Gill A, Khoudari G, et al
    Lower Rates of Colorectal Cancer in Patients With Inflammatory Bowel Disease Using Anti-TNF Therapy.
    Inflamm Bowel Dis. 2020 Oct 14. pii: 5923165. doi: 10.1093.
    PubMed     Abstract available


  508. VANDE CASTEELE N, Feagan BG, Wolf DC, Pop A, et al
    Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Crohn Disease: A Theoretical Construct to Apply Pharmacokinetics and Guidelines to Clinical Practice.
    Inflamm Bowel Dis. 2020 Oct 14. pii: 5923164. doi: 10.1093.
    PubMed     Abstract available


  509. DE FREITAS LF, Feitosa MR, Feres O, Parra RS, et al
    Cutaneous Vasculitis Associated With Vedolizumab in Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Oct 13. pii: 5922392. doi: 10.1093.
    PubMed    


  510. CHEN G, Lissoos T, Dieyi C, Null KD, et al
    Development and Validation of an Inflammatory Bowel Disease Severity Index Using US Administrative Claims Data: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920980. doi: 10.1093.
    PubMed     Abstract available


  511. DOS SANTOS CHM, Koga GA
    The Challenge of Treating Pyoderma Gangrenosum in a Patient With Crohn Disease Based on Poor Scientific Evidence.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920985. doi: 10.1093.
    PubMed    


  512. TRINDADE IA, Ferreira NB
    COVID-19 Pandemic's Effects on Disease and Psychological Outcomes of People With Inflammatory Bowel Disease in Portugal: A Preliminary Research.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920974. doi: 10.1093.
    PubMed     Abstract available


  513. MARKOVIC S, Ivanovski TK, Zogovic B, Cvetkovic M, et al
    Biological Therapy for Inflammatory Bowel Disease During the COVID-19 Pandemic: Experiences From a Tertiary IBD Service.
    Inflamm Bowel Dis. 2020 Oct 12. pii: 5920986. doi: 10.1093.
    PubMed    


  514. FANTINI MC, Biancone L, Dragoni G, Bezzio C, et al
    Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey.
    Inflamm Bowel Dis. 2020 Oct 8. pii: 5919368. doi: 10.1093.
    PubMed    


  515. FANG X, Vazquez-Baeza Y, Elijah E, Vargas F, et al
    Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiome and Metabolome Diversity.
    Inflamm Bowel Dis. 2020 Oct 7. pii: 5918916. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  516. YU Q
    Slc26a3 (DRA) in the Gut: Expression, Function, Regulation, Role in Infectious Diarrhea and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Sep 29. pii: 5912727. doi: 10.1093.
    PubMed     Abstract available


  517. PEMMASANI G, Elgendy I, Mamas MA, Leighton JA, et al
    Epidemiology and Clinical Outcomes of Patients With Inflammatory Bowel Disease Presenting With Acute Coronary Syndrome.
    Inflamm Bowel Dis. 2020 Sep 26. pii: 5911943. doi: 10.1093.
    PubMed     Abstract available


  518. KUROWSKI JA, Achkar JP, Gupta R, Barbur I, et al
    Adipokine Resistin Levels at Time of Pediatric Crohn Disease Diagnosis Predict Escalation to Biologic Therapy.
    Inflamm Bowel Dis. 2020 Sep 26. pii: 5911945. doi: 10.1093.
    PubMed     Abstract available


  519. SINH P, Cross R
    Cardiovascular Risk Assessment and Impact of Medications on Cardiovascular Disease in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Sep 26. pii: 5911946. doi: 10.1093.
    PubMed     Abstract available


  520. SANDBORN WJ, Feagan BG, Danese S, O'Brien CD, et al
    Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies.
    Inflamm Bowel Dis. 2020 Sep 23. pii: 5910238. doi: 10.1093.
    PubMed     Abstract available


  521. VIGANO C, Massironi S, Pirola L, Cristoferi L, et al
    COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy.
    Inflamm Bowel Dis. 2020 Sep 19. pii: 5908896. doi: 10.1093.
    PubMed    


  522. HONAP S, Cookson H, Sharma E, Samaan MA, et al
    Tofacitinib for the Treatment of Ulcerative Colitis, Alopecia Universalis, and Atopic Dermatitis: One Drug, Three Diseases.
    Inflamm Bowel Dis. 2020 Sep 18. pii: 5908061. doi: 10.1093.
    PubMed    


  523. CASTELLINI G, Savarese M, Leone S, Previtali E, et al
    Italian IBD Patients Coping With Covid-19 Emergency: The Mitigating Role of Psychological Readiness to Engage in Self-care.
    Inflamm Bowel Dis. 2020;26:e130-e131.
    PubMed    


  524. OCCHIPINTI V, Sociale OR, Pastorelli L
    Response to "Italian IBD Patients Coping With COVID-19 Emergency: The Mitigating Role of Psychological Readiness to Engage in Self-Care".
    Inflamm Bowel Dis. 2020;26:e123.
    PubMed    


  525. RIMONDI A, Tontini GE, Mazza S, Caprioli F, et al
    Fogging IBD Management: An Unusual Case of IBD Flare-up During the COVID-19 Outbreak.
    Inflamm Bowel Dis. 2020;26:e128-e129.
    PubMed    


  526. BURGUENO JF, Abreu MT
    Reply to the Letter to the Editor: The Incidence and Outcomes of COVID-19 in Patients With IBD: A Rapid Review and Meta-Analysis.
    Inflamm Bowel Dis. 2020;26:e127.
    PubMed    


  527. AZIZ M, Fatima R, Haghbin H, Lee-Smith W, et al
    The Incidence and Outcomes of COVID-19 in IBD Patients: A Rapid Review and Meta-analysis.
    Inflamm Bowel Dis. 2020;26:e132-e133.
    PubMed    


  528. CLOUGH JN, Hill KL, Duff A, Sharma E, et al
    Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective.
    Inflamm Bowel Dis. 2020;26:e125-e126.
    PubMed    


  529. NAVANEETHAN U, LehnerNoguera V
    Prolonged Duration of SARS-CoV-2 Viral Positivity in a Crohn's Disease Patient.
    Inflamm Bowel Dis. 2020;26:e124.
    PubMed    


  530. KORNBLUTH A, Kissous-Hunt M, George J, Legnani P, et al
    Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic.
    Inflamm Bowel Dis. 2020 Sep 3. pii: 5900880. doi: 10.1093.
    PubMed    


  531. KOUTROUMPAKIS F, Phillips AE, Yadav D, Machicado JD, et al
    Serum IgG4 Subclass Deficiency Defines a Distinct, Commonly Encountered, Severe Inflammatory Bowel Disease Subtype.
    Inflamm Bowel Dis. 2020 Sep 3. pii: 5900865. doi: 10.1093.
    PubMed     Abstract available


  532. SITKIN S, Vakhitov T, Kononova S, Skalinskaya M, et al
    Gut Microbiota-Mediated Pleiotropic Effects of Fucose Can Improve Inflammatory Bowel Disease by Modulating Bile Acid Metabolism and Enhancing Propionate Production.
    Inflamm Bowel Dis. 2020 Sep 3. pii: 5900883. doi: 10.1093.
    PubMed    


  533. SANDS BE, Colombel JF, Ha C, Farnier M, et al
    Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.
    Inflamm Bowel Dis. 2020 Sep 1. pii: 5900074. doi: 10.1093.
    PubMed     Abstract available


  534. SYED S, Stidham RW
    Potential for Standardization and Automation for Pathology and Endoscopy in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Sep 1. pii: 5900066. doi: 10.1093.
    PubMed     Abstract available


  535. BEZZIO C, Pellegrini L, Manes G, Arena I, et al
    Biologic Therapies May Reduce the Risk of COVID-19 in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Sep 1. pii: 5900070. doi: 10.1093.
    PubMed    


    August 2020
  536. ALBSHESH A, Ungar B, Ben-Horin S, Eliakim R, et al
    Terminal Ileum Thickness During Maintenance Therapy Is a Predictive Marker of the Outcome of Infliximab Therapy in Crohn Disease.
    Inflamm Bowel Dis. 2020 Aug 29. pii: 5898844. doi: 10.1093.
    PubMed     Abstract available


  537. GUERRA I, Algaba A, Jimenez L, Mar Aller M, et al
    Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain.
    Inflamm Bowel Dis. 2020 Aug 24. pii: 5896213. doi: 10.1093.
    PubMed     Abstract available


  538. COHEN BL, Gallinger ZR, Ha C, Holubar SD, et al
    Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States.
    Inflamm Bowel Dis. 2020;26:1291-1305.
    PubMed     Abstract available


  539. ZHANG Q, Chen D, Yang Y
    Incidence and Prevalence of Human Papilloma Virus-associated Cancers in IBD.
    Inflamm Bowel Dis. 2020;26:e101.
    PubMed    


  540. HU AB, Burke KE, Kochar B, Ananthakrishnan AN, et al
    Yield of Random Biopsies During Colonoscopies in Inflammatory Bowel Disease Patients Undergoing Dysplasia Surveillance.
    Inflamm Bowel Dis. 2020 Aug 19. pii: 5894187. doi: 10.1093.
    PubMed     Abstract available


  541. PALACIOS ARGUETA P, Salazar M, Attar B, Simons-Linares R, et al
    90-Day Specific Readmission for Clostridium difficile Infection After Hospitalization With an Inflammatory Bowel Disease Flare: Outcomes and Risk Factors.
    Inflamm Bowel Dis. 2020 Aug 19. pii: 5894152. doi: 10.1093.
    PubMed     Abstract available


  542. MAVRAGANI CP, Nezos A, Dovrolis N, Andreou NP, et al
    Type I and II Interferon Signatures Can Predict the Response to Anti-TNF Agents in Inflammatory Bowel Disease Patients: Involvement of the Microbiota.
    Inflamm Bowel Dis. 2020 Aug 19. pii: 5894175. doi: 10.1093.
    PubMed     Abstract available


  543. TOWNSEND T, Fiske J, Collins P, Bond A, et al
    Ambulatory Management of Acute Severe Ulcerative Colitis: A Pandemic-driven Initiative.
    Inflamm Bowel Dis. 2020 Aug 19. pii: 5894170. doi: 10.1093.
    PubMed    


  544. SUGIMOTO K, Fujita S, Miyazu T, Ishida N, et al
    Improvement in Ulcerative Colitis by Administration of Benralizumab for Comorbid Refractory Bronchial Asthma: A Novel Clinical Observation.
    Inflamm Bowel Dis. 2020 Aug 19. pii: 5894173. doi: 10.1093.
    PubMed    


  545. JOSE DA SILVA R, da Rocha Ribeiro TC, Chebli LA, Chebli JMF, et al
    An Unexpected Cause of Headache and Splenic Lesions During Anti-TNF Therapy in Crohn Disease.
    Inflamm Bowel Dis. 2020 Aug 19. pii: 5894171. doi: 10.1093.
    PubMed    


  546. DUBINSKY MC, DiBonaventura M, Fan H, Bushmakin AG, et al
    Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies.
    Inflamm Bowel Dis. 2020 Aug 14. pii: 5892619. doi: 10.1093.
    PubMed     Abstract available


  547. HOKAMA A, Omija H, Kishimoto K, Kinjo T, et al
    Response to "Histopathological Mimics of Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2020 Aug 14. pii: 5892558. doi: 10.1093.
    PubMed    


  548. BATRA SK, Heier CR, Diaz-Calderon L, Tully CB, et al
    Serum miRNAs Are Pharmacodynamic Biomarkers Associated With Therapeutic Response in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Aug 14. pii: 5892560. doi: 10.1093.
    PubMed     Abstract available


  549. BERNSTEIN CN, Ng SC, Banerjee R, Steinwurz F, et al
    Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey.
    Inflamm Bowel Dis. 2020 Aug 14. pii: 5892568. doi: 10.1093.
    PubMed     Abstract available


  550. LIU C, Yuan ZY, Yuan H, Wu KX, et al
    Status of Gene Methylation and Polymorphism in Different Courses of Ulcerative Colitis and Their Comparison with Sporadic Colorectal Cancer.
    Inflamm Bowel Dis. 2020 Aug 14. pii: 5892563. doi: 10.1093.
    PubMed     Abstract available


  551. LIN A, Roth H, Anyane-Yeboa A, Rubin DT, et al
    Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2020 Aug 11. pii: 5891018. doi: 10.1093.
    PubMed     Abstract available


  552. BORREN NZ, Plichta D, Joshi AD, Bonilla G, et al
    Multi-"-Omics" Profiling in Patients With Quiescent Inflammatory Bowel Disease Identifies Biomarkers Predicting Relapse.
    Inflamm Bowel Dis. 2020 Aug 7. pii: 5885066. doi: 10.1093.
    PubMed     Abstract available


  553. LICHTENSTEIN GR, Rogler G, Ciorba MA, Su C, et al
    Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program.
    Inflamm Bowel Dis. 2020 Aug 7. pii: 5885008. doi: 10.1093.
    PubMed     Abstract available


  554. LO SASSO G, Khachatryan L, Kondylis A, Battey JND, et al
    Inflammatory Bowel Disease-Associated Changes in the Gut: Focus on Kazan Patients.
    Inflamm Bowel Dis. 2020 Aug 7. pii: 5885057. doi: 10.1093.
    PubMed     Abstract available


  555. GARRIDO I, Lopes S, Macedo G
    Inflammatory Bowel Disease Management in a Major Referral Center During COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020 Aug 1. pii: 5879647. doi: 10.1093.
    PubMed    


    July 2020
  556. MAJSTER M, Lira-Junior R, Hoog CM, Almer S, et al
    Salivary and Serum Inflammatory Profiles Reflect Different Aspects of Inflammatory Bowel Disease Activity.
    Inflamm Bowel Dis. 2020 Jul 29. pii: 5877759. doi: 10.1093.
    PubMed     Abstract available


  557. JAGANNATH B, Lin KC, Pali M, Sankhala D, et al
    A Sweat-based Wearable Enabling Technology for Real-time Monitoring of IL-1beta and CRP as Potential Markers for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jul 28. pii: 5877396. doi: 10.1093.
    PubMed     Abstract available


  558. SEHGAL P, Ungaro RC, Foltz C, Iacoviello B, et al
    High Levels of Psychological Resilience Associated With Less Disease Activity, Better Quality of Life, and Fewer Surgeries in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jul 22. pii: 5874745. doi: 10.1093.
    PubMed     Abstract available


  559. TIAN WN, Huang YH, Dai C
    The Effect of the COVID-19 Pandemic on the Medical Mode of Patients With Inflammatory Bowel Disease in China.
    Inflamm Bowel Dis. 2020 Jul 22. pii: 5874746. doi: 10.1093.
    PubMed    


  560. GREEN ME, Brahmbhatt B, Baumgarten D, Krishna M, et al
    Meckel's Diverticulum Masquerading as Crohn Disease.
    Inflamm Bowel Dis. 2020 Jul 21. pii: 5874417. doi: 10.1093.
    PubMed    


  561. VERDON C, Reinglas J, Coulombe J, Gonczi L, et al
    No Change in Surgical and Hospitalization Trends Despite Higher Exposure to Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease in the Quebec Provincial Database From 1996 to 2015.
    Inflamm Bowel Dis. 2020 Jul 17. pii: 5872809. doi: 10.1093.
    PubMed     Abstract available


  562. NAVANEETHAN U, Lourdusamy D, LehnerNoguera V, Shen B, et al
    Safety of Endoscopy in Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020 Jul 17. pii: 5872834. doi: 10.1093.
    PubMed    


  563. CRISTOBAL I, Madoz-Gurpide J, Rojo F, Garcia-Foncillas J, et al
    The Molecular Mechanisms Involved in the miR-29a-5p/STAT3 Signaling Loop in Ulcerative Colitis-Associated Colorectal Cancer Still Remain Unclear.
    Inflamm Bowel Dis. 2020;26:e87.
    PubMed    


  564. BERINSTEIN JA, Cohen-Mekelburg SA, Steiner CA, McLeod M, et al
    Variations in Health Care Utilization Patterns Among Inflammatory Bowel Disease Patients at Risk for High Medical Service Utilization Enrolled in High Deductible Health Plans.
    Inflamm Bowel Dis. 2020 Jul 17. pii: 5872817. doi: 10.1093.
    PubMed     Abstract available


  565. HERNANDEZ BENABE S, Langshaw AH
    IBD in the Times of COVID-19.
    Inflamm Bowel Dis. 2020;26:e92.
    PubMed    


  566. BAMIAS G, Lagou S, Gizis M, Karampekos G, et al
    The Greek Response to COVID-19: A True Success Story from an IBD Perspective.
    Inflamm Bowel Dis. 2020;26:1144-1148.
    PubMed     Abstract available


  567. GOYAL A
    Clostridium Difficile and Increased Risk of Surgery in Crohn's Disease. Can Early Microbial Signatures Forecast Risk of Disease Progression?
    Inflamm Bowel Dis. 2020;26:1222-1224.
    PubMed    


  568. AYOUB A, Jairath V, Aldraiweesh S, Khanna R, et al
    Safety of Biologic Therapy in Octogenarians and Nonagenarians With Inflammatory Bowel Disease in Ontario: A Case Series.
    Inflamm Bowel Dis. 2020 Jul 11. pii: 5870254. doi: 10.1093.
    PubMed    


  569. GEORGIOU AN, Ntritsos G, Papadimitriou N, Dimou N, et al
    Cigarette Smoking, Coffee Consumption, Alcohol Intake, and Risk of Crohn's Disease and Ulcerative Colitis: A Mendelian Randomization Study.
    Inflamm Bowel Dis. 2020 Jul 6. pii: 5867966. doi: 10.1093.
    PubMed     Abstract available


  570. DI RUSCIO M, Variola A, Angheben A, Resimini S, et al
    A Challenging Colectomy for Acute Severe Ulcerative Colitis Complicated by COVID-19.
    Inflamm Bowel Dis. 2020 Jul 6. pii: 5867642. doi: 10.1093.
    PubMed    


  571. GROSSBERG LB, Pellish RS, Cheifetz AS, Feuerstein JD, et al
    Review of Societal Recommendations Regarding Management of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic.
    Inflamm Bowel Dis. 2020 Jul 3. pii: 5866902. doi: 10.1093.
    PubMed    


  572. CARD TR, Zittan E, Nguyen GC, Grainge MJ, et al
    Disease Activity in Inflammatory Bowel Disease Is Associated With Arterial Vascular Disease.
    Inflamm Bowel Dis. 2020 Jul 3. pii: 5866856. doi: 10.1093.
    PubMed     Abstract available


  573. SAHU P, Kedia S, Padhan R, Ahuja V, et al
    Pregnancy-Onset Inflammatory Bowel Disease (PO-IBD): A Riddle Inside an Enigma.
    Inflamm Bowel Dis. 2020 Jul 3. pii: 5866857. doi: 10.1093.
    PubMed    


    June 2020
  574. SEGAL JP, Askari A, Clark SK, Hart AL, et al
    HPV-related Cancers in Inflammatory Bowel Disease: Association Not Yet Causation.
    Inflamm Bowel Dis. 2020 Jun 29. pii: 5864595. doi: 10.1093.
    PubMed    


  575. DULAI PS, Jairath V, Zou G, Stitt LW, et al
    Early Combined Immunosuppression May Be More Effective for Reducing Complications in Isolated Colonic- vs Ileal-Dominant Crohn Disease.
    Inflamm Bowel Dis. 2020 Jun 27. pii: 5863990. doi: 10.1093.
    PubMed     Abstract available


  576. PEPE M, Carulli E, Forleo C, Moscarelli M, et al
    Inflammatory Bowel Disease and Acute Coronary Syndromes: From Pathogenesis to the Fine Line Between Bleeding and Ischemic Risk.
    Inflamm Bowel Dis. 2020 Jun 27. pii: 5863988. doi: 10.1093.
    PubMed     Abstract available


  577. LEE JA, Magavi PR, Konijeti GG
    Treatment of Ulcerative Colitis and Seronegative Inflammatory Spondyloarthritis With Vedolizumab and Tofacitinib.
    Inflamm Bowel Dis. 2020 Jun 27. pii: 5863987. doi: 10.1093.
    PubMed    


  578. AXELRAD JE, Malter L, Hong S, Chang S, et al
    From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area.
    Inflamm Bowel Dis. 2020 Jun 24. pii: 5861860. doi: 10.1093.
    PubMed     Abstract available


  579. GRANT RK, Jones GR, Plevris N, Lynch RW, et al
    The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Jun 23. pii: 5861142. doi: 10.1093.
    PubMed     Abstract available


  580. NAKASEKO H, Nishida D, Abe N, Tanaka K, et al
    Effect of Exclusive Enteral Nutrition on Renal Function for Granulomatous Interstitial Nephritis Associated With Crohn Disease.
    Inflamm Bowel Dis. 2020 Jun 22. pii: 5860630. doi: 10.1093.
    PubMed    


  581. HONAP S, Pavlidis P, Ray S, Sharma E, et al
    Tofacitinib in Acute Severe Ulcerative Colitis-A Real-World Tertiary Center Experience.
    Inflamm Bowel Dis. 2020 Jun 22. pii: 5860628. doi: 10.1093.
    PubMed    


  582. SCHAFER E, Shyu I, Walker C, Smallfield G, et al
    New Presentation of Hepatic Inflammatory Pseudotumor and Crohn Disease.
    Inflamm Bowel Dis. 2020 Jun 20. pii: 5860196. doi: 10.1093.
    PubMed    


  583. KELSEN JR, Dawany N, Conrad MA, Karakasheva TA, et al
    Colonoids From Patients With Pediatric Inflammatory Bowel Disease Exhibit Decreased Growth Associated With Inflammation Severity and Durable Upregulation of Antigen Presentation Genes.
    Inflamm Bowel Dis. 2020 Jun 19. pii: 5859746. doi: 10.1093.
    PubMed     Abstract available


  584. TSURUTA Y, Furuta Y, Naoe H, Tanaka M, et al
    Multiple Gastric Polyps Improved After Treatment for Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Jun 18. pii: 5859375. doi: 10.1093.
    PubMed    


  585. GUO L, Rohde J, Farraye FA
    Stigma and Disclosure in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020;26:1010-1016.
    PubMed     Abstract available


  586. GRASSIA R, Soro S, Conti CB
    Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not?
    Inflamm Bowel Dis. 2020;26:e71.
    PubMed    


  587. FLESHNER P
    Editorial on Hirten et al.
    Inflamm Bowel Dis. 2020;26:1059.
    PubMed    


  588. LIGHTNER AL
    Inflammation of the Ileal Anal Pouch: Do Biologics Really Change the Trajectory?
    Inflamm Bowel Dis. 2020;26:1087-1088.
    PubMed    


  589. ORTEGA MORENO L, Fernandez-Tome S, Chaparro M, Marin AC, et al
    Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates Between Type and Mucosal Status in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jun 17. pii: 5858322. doi: 10.1093.
    PubMed     Abstract available


  590. JEROME R, Sebastien H, Delphine WV, Jean-Francois E, et al
    Refractory Inflammatory Bowel Disease Associated With Sclerosing Cholangitis, Diabetes Insipidus, and Myeloid Neoplasm: Langerhans Cell Histiocytosis Was Hiding Since the Beginning.
    Inflamm Bowel Dis. 2020 Jun 12. pii: 5856440. doi: 10.1093.
    PubMed    


  591. SCHLABITZ F, Teich N, Michl P, Walldorf J, et al
    Inflammatory Bowel Disease and COVID-19-"Preventive" Sick Certificates as a Frequent Coping Strategy in the Face of the Pandemic.
    Inflamm Bowel Dis. 2020 Jun 12. pii: 5856424. doi: 10.1093.
    PubMed    


  592. JOHN RA, Gearry RB
    Smoking Cessation for Patients With Crohn Disease: Not Just for the Patient?
    Inflamm Bowel Dis. 2020 Jun 12. pii: 5856324. doi: 10.1093.
    PubMed    


  593. COELHO-PRABHU N, Bruining DH, Faubion WA, Kane SV, et al
    A 1-Year Cross-sectional Inflammatory Bowel Disease Surveillance Colonoscopy Cohort Comparing High-definition White Light Endoscopy and Chromoendoscopy.
    Inflamm Bowel Dis. 2020 Jun 12. pii: 5856329. doi: 10.1093.
    PubMed     Abstract available


  594. DUZENLI T, Koseoglu H, Akyol T
    NLR and PLR as Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated with Anti-TNF.
    Inflamm Bowel Dis. 2020 Jun 9. pii: 5854914. doi: 10.1093.
    PubMed    


  595. BERTANI L, Costa F, Barberio B, Savarino E, et al
    Reply to Letter to the Editor: NLR and PLR as Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF.
    Inflamm Bowel Dis. 2020 Jun 9. pii: 5854915. doi: 10.1093.
    PubMed    


  596. LIU B, Yang MQ, Yu TY, Yin YY, et al
    Mast Cell Tryptase Promotes Inflammatory Bowel Disease-Induced Intestinal Fibrosis.
    Inflamm Bowel Dis. 2020 Jun 8. pii: 5854445. doi: 10.1093.
    PubMed     Abstract available


  597. KOBAYASHI Y, Ohfuji S, Kondo K, Fukushima W, et al
    Association of Dietary Fatty Acid Intake With the Development of Ulcerative Colitis: A Multicenter Case-Control Study in Japan.
    Inflamm Bowel Dis. 2020 Jun 8. pii: 5854441. doi: 10.1093.
    PubMed     Abstract available


  598. QIAN XX
    Temporal, Sexual, and Geographic Distributions of the Coexistence of Ulcerative Colitis and Graves Disease.
    Inflamm Bowel Dis. 2020 Jun 8. pii: 5854442. doi: 10.1093.
    PubMed    


  599. MARTIN ARRANZ E, Suarez Ferrer C, Garcia Ramirez L, Rueda Garcia JL, et al
    Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey.
    Inflamm Bowel Dis. 2020 Jun 4. pii: 5851307. doi: 10.1093.
    PubMed     Abstract available


  600. CHUDY-ONWUGAJE K, Mamunes AP, Schwartz DA, Horst S, et al
    Predictors of High Health Care Utilization in Patients With Inflammatory Bowel Disease Within 1 Year of Establishing Specialist Care.
    Inflamm Bowel Dis. 2020 Jun 3. pii: 5850604. doi: 10.1093.
    PubMed     Abstract available


  601. PEKOW J, Patel P
    Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease. Reply Letter to Elia et al.
    Inflamm Bowel Dis. 2020 Jun 2. pii: 5850168. doi: 10.1093.
    PubMed    


  602. ELIA JR
    Aspirin, NSAIDs, and Inflammatory Bowel Disease: An Exercise Physiology Perspective.
    Inflamm Bowel Dis. 2020 Jun 2. pii: 5850171. doi: 10.1093.
    PubMed    


    May 2020
  603. RAMPAL R, Wari N, Singh AK, Das U, et al
    Retinoic Acid Is Elevated in the Mucosa of Patients With Active Ulcerative Colitis and Displays a Proinflammatory Role by Augmenting IL-17 and IFNgamma Production.
    Inflamm Bowel Dis. 2020 May 29. pii: 5848464. doi: 10.1093.
    PubMed     Abstract available


  604. NOURELDIN M, Cohen-Mekelburg S, Mahmood A, Stidham R, et al
    Trends of 5-Aminosalicylate Medication Use in Patients With Crohn Disease.
    Inflamm Bowel Dis. 2020 May 29. pii: 5848467. doi: 10.1093.
    PubMed     Abstract available


  605. LEUNG KK, Tandon P, Govardhanam V, Maxwell C, et al
    The Risk of Adverse Neonatal Outcomes With Maternal Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2020 May 29. pii: 5848466. doi: 10.1093.
    PubMed     Abstract available


  606. MURPHY LK, de la Vega R, Kohut SA, Kawamura JS, et al
    Systematic Review: Psychosocial Correlates of Pain in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 May 27. pii: 5847655. doi: 10.1093.
    PubMed     Abstract available


  607. VALDES DELGADO T, Maldonado Perez B, Castro Laria L
    Erythema Nodosum: As an Extraintestinal Manifestation or Complication in Ulcerative Colitis?
    Inflamm Bowel Dis. 2020 May 25. pii: 5843661. doi: 10.1093.
    PubMed     Abstract available


  608. KRONER PT, Lee A, Farraye FA
    Respiratory Tract Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 May 25. pii: 5843660. doi: 10.1093.
    PubMed     Abstract available


  609. QAZI T, Smith A, Alexander M, Hammer D, et al
    Disparities in Objective Sleep Quality as Assessed Through Wrist Actigraphy in Minority Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 May 25. pii: 5843655. doi: 10.1093.
    PubMed     Abstract available


  610. LYLES JL, Mulgund AA, Bauman LE, Su W, et al
    Effect of a Practice-wide Anti-TNF Proactive Therapeutic Drug Monitoring Program on Outcomes in Pediatric Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 May 25. pii: 5843647. doi: 10.1093.
    PubMed     Abstract available


  611. FASOULAS K, Kafalis N, Soufleris K
    Alphazathioprine-Induced Tremor: A Rare, Dose-Dependent Side Effect of Azathioprine in a Patient With Active Crohn Disease.
    Inflamm Bowel Dis. 2020 May 23. pii: 5843195. doi: 10.1093.
    PubMed    


  612. HUANG JS, Cruz R, Yueh R, Parker J, et al
    A Systemwide Electronic Health Record Checklist to Improve Comorbidity Screening of Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 May 22. pii: 5841913. doi: 10.1093.
    PubMed    


  613. BARASH Y, Klang E, Tau N, Ben-Horin S, et al
    Evolution of Inflammatory Bowel Disease Research From a Bird's-Eye Perspective: A Text-Mining Analysis of Publication Trends and Topics.
    Inflamm Bowel Dis. 2020 May 22. pii: 5841908. doi: 10.1093.
    PubMed     Abstract available


  614. MARTINELLI M, Strisciuglio C, Fedele F, Miele E, et al
    Clinical and Psychological Issues in Children with Inflammatory Bowel Disease During COVID-19 Pandemic.
    Inflamm Bowel Dis. 2020 May 22. pii: 5841894. doi: 10.1093.
    PubMed    


  615. MINTZ MJ, Ananthakrishnan AN
    Phenotype and Natural History of Inflammatory Bowel Disease in Patients With Concomitant Eosinophilic Esophagitis.
    Inflamm Bowel Dis. 2020 May 20. pii: 5840920. doi: 10.1093.
    PubMed     Abstract available


  616. DRAGONI G, De Hertogh G, Vermeire S
    The Role of Citrullination in Inflammatory Bowel Disease: A Neglected Player in Triggering Inflammation and Fibrosis?
    Inflamm Bowel Dis. 2020 May 19. pii: 5840491. doi: 10.1093.
    PubMed     Abstract available


  617. YU A, Friedman S, Ananthakrishnan AN
    Characteristics and Long-Term Outcomes of Pregnancy-Onset Inflammatory Bowel Disease: A Case-Control Study.
    Inflamm Bowel Dis. 2020 May 19. pii: 5840482. doi: 10.1093.
    PubMed     Abstract available


  618. EGBERG MD, Phillips M, Galanko JA, Kappelman M, et al
    Total Abdominal Colectomies With Proctectomy Are Associated With Higher 30-Day Readmission Rates in Children With Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 May 19. pii: 5840483. doi: 10.1093.
    PubMed     Abstract available


  619. RYBINSKI F, Weisser M, Niess JH, Hruz P, et al
    Amoebic Liver Abscess in Crohn Disease Treated With Ustekinumab.
    Inflamm Bowel Dis. 2020 May 14. pii: 5836916. doi: 10.1093.
    PubMed    


  620. BARNES EL, Bauer CM, Sandler RS, Kappelman MD, et al
    Black and White Patients With Inflammatory Bowel Disease Show Similar Biologic Use Patterns With Medicaid Insurance.
    Inflamm Bowel Dis. 2020 May 14. pii: 5836912. doi: 10.1093.
    PubMed     Abstract available


  621. ROSEN MH, Axelrad J, Hudesman D, Rubin DT, et al
    Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.
    Inflamm Bowel Dis. 2020 May 12. pii: 5836016. doi: 10.1093.
    PubMed     Abstract available


  622. XU F, Chen D, Yang Y
    Response to "Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease".
    Inflamm Bowel Dis. 2020;26:e47.
    PubMed    


  623. MCHENRY S, Ciorba MA, Deepak P
    Reply to the Letter to the Editor: Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:e46.
    PubMed    


  624. DAVIS BC
    Safety of Biologic Therapy in Liver Transplant Recipients: Case Closed?
    Inflamm Bowel Dis. 2020;26:960.
    PubMed    


  625. ZUNDLER S
    Utilization of Diagnostic Imaging and Ionizing Radiation Exposure-Has the Tide Already Turned?
    Inflamm Bowel Dis. 2020;26:907-908.
    PubMed     Abstract available


  626. LUKIN DJ
    Predictors of Perianal Fistula Relapse in Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:932-933.
    PubMed    


  627. KERUR B, Benchimol EI, Fiedler K, Stahl M, et al
    Natural History of Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2020 May 9. pii: 5835042. doi: 10.1093.
    PubMed     Abstract available


  628. CORRIDONI D, Chapman T, Antanaviciute A, Satsangi J, et al
    Inflammatory Bowel Disease Through the Lens of Single-cell RNA-seq Technologies.
    Inflamm Bowel Dis. 2020 May 9. pii: 5834990. doi: 10.1093.
    PubMed     Abstract available


  629. GUZMAN-PRADO Y, Samson O, Segal JP, Limdi JK, et al
    Vitamin D Therapy in Adults With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2020 May 9. pii: 5834989. doi: 10.1093.
    PubMed     Abstract available


  630. TURSI A, Vetrone LM, Papa A
    Anti-TNF-alpha Agents in Inflammatory Bowel Disease and Course of COVID-19.
    Inflamm Bowel Dis. 2020 May 8. pii: 5831990. doi: 10.1093.
    PubMed    


  631. VAN GENNEP S, Evers SW, Rietdijk ST, Gielen ME, et al
    High Disease Burden Drives Indirect Costs in Employed Inflammatory Bowel Disease Patients: The WORK-IBD Study.
    Inflamm Bowel Dis. 2020 May 7. pii: 5831697. doi: 10.1093.
    PubMed     Abstract available


  632. PARK KT, Ehrlich OG, Allen JI, Meadows P, et al
    Corrigendum to The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
    Inflamm Bowel Dis. 2020 May 6. pii: 5831199. doi: 10.1093.
    PubMed    


    April 2020
  633. JACOBS J, Clark-Snustad K, Lee S
    Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib.
    Inflamm Bowel Dis. 2020 Apr 28. pii: 5826022. doi: 10.1093.
    PubMed    


  634. FENTON CG, Taman H, Florholmen J, Sorbye SW, et al
    Transcriptional Signatures That Define Ulcerative Colitis in Remission.
    Inflamm Bowel Dis. 2020 Apr 23. pii: 5823961. doi: 10.1093.
    PubMed     Abstract available


  635. LEVHAR N, Ungar B, Kopylov U, Fudim E, et al
    Propagation of EBV-driven Lymphomatous Transformation of Peripheral Blood B Cells by Immunomodulators and Biologics Used in the Treatment of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Apr 23. pii: 5823959. doi: 10.1093.
    PubMed     Abstract available


  636. YAO J, Jiang X, You JHS
    A Systematic Review on Cost-effectiveness Analyses of Therapeutic Drug Monitoring for Patients with Inflammatory Bowel Disease: From Immunosuppressive to Anti-TNF Therapy.
    Inflamm Bowel Dis. 2020 Apr 20. pii: 5822887. doi: 10.1093.
    PubMed     Abstract available


  637. KOUTROUMPAKIS F, Lodhi M, Ahsan M, Ramos Rivers C, et al
    The Impact of Cholecystectomy on Long-Term Disease Outcomes and Quality of Life in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2020 Apr 20. pii: 5822893. doi: 10.1093.
    PubMed     Abstract available


  638. LINHARES M, Ramos D, Pereira F, Azevedo R, et al
    Hidradenitis Suppurativa and Crohn Disease: A Rare Association.
    Inflamm Bowel Dis. 2020 Apr 18. pii: 5822088. doi: 10.1093.
    PubMed    


  639. DERER S, Brethack AK, Pietsch C, Jendrek ST, et al
    Inflammatory Bowel Disease-associated GP2 Autoantibodies Inhibit Mucosal Immune Response to Adherent-invasive Bacteria.
    Inflamm Bowel Dis. 2020 Apr 18. pii: 5822108. doi: 10.1093.
    PubMed     Abstract available



  640. Corrigendum to: Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Apr 18. pii: 5822087. doi: 10.1093.
    PubMed    



  641. DPP-4 as a Novel Biomarker for Inflammatory Bowel Disease: Is It Ready for Clinical Use?
    Inflamm Bowel Dis. 2020 Apr 16. pii: 5820737. doi: 10.1093.
    PubMed    


  642. TURNER D
    Antibiotics in Refractory IBD: Not Without Risks but Are the Alternatives Better? Response to Gilmore et al.
    Inflamm Bowel Dis. 2020;26:e42.
    PubMed    


  643. LIN S, Lin X, Li X, Chen M, et al
    Making Qualitative Intestinal Stricture Quantitative: Embracing Radiomics in IBD.
    Inflamm Bowel Dis. 2020;26:743-745.
    PubMed    


  644. LEE AS, Hubers J, Osman F, Caldera F, et al
    Don't Be Blue: A Case Series Describing Colonoscope Damage After Chromoendoscopy for Surveillance of Dysplasia in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Apr 6. pii: 5816423. doi: 10.1093.
    PubMed    


    March 2020
  645. BERTANI L, Rossari F, Barberio B, Demarzo MG, et al
    Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio.
    Inflamm Bowel Dis. 2020 Mar 31. pii: 5813970. doi: 10.1093.
    PubMed     Abstract available


  646. PATEL P, Gao G, Gulotta G, Dalal S, et al
    Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Mar 27. pii: 5812729. doi: 10.1093.
    PubMed     Abstract available


  647. ORFANOUDAKI E, Foteinogiannopoulou K, Theodoraki E, Koutroubakis IE, et al
    Clinical Value of Proactive Infliximab Drug Monitoring in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Mar 24. pii: 5811190. doi: 10.1093.
    PubMed    


  648. MCCURDY JD, Benchimol EI
    Response to Letter, "Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2020 Mar 21. pii: 5810826. doi: 10.1093.
    PubMed    


  649. XIE H, Zeng D, Chen D, Tang W, et al
    Letter to the Editor: Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.
    Inflamm Bowel Dis. 2020 Mar 20. pii: 5810369. doi: 10.1093.
    PubMed    


  650. NAYMAGON L, Tremblay D, Zubizarreta N, Moshier E, et al
    The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Mar 18. pii: 5809340. doi: 10.1093.
    PubMed     Abstract available


  651. OSTERMAN MT, Scott FI, Fogt FF, Gilroy ED, et al
    Endoscopic and Histological Assessment, Correlation, and Relapse in Clinically Quiescent Ulcerative Colitis (MARQUEE).
    Inflamm Bowel Dis. 2020 Mar 14. pii: 5805376. doi: 10.1093.
    PubMed     Abstract available


  652. YVELLEZ OV, Rai V, Sossenheimer PH, Hart J, et al
    Cumulative Histologic Inflammation Predicts Colorectal Neoplasia in Ulcerative Colitis: A Validation Study.
    Inflamm Bowel Dis. 2020 Mar 10. pii: 5802337. doi: 10.1093.
    PubMed     Abstract available


  653. BODIWALA V, Marshall T, Das KM, Brant SR, et al
    Comparison of Disease Phenotypes and Clinical Characteristics Among South Asian and White Patients with Inflammatory Bowel Disease at a Tertiary Referral Center.
    Inflamm Bowel Dis. 2020 Mar 7. pii: 5799010. doi: 10.1093.
    PubMed     Abstract available


  654. KARMIRIS K
    Racial Differences in Inflammatory Bowel Disease: A Race With Alternating Winners?
    Inflamm Bowel Dis. 2020 Mar 7. pii: 5799011. doi: 10.1093.
    PubMed    


  655. GEORGE LA, Cross RK
    How Do We Sequence Biologic Therapies in 2019?
    Inflamm Bowel Dis. 2020;26:617-618.
    PubMed    


  656. SYAL G, Melmed GY
    Is It Time For High Dose Influenza Vaccination In Inflammatory Bowel Diseases?
    Inflamm Bowel Dis. 2020;26:603-605.
    PubMed    


  657. ROSH JR
    The Cost of Pediatric IBD Care: How to Best Invest in our Children.
    Inflamm Bowel Dis. 2020;26:641-642.
    PubMed    


  658. LIMKETKAI BN, Gordon M, Mutlu EA, De Silva PS, et al
    Diet Therapy for Inflammatory Bowel Diseases: A Call to the Dining Table.
    Inflamm Bowel Dis. 2020;26:510-514.
    PubMed     Abstract available


  659. BRONSWIJK M, Moens A, Lenfant M, Tops S, et al
    Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center.
    Inflamm Bowel Dis. 2020;26:628-634.
    PubMed     Abstract available


  660. JANGI S, Ruan A, Korzenik J, de Silva P, et al
    South Asian Patients With Inflammatory Bowel Disease in the United States Demonstrate More Fistulizing and Perianal Crohn Phenotype.
    Inflamm Bowel Dis. 2020 Mar 2. pii: 5771121. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  661. LIN E, Katz S
    Acute Pancreatitis in a Patient With Ulcerative Colitis on Vedolizumab.
    Inflamm Bowel Dis. 2020 Feb 26. pii: 5758182. doi: 10.1093.
    PubMed    


  662. DAI C, Cao Q, Jiang M
    Risk of Venous Thromboembolism After Hospital Discharge in Patients with Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2020 Feb 25. pii: 5755895. doi: 10.1093.
    PubMed    


  663. LI H, Tian F
    Toxic Epidermal Necrolysis Because of Various Herpesviruses Infection After Accelerated Infliximab Induction in a Chinese Patient With Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Feb 22. pii: 5748143. doi: 10.1093.
    PubMed    


  664. LEY D, Martin B, Caldera F
    Use of an iPhone Application to Increase Adherence in Patients With Ulcerative Colitis in Remission: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2020 Feb 22. pii: 5748139. doi: 10.1093.
    PubMed    


  665. PEVERELLE M, Mills C, Testro A, Gow P, et al
    Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Feb 20. pii: 5741005. doi: 10.1093.
    PubMed    


  666. OKAMOTO D, Kawai Y, Kakuta Y, Naito T, et al
    Genetic Analysis of Ulcerative Colitis in Japanese Individuals Using Population-specific SNP Array.
    Inflamm Bowel Dis. 2020 Feb 19. pii: 5740361. doi: 10.1093.
    PubMed     Abstract available


  667. HAMDEH S, Aziz M, Altayar O, Olyaee M, et al
    Early vs Late Use of Anti-TNFa Therapy in Adult Patients With Crohn Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2020 Feb 17. pii: 5739148. doi: 10.1093.
    PubMed     Abstract available


  668. LAW CCY, Koh D, Bao Y, Jairath V, et al
    Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2020 Feb 12. pii: 5734556. doi: 10.1093.
    PubMed     Abstract available


  669. PIGNICZKI D, Farkas K, Molnar T
    The Theoretical Scenario Experienced in a Real-Life Case of Ulcerative Colitis and Associated Primary Sclerosing Cholangitis: Case 123.
    Inflamm Bowel Dis. 2020 Feb 11. pii: 5733139. doi: 10.1093.
    PubMed    


  670. LEE TW
    Editorial: Risk of Cancer Development in IBD-Inflammation vs Immunosuppression.
    Inflamm Bowel Dis. 2020;26:460-461.
    PubMed    


  671. BERNSTEIN CN
    Is Antibiotic Use a Cause of IBD Worldwide?
    Inflamm Bowel Dis. 2020;26:448-449.
    PubMed    


  672. GARCIA MJ, Arminanzas C, Rivero M, Ramos M, et al
    Crohn's Disease and Immunosupressive Treatment: Hepatosplenic Lesions as an Atypical Case of Bartonella henselae.
    Inflamm Bowel Dis. 2020;26:e17-e18.
    PubMed    


  673. JUKEMA JB, Brandse JF, de Boer NKH
    Successful Treatment of Oral Crohn's Disease by Ustekinumab.
    Inflamm Bowel Dis. 2020;26:e19.
    PubMed    


  674. SAYOC-BECERRA A, Krishnan M, Fan S, Jimenez J, et al
    The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.
    Inflamm Bowel Dis. 2020;26:407-422.
    PubMed     Abstract available


  675. JUN X, Ning C, Yang S, Zhe W, et al
    Alteration of Fungal Microbiota After 5-ASA Treatment in UC Patients.
    Inflamm Bowel Dis. 2020;26:380-390.
    PubMed     Abstract available


  676. CORDES F, Lenker E, Spille LJ, Weinhage T, et al
    Tofacitinib Reprograms Human Monocytes of IBD Patients and Healthy Controls Toward a More Regulatory Phenotype.
    Inflamm Bowel Dis. 2020;26:391-406.
    PubMed     Abstract available


  677. VASUDEVAN A, Ip F, Liew D, van Langenberg DR, et al
    The Cost-effectiveness of Initial Immunomodulators or Infliximab Using Modern Optimization Strategies for Crohn's Disease in the Biosimilar Era.
    Inflamm Bowel Dis. 2020;26:369-379.
    PubMed     Abstract available


  678. GAINES LS, Slaughter JC, Schwartz DA, Beaulieu DB, et al
    Does Reverse Causality Underlie the Temporal Relationship Between Depression and Crohn's Disease?
    Inflamm Bowel Dis. 2020;26:423-428.
    PubMed     Abstract available


  679. EL-DALLAL M, Chen Y, Lin Q, Rakowsky S, et al
    Meta-analysis of Virtual-based Chromoendoscopy Compared With Dye-spraying Chromoendoscopy Standard and High-definition White Light Endoscopy in Patients With Inflammatory Bowel Disease at Increased Risk of Colon Cancer.
    Inflamm Bowel Dis. 2020 Feb 8. pii: 5731339. doi: 10.1093.
    PubMed     Abstract available


  680. KORNBLUTH A
    Histologic Healing in Ulcerative Colitis: Benefits. And Risks. Was Voltaire Right?
    Inflamm Bowel Dis. 2020 Feb 7. pii: 5729887. doi: 10.1093.
    PubMed    


  681. CARNEY H, Marrie RA, Bolton JM, Patten SB, et al
    Prevalence and Risk Factors of Substance Use Disorder in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Feb 6. pii: 5728525. doi: 10.1093.
    PubMed     Abstract available


  682. PENG Y, Thomas AS, Wei D, Tan D, et al
    An Aggressive Approach Toward a Case of Refractory Ulcerative Colitis With Uncertain Etiology in the Context of Chronic Myeloid Leukemia.
    Inflamm Bowel Dis. 2020 Feb 4. pii: 5721970. doi: 10.1093.
    PubMed    


  683. JABANDZIEV P, Bohosova J, Pinkasova T, Kunovsky L, et al
    The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Feb 3. pii: 5721205. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  684. MCCURDY JD, Kuenzig ME, Smith G, Spruin S, et al
    Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.
    Inflamm Bowel Dis. 2020 Jan 29. pii: 5717328. doi: 10.1093.
    PubMed     Abstract available


  685. BAFFORD AC, Cross RK
    Risk of Venous Thromboembolism in Patients with Inflammatory Bowel Disease Extends beyond Hospitalization.
    Inflamm Bowel Dis. 2020 Jan 29. pii: 5717307. doi: 10.1093.
    PubMed    


  686. SZANTO KJ, Rutka M, Pigniczki D, Farkas K, et al
    Serological Status of Inflammatory Bowel Disease Patients Before Starting Biological Therapy - Data From a Tertiary Centre of the Best Vaccined Country.
    Inflamm Bowel Dis. 2020 Jan 24. pii: 5715025. doi: 10.1093.
    PubMed    


  687. MARTINELLI M, Miele E
    Implementation and Widespread of Inflammatory Bowel Disease Vaccination and Immunization Guidelines: Not an Easy Task.
    Inflamm Bowel Dis. 2020 Jan 24. pii: 5715024. doi: 10.1093.
    PubMed    


  688. LEE AA, Rao K, Limsrivilai J, Gillilland M, et al
    Temporal Gut Microbial Changes Predict Recurrent Clostridiodes Difficile Infection in Patients With and Without Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Jan 23. pii: 5714595. doi: 10.1093.
    PubMed     Abstract available


  689. COLLINS SM
    Interrogating the Gut-Brain Axis in the Context of Inflammatory Bowel Disease: A Translational Approach.
    Inflamm Bowel Dis. 2020 Jan 22. pii: 5714219. doi: 10.1093.
    PubMed     Abstract available


  690. HOU G, Bishu S
    Th17 Cells in Inflammatory Bowel Disease: An Update for the Clinician.
    Inflamm Bowel Dis. 2020 Jan 22. pii: 5714220. doi: 10.1093.
    PubMed    


  691. CONRAD MA, Kelsen JR
    Editorial to Temporal Gut Microbial Changes Predict Recurrent Clostridium difficile Infection in Patients With and Without Ulcerative Colitis.
    Inflamm Bowel Dis. 2020 Jan 22. pii: 5714218. doi: 10.1093.
    PubMed    


  692. GUPTA N, Liu C, King E, Sylvester F, et al
    Continued Statural Growth in Older Adolescents and Young Adults With Crohn's Disease and Ulcerative Colitis Beyond the Time of Expected Growth Plate Closure.
    Inflamm Bowel Dis. 2020 Jan 22. pii: 5714217. doi: 10.1093.
    PubMed     Abstract available


  693. PRATHAPAN KM, Ramos Rivers C, Anderson A, Koutroumpakis F, et al
    Peripheral Blood Eosinophilia and Long-term Severity in Pediatric-Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jan 21. pii: 5711281. doi: 10.1093.
    PubMed     Abstract available


  694. GUBATAN J, Mehigan GA, Villegas F, Mitsuhashi S, et al
    Cathelicidin Mediates a Protective Role of Vitamin D in Ulcerative Colitis and Human Colonic Epithelial Cells.
    Inflamm Bowel Dis. 2020 Jan 18. pii: 5709590. doi: 10.1093.
    PubMed     Abstract available


  695. DIN H, Anderson AJ, Ramos Rivers C, Proksell S, et al
    Disease Characteristics and Severity in Patients With Inflammatory Bowel Disease With Coexistent Diabetes Mellitus.
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707489. doi: 10.1093.
    PubMed     Abstract available


  696. MARTINELLI M, Miele E
    Evaluation of EBV Status and Thiopurine Use in Pediatric Inflammatory Bowel Disease: Time to be a Standard of Care.
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707490. doi: 10.1093.
    PubMed    


  697. EL-MATARY W
    Routine Testing for EBV Status in Children With Inflammatory Bowel Disease: Are We Overreacting?
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707482. doi: 10.1093.
    PubMed    


  698. KATINIOS G, Casado-Bedmar M, Walter SA, Vicario M, et al
    Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health.
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707481. doi: 10.1093.
    PubMed     Abstract available


  699. PEVERELLE M, Paleri S, Hughes J, De Cruz P, et al
    Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707461. doi: 10.1093.
    PubMed     Abstract available


  700. WONG U, Cross RK
    Are Inflammatory Bowel Disease Patients With Diabetes Mellitus at Increased Risk for Poor Outcomes Including Greater Health Care Utilization?
    Inflamm Bowel Dis. 2020 Jan 16. pii: 5707487. doi: 10.1093.
    PubMed    


  701. PERRY C, Kapur N, Barrett TA
    DDP-4 as a Novel Biomarker for Inflammatory Bowel Disease: Is It Ready for Clinical Use?
    Inflamm Bowel Dis. 2020 Jan 8. pii: 5698302. doi: 10.1093.
    PubMed    


  702. PINTO-LOPES P, Afonso J, Pinto-Lopes R, Rocha C, et al
    Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jan 8. pii: 5698249. doi: 10.1093.
    PubMed     Abstract available


  703. ROOSENBOOM B, van Lochem EG, Smids C, Groenen MJM, et al
    Analysis of Intestinal T-Cell Subsets in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020;26:e13.
    PubMed    


  704. BAUER CM, Younis A, Herfarth H, Barnes EL, et al
    Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:e5.
    PubMed    


  705. CASANOVA MJ, Chaparro M, Gisbert JP
    Response to the Letter to the Editor: "Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease".
    Inflamm Bowel Dis. 2020;26:e6.
    PubMed    


  706. BARNES EL
    Opportunistic Infections and Opportunities for Action.
    Inflamm Bowel Dis. 2020;26:301-303.
    PubMed    


  707. ANNESE V
    TDM of Anti-TNF Agents: The Importance of Being Active!
    Inflamm Bowel Dis. 2020;26:271-272.
    PubMed    


  708. CHANG S, Hamilton M, Lees C, Atreja A, et al
    Mobile Health in IBD: Enhancing Care, One Phone at a Time.
    Inflamm Bowel Dis. 2020;26:163-166.
    PubMed    


  709. WANDERS LK, Cordes M, Voorham Q, Sie D, et al
    IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic Adenomas.
    Inflamm Bowel Dis. 2020;26:167-180.
    PubMed     Abstract available


  710. KARUPPUCHAMY T, Tyler CJ, Lundborg LR, Perez-Jeldres T, et al
    Sphingosine-1-Phosphate Lyase Inhibition Alters the S1P Gradient and Ameliorates Crohn's-Like Ileitis by Suppressing Thymocyte Maturation.
    Inflamm Bowel Dis. 2020;26:216-228.
    PubMed     Abstract available


  711. WANG X, Bootsma H, Kroese F, Dijkstra G, et al
    Senescent Stem and Transient Amplifying Cells in Crohn's Disease Intestine.
    Inflamm Bowel Dis. 2020;26:e8-e9.
    PubMed    


  712. LEWIS JD, Rutgeerts P, Feagan BG, D'haens G, et al
    Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:304-313.
    PubMed     Abstract available


  713. EGBERG MD, Galanko JA, Kappelman MD
    Weekend Surgical Admissions of Pediatric IBD Patients Have a Higher Risk of Complication in Hospitals Across the US.
    Inflamm Bowel Dis. 2020;26:254-260.
    PubMed     Abstract available


  714. LAURETI S, Gionchetti P, Cappelli A, Vittori L, et al
    Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection.
    Inflamm Bowel Dis. 2020;26:321-330.
    PubMed     Abstract available


  715. MORAES L, Magnusson MK, Mavroudis G, Polster A, et al
    Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms.
    Inflamm Bowel Dis. 2020 Jan 4. pii: 5696669. doi: 10.1093.
    PubMed     Abstract available


  716. YU A, Friedman S, Ananthakrishnan AN
    Incidence and Predictors of Flares in the Postpartum Year Among Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2020 Jan 2. pii: 5694104. doi: 10.1093.
    PubMed     Abstract available


  717. KUROWSKI JA, Achkar JP
    Underutilization of Combination Anti-TNF Therapy in Population-based Study.
    Inflamm Bowel Dis. 2020;26:158-159.
    PubMed    


  718. DE FELICE KM
    Patients Perception of Risks and Benefits of Biologic Therapy.
    Inflamm Bowel Dis. 2020;26:147-149.
    PubMed     Abstract available


  719. FRANCO DL, Click B
    Proactive Versus Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: Is the Juice Worth the Squeeze?
    Inflamm Bowel Dis. 2020;26:112-113.
    PubMed    


  720. SILVA JC, Rodrigues A, Carvalho J
    Spontaneous Resolution of Enterocutaneous Fistula After Disseminated Tuberculosis Treatment in a Patient With Crohn's Disease: Challenges in Biologic Therapy.
    Inflamm Bowel Dis. 2020;26:e1-e2.
    PubMed    


  721. CHIBA M, Tsuji T, Nakane K, Obara Y, et al
    Swift Efficacy with Infliximab 4 Years after Initial Standard Induction Therapy Followed by Severe Delayed Infusion Reaction in Crohn's Disease.
    Inflamm Bowel Dis. 2020;26:e4.
    PubMed    


  722. SHANKAR U, Vijayasekar K, Bansal R, Walfish A, et al
    Treatment of Rituximab-induced Crohn's Disease With Ustekinumab Induction and Long-term Maintenance of Remission.
    Inflamm Bowel Dis. 2020;26:e3.
    PubMed    


  723. FAHAD H, Abu-Elmagd K, Lashner B, Fiocchi C, et al
    Recurrence of Crohn's Disease After Small Bowel Transplantation: Fact or Fiction.
    Inflamm Bowel Dis. 2020;26:21-23.
    PubMed     Abstract available


  724. YU Y, Yang W, Li Y, Cong Y, et al
    Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2020;26:11-20.
    PubMed     Abstract available


  725. WILSON R, Gundamaraju R, Vemuri R, Angelucci C, et al
    Identification of Key Pro-Survival Proteins in Isolated Colonic Goblet Cells of Winnie, a Murine Model of Spontaneous Colitis.
    Inflamm Bowel Dis. 2020;26:80-92.
    PubMed     Abstract available


  726. ELIAS ED, Targownik LE, Singh H, Bernstein CN, et al
    A Population-Based Study of Combination vs Monotherapy of Anti-TNF in Persons With IBD.
    Inflamm Bowel Dis. 2020;26:150-157.
    PubMed     Abstract available


  727. KOLIANI-PACE JL, Haron AM, Zisman-Ilani Y, Thompson KD, et al
    Patients' Perceive Biologics to Be Riskier and More Dreadful Than Other IBD Medications.
    Inflamm Bowel Dis. 2020;26:141-146.
    PubMed     Abstract available


  728. STOLZER I, Kaden-Volynets V, Ruder B, Letizia M, et al
    Environmental Microbial Factors Determine the Pattern of Inflammatory Lesions in a Murine Model of Crohn's Disease-Like Inflammation.
    Inflamm Bowel Dis. 2020;26:66-79.
    PubMed     Abstract available


  729. CHRISTIAN KE, Russman KM, Rajan DP, Barr EA, et al
    Gender Differences and Other Factors Associated with Weight Gain Following Initiation of Infliximab: A Post Hoc Analysis of Clinical Trials.
    Inflamm Bowel Dis. 2020;26:125-131.
    PubMed     Abstract available


  730. WINTER RW, Friedman S
    Understanding the Cause of Weight Gain in Patients With IBD on Anti-TNF Medications.
    Inflamm Bowel Dis. 2020;26:132-133.
    PubMed    


  731. NEGOESCU DM, Enns EA, Swanhorst B, Baumgartner B, et al
    Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: A Cost-Effectiveness Analysis in a Simulated Cohort.
    Inflamm Bowel Dis. 2020;26:103-111.
    PubMed     Abstract available


  732. PASHA SF, Pennazio M, Rondonotti E, Wolf D, et al
    Capsule Retention in Crohn's Disease: A Meta-analysis.
    Inflamm Bowel Dis. 2020;26:33-42.
    PubMed     Abstract available


    December 2019
  733. DAI C, Jiang M, Sun MJ
    Disease Duration and the Risk of Treatment Failure in Biologic-Treated Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Dec 30. pii: 5690100. doi: 10.1093.
    PubMed    


  734. KEVANS D, Kirsch R, Dargavel C, Kabakchiev B, et al
    Histological Markers of Clinical Relapse in Endoscopically Quiescent Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Dec 28. pii: 5688912. doi: 10.1093.
    PubMed     Abstract available


  735. ESCUDERO-HERNANDEZ C, Montalvillo E, Antolin B, Bernardo D, et al
    Different Intraepithelial CD3+ Cell Numbers in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Dec 28. pii: 5688873. doi: 10.1093.
    PubMed    


  736. FAYE AS, Oh A, Kumble LD, Kiran RP, et al
    Fertility Impact of Initial Operation Type for Female Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2019 Dec 27. pii: 5688242. doi: 10.1093.
    PubMed     Abstract available


  737. KUENZIG ME, Hawken S, Wilson K, Talarico R, et al
    Serum Newborn Screening Blood Metabolites Are not Associated With Childhood-onset Inflammatory Bowel Disease: A Population-based Matched Case-control Study.
    Inflamm Bowel Dis. 2019 Dec 12. pii: 5674034. doi: 10.1093.
    PubMed     Abstract available


  738. CHEN LA
    Intestinal Microbiota Transplantation for Patients With Inflammatory Bowel Disease Prevents Recurrence of C. difficile Infections but Not Recurrence of Gastrointestinal Symptoms.
    Inflamm Bowel Dis. 2019 Dec 10. pii: 5673070. doi: 10.1093.
    PubMed    


  739. TARIQ R, Disbrow MB, Dibaise JK, Orenstein R, et al
    Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Dec 9. pii: 5673067. doi: 10.1093.
    PubMed     Abstract available


  740. POUILLON L, Hoefkens E, Verheyen V, Bronswijk M, et al
    Letter to the Editor: Feasibility and Efficiency of an E-Health Preadmission Assessment System for Intravenous Therapy in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Dec 3. pii: 5650900. doi: 10.1093.
    PubMed    


  741. YANG B, Liu X, Mei Q
    HMGB1-Positive Platelet Microparticles May Be a Biomarker of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Dec 3. pii: 5650909. doi: 10.1093.
    PubMed    



  742. Corrigendum to A Diagnosis of Inflammatory Bowel Disease and Access to Psychotherapy: Rural Patients Who Accept Treatment Report Psychosomatic Benefits.
    Inflamm Bowel Dis. 2019 Dec 3. pii: 5650796. doi: 10.1093.
    PubMed    


  743. OUAHED J, Spencer E, Kotlarz D, Shouval DS, et al
    Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.
    Inflamm Bowel Dis. 2019 Dec 3. pii: 5675340. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  744. CHENG J, Shen H, Chowdhury R, Abdi T, et al
    Potential of Electrical Neuromodulation for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 29. pii: 5648005. doi: 10.1093.
    PubMed     Abstract available


  745. JODELEIT H, Caesar J, Villarroel Aguilera C, Sterz S, et al
    The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rgamma null Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for
    Inflamm Bowel Dis. 2019 Nov 29. pii: 5648003. doi: 10.1093.
    PubMed     Abstract available


  746. CHATEAU T, Peyrin-Biroulet L
    Two Cases of Inflammatory Bowel Disease Patients Treated With Ustekinumab 90 mg Every 3 Weeks.
    Inflamm Bowel Dis. 2019 Nov 26. pii: 5643743. doi: 10.1093.
    PubMed    


  747. CHANDRAKUMAR A, Zohni H, El-Matary W
    Clostridioides difficile Infection in Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 25. pii: 5643019. doi: 10.1093.
    PubMed     Abstract available


  748. BASSON AR, Gomez-Nguyen A, Menghini P, Butto LF, et al
    Human Gut Microbiome Transplantation in Ileitis Prone Mice: A Tool for the Functional Characterization of the Microbiota in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Nov 21. pii: 5637456. doi: 10.1093.
    PubMed     Abstract available


  749. NGUYEN NH, Kurnool S, Dulai PS, Boland BS, et al
    Short Disease Duration Is Associated With Increased Risk of Treatment Failure in Biologic-Treated Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Nov 21. pii: 5636894. doi: 10.1093.
    PubMed     Abstract available


  750. MARCIL V, Levy E, Amre D, Bitton A, et al
    Erratum: A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?
    Inflamm Bowel Dis. 2019 Nov 20. pii: 5634260. doi: 10.1093.
    PubMed    


  751. THAKUR ER, Sansgiry S, Kramer JR, Waljee AK, et al
    The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 15. pii: 5625871. doi: 10.1093.
    PubMed     Abstract available


  752. HANSEN TM, Sabourin BC, Oketola B, Bernstein CN, et al
    Cannabis Use in Persons With Inflammatory Bowel Disease and Vulnerability to Substance Misuse.
    Inflamm Bowel Dis. 2019 Nov 14. pii: 5625670. doi: 10.1093.
    PubMed     Abstract available


  753. SHMIDT E, Saha S, Sands BE
    Reply to Letter to the Editor of Dr. Lai and Colleagues.
    Inflamm Bowel Dis. 2019;25:e166.
    PubMed    


  754. FAYE AS, Hung KW, Cheng K, Blackett JW, et al
    Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 5. pii: 5613524. doi: 10.1093.
    PubMed     Abstract available


  755. MARTINELLI M, Giugliano FP, Strisciuglio C, Urbonas V, et al
    Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN.
    Inflamm Bowel Dis. 2019 Nov 5. pii: 5613525. doi: 10.1093.
    PubMed     Abstract available


  756. LOPETUSO LR, Gasbarrini A
    Fighting the Hype for Predictors of Efficacy in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Nov 5. pii: 5613523. doi: 10.1093.
    PubMed    


  757. VADSTRUP K, Alulis S, Borsi A, Gustafsson N, et al
    Cost Burden of Crohn's Disease and Ulcerative Colitis in the 10-Year Period Before Diagnosis-A Danish Register-Based Study From 2003-2015.
    Inflamm Bowel Dis. 2019 Nov 4. pii: 5613986. doi: 10.1093.
    PubMed     Abstract available


  758. DE JONG ME, Gillis VELM, Derikx LAAP, Hoentjen F, et al
    No Increased Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease and Postinflammatory Polyps.
    Inflamm Bowel Dis. 2019 Nov 2. pii: 5611176. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  759. SHAH NB, Haydek J, Slaughter J, Ashton JR, et al
    Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 31. pii: 5610710. doi: 10.1093.
    PubMed     Abstract available


  760. CLICK B, Lopez R, Arrigain S, Schold J, et al
    Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 31. pii: 5610752. doi: 10.1093.
    PubMed     Abstract available


  761. TRUTA B, Leeds IL, Canner JK, Efron JE, et al
    Early Discontinuation of Infliximab in Pregnant Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 31. pii: 5610578. doi: 10.1093.
    PubMed     Abstract available


  762. GU P, Feagins LA
    Dining With Inflammatory Bowel Disease: A Review of the Literature on Diet in the Pathogenesis and Management of IBD.
    Inflamm Bowel Dis. 2019 Oct 31. pii: 5610412. doi: 10.1093.
    PubMed     Abstract available


  763. AL DRAIWEESH S, Ma C, Alkhattabi M, McDonald C, et al
    Safety of Combination Biologic and Antirejection Therapy Post-Liver Transplantation in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 28. pii: 5608313. doi: 10.1093.
    PubMed     Abstract available


  764. MCCOMBIE A, Walmsley R, Barclay M, Ho C, et al
    A Noninferiority Randomized Clinical Trial of the Use of the Smartphone-Based Health Applications IBDsmart and IBDoc in the Care of Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Oct 23. pii: 5603780. doi: 10.1093.
    PubMed     Abstract available


  765. CALVET X, Saldana R, Carpio D, Minguez M, et al
    Improving Quality of Care in Inflammatory Bowel Disease Through Patients' Eyes: IQCARO Project.
    Inflamm Bowel Dis. 2019 Oct 21. pii: 5571234. doi: 10.1093.
    PubMed     Abstract available


  766. BARNES EL, Jiang Y, Kappelman MD, Long MD, et al
    Decreasing Colectomy Rate for Ulcerative Colitis in the United States Between 2007 and 2016: A Time Trend Analysis.
    Inflamm Bowel Dis. 2019 Oct 21. pii: 5601649. doi: 10.1093.
    PubMed     Abstract available


  767. HAAC BE, Nemirovsky A, Teeter W, Geyer A, et al
    Injury Characteristics and Outcomes of Patients With Inflammatory Bowel Disease After Trauma: A Propensity Score Matched Analysis.
    Inflamm Bowel Dis. 2019 Oct 21. pii: 5601417. doi: 10.1093.
    PubMed     Abstract available


  768. GROSSI V, Hyams JS, Glidden NC, Knight BE, et al
    Characterizing Clinical Features and Creating a Gene Expression Profile Associated With Pain Burden in Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 18. pii: 5599699. doi: 10.1093.
    PubMed     Abstract available


  769. KRISTENSEN MS, Kjaerulff TM, Ersboll AK, Green A, et al
    Erratum: The Influence of Antidepressants on the Disease Course Among Patients With Crohn's Disease and Ulcerative Colitis-A Danish Nationwide Register-Based Cohort Study.
    Inflamm Bowel Dis. 2019;25:e152.
    PubMed    


  770. WANG MH, Mousa OY, Friton JJ, Raffals LE, et al
    Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience.
    Inflamm Bowel Dis. 2019 Oct 18. pii: 5593848. doi: 10.1093.
    PubMed     Abstract available


  771. VAN DER HAVE M, Oldenburg B
    Is Ulcerative Colitis Associated With Primary Sclerosing Cholangitis an Undertreated Condition?
    Inflamm Bowel Dis. 2019 Oct 18. pii: 5598454. doi: 10.1093.
    PubMed    


  772. SINGH A, Koenen B, Kirby DF
    Bariatric Surgery and Its Complications in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Oct 18. pii: 5598917. doi: 10.1093.
    PubMed     Abstract available


  773. KANE S
    Contraception and Antibiotics.
    Inflamm Bowel Dis. 2019;25:e148.
    PubMed    


  774. MIRJALALI H, Shahrokh S, Asadzadeh Aghdaei H, Zali MR, et al
    Letter to the Editor: Activated Toxoplasma May Attenuate the Effect of Azathioprine and Deteriorate the Symptoms in IBD Patients via mTORC1 Manipulation.
    Inflamm Bowel Dis. 2019;25:e137.
    PubMed    


  775. EISENSTEIN S, Holubar SD, Hilbert N, Bordeianou L, et al
    The ACS National Surgical Quality Improvement Program-Inflammatory Bowel Disease Collaborative: Design, Implementation, and Validation of a Disease-specific Module.
    Inflamm Bowel Dis. 2019 Oct 17. pii: 5589173. doi: 10.1093.
    PubMed     Abstract available


  776. LAI SW, Kuo YH, Fang CW, Liao KF, et al
    Inflammatory Bowel Disease and the Risk of Erectile Dysfunction.
    Inflamm Bowel Dis. 2019 Oct 17. pii: 5589171. doi: 10.1093.
    PubMed    


  777. WATT P
    Recommendations for the Provision of Psychological Support in a Rural Inflammatory Bowel Disease Clinic.
    Inflamm Bowel Dis. 2019 Oct 17. pii: 5589169. doi: 10.1093.
    PubMed    


  778. NETO MBB, Gregory MH, Ramos GP, Bazerbachi F, et al
    Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 15. pii: 5588067. doi: 10.1093.
    PubMed     Abstract available


  779. KAFIL TS, Nguyen TM, MacDonald JK, Chande N, et al
    Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews.
    Inflamm Bowel Dis. 2019 Oct 15. pii: 5588062. doi: 10.1093.
    PubMed     Abstract available


  780. LAI SW, Kuo YH, Liao KF
    Cancer Risk in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 14. pii: 5587055. doi: 10.1093.
    PubMed    


  781. SCHOFIELD JB, Haboubi N
    Histopathological Mimics of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Oct 10. pii: 5584939. doi: 10.1093.
    PubMed     Abstract available


  782. KRISHNA M, Salako A, Fofanova T, Kellermayer R, et al
    Parental Education May Differentially Impact Pediatric Inflammatory Bowel Disease Phenotype Risk.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581966. doi: 10.1093.
    PubMed     Abstract available


  783. DAY AS
    Re: Parental Education May Differentially Modulate Pediatric Inflammatory Bowel Disease Phenotype Risk.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581964. doi: 10.1093.
    PubMed    


  784. NARDONE OM, Shivaji UN, Ferruzza V, Ghosh S, et al
    Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581902. doi: 10.1093.
    PubMed     Abstract available


  785. KAYAL M, Plietz M, Rizvi A, Radcliffe M, et al
    Inflammatory Pouch Conditions Are Common After Ileal Pouch Anal Anastomosis in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2019 Oct 6. pii: 5581903. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  786. DANILUK U, Daniluk J, Ciborowski M
    Reply to Letter to the Editor of Dr. Sitkin et al., Regarding "Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome is Another Key to the Pathogenesis of Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574842. doi: 10.1093.
    PubMed    


  787. SITKIN S, Demyanova E, Vakhitov T, Pokrotnieks J, et al
    Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome Is Another Key to the Pathogenesis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574840. doi: 10.1093.
    PubMed    


  788. CHANDE N, Costello SP, Limketkai BN, Parker CE, et al
    Alternative and Complementary Approaches for the Treatment of Inflammatory Bowel Disease: Evidence From Cochrane Reviews.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574841. doi: 10.1093.
    PubMed    


  789. MOSER T, Bubel NE, Machegger L, Pikija S, et al
    Cerebral Vasculitis in Crohn's Disease: Always a Complication of Inflammatory Bowel Disease or Tumor Necrosis Factor-Alpha Inhibition?
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574838. doi: 10.1093.
    PubMed    


  790. KELSEN JR, Conrad MA, Dawany N, Patel T, et al
    The Unique Disease Course of Children with Very Early onset-Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5575070. doi: 10.1093.
    PubMed     Abstract available


  791. GIRON F, Pasto A, Tasciotti E, Abraham BP, et al
    Nanotechnology in the Treatment of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574918. doi: 10.1093.
    PubMed     Abstract available


  792. LONG MD, Smith TW, Dibonaventura M, Gruben D, et al
    Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574848. doi: 10.1093.
    PubMed     Abstract available


  793. ABU-SBEIH H, Wang Y
    Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574910. doi: 10.1093.
    PubMed     Abstract available


  794. NGUYEN GC, Low D, Chong RY, Diong C, et al
    Utilization of Diagnostic Imaging and Ionization Radiation Exposure Among an Inflammatory Bowel Disease Inception Cohort.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574895. doi: 10.1093.
    PubMed     Abstract available


  795. CHIBA M, Nakane K, Abe H, Komatsu M, et al
    Onset of Ulcerative Colitis in a Patient with Nonalcoholic Fatty Liver Disease (NAFLD): Dramatic Effect of Plant-based Diet for NAFLD.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574851. doi: 10.1093.
    PubMed     Abstract available


  796. CLARKE WT, Papamichael K, Casteele NV, Germansky KA, et al
    Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients With Inflammatory Bowel Disease: A Prospective Cross-Sectional Observational Study.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574728. doi: 10.1093.
    PubMed    


  797. VAN DE VEN SEM, Derikx LAAP, Nagtegaal ID, van Herpen CM, et al
    Laryngeal Carcinoma in Patients With Inflammatory Bowel Disease: Clinical Outcomes and Risk Factors.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574717. doi: 10.1093.
    PubMed     Abstract available


  798. BOLAND K, Greener T, Kabakchiev B, Stempak J, et al
    Identification of Target Golimumab Levels in Maintenance Therapy of Crohn's Disease and Ulcerative Colitis Associated With Mucosal Healing.
    Inflamm Bowel Dis. 2019 Sep 17. pii: 5570706. doi: 10.1093.
    PubMed     Abstract available


  799. LUTHER J, Dave M
    Rising Inflammatory Bowel Disease Prevalence Highlights the Need for Effective, Cost-Effective Therapies.
    Inflamm Bowel Dis. 2019 Sep 7. pii: 5565004. doi: 10.1093.
    PubMed    


    August 2019
  800. DEBRUYN J
    Response to the Letter by Dr. Freddy Calder.
    Inflamm Bowel Dis. 2019;25:e104.
    PubMed    


    July 2019
  801. BORUM ML, Taneja SL, Corinaldi M
    Health Literacy Assessments May Be Inconsistently Conducted in IBD Patients.
    Inflamm Bowel Dis. 2019;25:e94.
    PubMed    


  802. SAROLI PALUMBO C, Bessissow T, Sebastiani G
    Reply to "Transient Elastography in IBD Patients".
    Inflamm Bowel Dis. 2019;25:e95.
    PubMed    


  803. VAN EVERDINGEN CK, Meijer B, Gearry RB
    Transient Elastography in IBD Patients.
    Inflamm Bowel Dis. 2019;25:e96.
    PubMed    


  804. GOYAL A, Morowitz M
    Author's Reply to Drs. Franco Scaldaferri and Valentina Petito, PhD.
    Inflamm Bowel Dis. 2019;25:e102.
    PubMed    


  805. KOCHAR B, Long MD, Herfarth HH
    Antidepressants in IBD: Healthy Adherer Effect?
    Inflamm Bowel Dis. 2019;25:e98.
    PubMed    


  806. NARULA N, Pinto-Sanchez MI, Calo NC, Ford AC, et al
    Response to Letter by Moulton et al.
    Inflamm Bowel Dis. 2019;25:e99.
    PubMed    


    June 2019
  807. ZHAO S, Xie Q, Zhao Z
    Reply to Comment on "Inflammatory Bowel Diseases Were Associated With Risk of Sexual Dysfunction in Both Sexes: A Meta-analysis" by Li Y and Liu X.
    Inflamm Bowel Dis. 2019;25:e78-e81.
    PubMed    


  808. GIANNINI EG, Demarzo MG, Bodini G
    Reproducibility and Transportability of the Absence of Incremental Infectious Adverse Events in Patients With Higher Anti-TNF Drug Levels.
    Inflamm Bowel Dis. 2019;25:e73.
    PubMed    


  809. KRUGER AJ, Hinton A, Afzali A
    To the Editors: Index Severity Score and Early Readmission Predicts Increased Mortality in Crohn's Disease Patients.
    Inflamm Bowel Dis. 2019;25:e74-e76.
    PubMed    


  810. KURIN M, Katz J, Kodish E, Lashner B, et al
    Informed Consent in IBD Trials: Where We Are and Where We Need to Go.
    Inflamm Bowel Dis. 2019;25:1115-1119.
    PubMed     Abstract available


  811. GROSSBERG LB
    A Case Report of Successful Treatment of Crohn's Disease and Psoriasis With Guselkumab.
    Inflamm Bowel Dis. 2019;25:e84.
    PubMed    


  812. GARCIA GARCIA MJ, Rivero Tirado M, Callizo MEP
    Paradoxical Arthritis in Inflammatory Bowel Diasease Patients on Ustekinumab Treatment.
    Inflamm Bowel Dis. 2019;25:e89.
    PubMed    


  813. SIMONS-LINARES CR, Chahal P
    Successful EUS-guided Drainage of a Persistent Subdiaphragmatic Fluid Collection in a Patient With Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:e85-e86.
    PubMed    


  814. LIGHTNER AL, Alsughayer A, Wang Z, McKenna NP, et al
    Short- and Long-term Outcomes After Ileal Pouch Anal Anastomosis in Pediatric Patients: A Systematic Review.
    Inflamm Bowel Dis. 2019;25:1152-1168.
    PubMed     Abstract available


  815. KRISHNAKUMAR C, Ballengee CR, Liu C, Kim MO, et al
    Variation in Care in the Management of Children With Crohn's Disease: Data From a Multicenter Inception Cohort Study.
    Inflamm Bowel Dis. 2019;25:1208-1217.
    PubMed     Abstract available


  816. ZHAO M, Lo BZS, Vester-Andersen MK, Vind I, et al
    A 10-Year Follow-up Study of the Natural History of Perianal Crohn's Disease in a Danish Population-Based Inception Cohort.
    Inflamm Bowel Dis. 2019;25:1227-1236.
    PubMed     Abstract available


  817. EVERHOV AH, Khalili H, Askling J, Myrelid P, et al
    Work Loss Before and After Diagnosis of Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:1237-1247.
    PubMed     Abstract available


    May 2019
  818. DELDAY M, Mulder I, Logan ET, Grant G, et al
    Reply to the Letter to the Editor of Drs. Sitkin and Pokrotnieks.
    Inflamm Bowel Dis. 2019;25:e72.
    PubMed    


  819. FUKUDA T, Naganuma M, Kanai T
    How Can We Assess "Complete Healing" Beyond Endoscopic Remission?
    Inflamm Bowel Dis. 2019;25:e68.
    PubMed    


  820. BRYANT RV, Schultz CG, Ooi S, Goess C, et al
    Authors' reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin and Quality of Life.
    Inflamm Bowel Dis. 2019;25:e62-e63.
    PubMed    


  821. DAI C, Jiang M, Huang YH
    The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life.
    Inflamm Bowel Dis. 2019;25:e61.
    PubMed    


  822. GREENFEST A, Szvarca D, Clarke L, Tabbara N, et al
    New Vaccine, New Guidelines, Same Problem: The Rates of Herpes Zoster Infection and Vaccination in IBD Patients.
    Inflamm Bowel Dis. 2019;25:e60.
    PubMed    


  823. COUCH DG, Cook H, Ortori C, Barrett D, et al
    Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.
    Inflamm Bowel Dis. 2019;25:1006-1018.
    PubMed     Abstract available


  824. CALDERA F, Hayney MS, Cross RK
    Using Number Needed to Harm to Put the Risk of Herpes Zoster From Tofacitinib in Perspective.
    Inflamm Bowel Dis. 2019;25:955-957.
    PubMed    


  825. MOORE AC, Huang VW, Bourdages R, Fedorak RN, et al
    IBDoc Canadian User Performance Evaluation.
    Inflamm Bowel Dis. 2019;25:1107-1114.
    PubMed     Abstract available


  826. KOTZEV A, Tanchev L, Encheva L, Kovachev N, et al
    Sigmoidouterine Fistula in Crohn's Disease: A First Case Report.
    Inflamm Bowel Dis. 2019;25:e65-e66.
    PubMed    


  827. QAZI T, Verma R, Hamilton MJ, Kaplan ER, et al
    The Use of Actigraphy Differentiates Sleep Disturbances in Active and Inactive Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:1044-1053.
    PubMed     Abstract available


  828. SADO AI, Kalla R, Sharma A
    A Case of IBD Immunosuppression Related Salmonella Aortitis Requiring Emergency Vascular Grafting.
    Inflamm Bowel Dis. 2019;25:e64.
    PubMed    


  829. SCHMIDT T, Feagins LA
    How Can We Improve to Keep Our Patients Out of the Hospital?
    Inflamm Bowel Dis. 2019;25:980-986.
    PubMed     Abstract available


  830. PARK SH, Aniwan S, Scott Harmsen W, Tremaine WJ, et al
    Update on the Natural Course of Fistulizing Perianal Crohn's Disease in a Population-Based Cohort.
    Inflamm Bowel Dis. 2019;25:1054-1060.
    PubMed     Abstract available


  831. PLEVRIS N, Lyons M, Jenkinson PW, Chuah CS, et al
    Higher Adalimumab Drug Levels During Maintenance Therapy for Crohn's Disease Are Associated With Biologic Remission.
    Inflamm Bowel Dis. 2019;25:1036-1043.
    PubMed     Abstract available


    April 2019
  832. SHMIDT E, Dulai PS
    Reply to the Letter to the Editor of Dr. Pauwels et al.
    Inflamm Bowel Dis. 2019;25:e58.
    PubMed    


  833. JUN S
    Ethnicity May Be Important for Studying the Role of the Microbiome and Vitamin D Receptor in IBD.
    Inflamm Bowel Dis. 2019;25:e54.
    PubMed    


  834. SZYMCZAK-TOMCZAK A, Krela-Kazmierczak I, Kaczmarek-Rys M, Hryhorowicz S, et al
    Does Only Sex Matter? Complexity of the Association Between Vdr Gene BsmI Single Nucleotide Polymorphism and Immune Response in IBD.
    Inflamm Bowel Dis. 2019;25:e56-e57.
    PubMed    


  835. CHETCUTI ZAMMIT S, McAlindon ME, Hale MF, Sanders DS, et al
    Small Bowel Ulcers on Capsule Endoscopy and Their Significance.
    Inflamm Bowel Dis. 2019;25:e55.
    PubMed    


  836. KANE S
    Leter to the Editor.
    Inflamm Bowel Dis. 2019;25:e52.
    PubMed    


  837. FRANCO DL, Holubar SD, Lightner AL, Lashner BA, et al
    Local Stem Cell Therapy for Crohn's Perianal Fistulae.
    Inflamm Bowel Dis. 2019;25:816-819.
    PubMed    


  838. SCOTT FI, Johnson FR, Bewtra M, Brensinger CM, et al
    Improved Quality of Life With Anti-TNF Therapy Compared With Continued Corticosteroid Utilization in Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:925-936.
    PubMed     Abstract available


  839. CHUDY-ONWUGAJE KO, Christian KE, Farraye FA, Cross RK, et al
    A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD.
    Inflamm Bowel Dis. 2019;25:820-830.
    PubMed     Abstract available


  840. CLICK B, Regueiro M
    A Practical Guide to the Safety and Monitoring of New IBD Therapies.
    Inflamm Bowel Dis. 2019;25:831-842.
    PubMed     Abstract available


  841. NUCERA E, Andriollo G, Buonomo A, Di Rienzo A, et al
    Interesting Case of Infliximab IV Type Hypersensitivity.
    Inflamm Bowel Dis. 2019;25:e49-e51.
    PubMed    


    March 2019
  842. GOREN I, Godny L, Reshef L, Yanai H, et al
    Starch Consumption May Modify Antiglycan Antibodies and Fecal Fungal Composition in Patients With Ileo-Anal Pouch.
    Inflamm Bowel Dis. 2019;25:742-749.
    PubMed     Abstract available


  843. ZHAO S, Wang J, Liu Y, Luo L, et al
    Inflammatory Bowel Diseases Were Associated With Risk of Sexual Dysfunction in Both Sexes: A Meta-analysis.
    Inflamm Bowel Dis. 2019;25:699-707.
    PubMed     Abstract available


  844. WEAVER KN, Gregory M, Syal G, Hoversten P, et al
    Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter Cohort.
    Inflamm Bowel Dis. 2019;25:767-774.
    PubMed     Abstract available


  845. DURICOVA D, Dvorakova E, Hradsky O, Mitrova K, et al
    Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation.
    Inflamm Bowel Dis. 2019;25:789-796.
    PubMed     Abstract available


  846. CARUSO ML, Cavalcanti E, Ignazzi A, Lantone G, et al
    Infliximab Has a Number of Well-Described Adverse Effects. Is Myeloid Metaplasia One of These in Elderly Long-standing IBD Patients?
    Inflamm Bowel Dis. 2019;25:e44-e45.
    PubMed    


    February 2019
  847. MAO R, Kurada S, Gordon IO, Baker ME, et al
    The Mesenteric Fat and Intestinal Muscle Interface: Creeping Fat Influencing Stricture Formation in Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:421-426.
    PubMed     Abstract available


  848. BRYANT RV, Schultz CG, Ooi S, Goess C, et al
    Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life.
    Inflamm Bowel Dis. 2019;25:592-600.
    PubMed     Abstract available


  849. ARMUZZI A, Fiorino G, Variola A, Manetti N, et al
    The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy.
    Inflamm Bowel Dis. 2019;25:568-579.
    PubMed     Abstract available


  850. DENSON LA, Jurickova I, Karns R, Shaw KA, et al
    Genetic and Transcriptomic Variation Linked to Neutrophil Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Pediatric Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:547-560.
    PubMed     Abstract available


  851. QUINN KP, Lightner AL, Faubion WA, Raffals LE, et al
    A Comprehensive Approach to Pouch Disorders.
    Inflamm Bowel Dis. 2019;25:460-471.
    PubMed     Abstract available


  852. NUGENT Z, Singh H, Targownik LE, Bernstein CN, et al
    Herpes Zoster Infection and Herpes Zoster Vaccination in a Population-Based Sample of Persons With IBD: Is There Still an Unmet Need?
    Inflamm Bowel Dis. 2019;25:532-540.
    PubMed     Abstract available


  853. MIZUNO S, Naganuma M, Kanai T
    Idiopathic Thrombocytopenic Purpura Responsive to Surgery for Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:e26.
    PubMed    


  854. NOVELLO M, Shen B, Stocchi L
    Pouchitis as an Indication for Ileal Pouch Surgical Revision.
    Inflamm Bowel Dis. 2019;25:e25.
    PubMed    


  855. GLAPA A, Waraczewski K, Nowak JK, Paszkowski J, et al
    Vitamin K Deficiency in Patients After Restorative Proctocolectomy.
    Inflamm Bowel Dis. 2019;25:e17-e18.
    PubMed    


  856. EL OUALI S, Kessler H, Shen B
    Self-Expandable Metal Stent in the Treatment of Refractory Long Pouch Inlet Stricture.
    Inflamm Bowel Dis. 2019;25:e13-e14.
    PubMed    


    January 2019
  857. DOVROLIS N, Drygiannakis I, Filidou E, Kandilogiannakis L, et al
    Gut Microbial Signatures Underline Complicated Crohn's Disease but Vary Between Cohorts; An In Silico Approach.
    Inflamm Bowel Dis. 2019;25:217-225.
    PubMed     Abstract available


  858. WEIZMAN AV, Nguyen GC, Seow CH, Targownik L, et al
    Appropriateness of Biologics in the Management of Crohn's Disease Using RAND/UCLA Appropriateness Methodology.
    Inflamm Bowel Dis. 2019;25:328-335.
    PubMed     Abstract available


  859. SHEN W, Li Y, Zou Y, Cao L, et al
    Mesenteric Adipose Tissue Alterations in Crohn's Disease Are Associated With the Lymphatic System.
    Inflamm Bowel Dis. 2019;25:283-293.
    PubMed     Abstract available


  860. SCHIRBEL A, Rebert N, Sadler T, West G, et al
    Mutual Regulation of TLR/NLR and CEACAM1 in the Intestinal Microvasculature: Implications for IBD Pathogenesis and Therapy.
    Inflamm Bowel Dis. 2019;25:294-305.
    PubMed     Abstract available


  861. BEN-SHACHAR S, Finezilber Y, Elad H, Rabinowitz K, et al
    Genotype-Serotype Interactions Shed Light on Genetic Components of Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2019;25:336-344.
    PubMed     Abstract available


  862. BITTON A, Vutcovici M, Lytvyak E, Kachan N, et al
    Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives.
    Inflamm Bowel Dis. 2019;25:403-409.
    PubMed     Abstract available


  863. DURICOVA D, Sarter H, Savoye G, Leroyer A, et al
    Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn's Disease: A French Population-Based Study.
    Inflamm Bowel Dis. 2019;25:394-402.
    PubMed     Abstract available


  864. XU Y, Yang L, An P, Zhou B, et al
    Meta-Analysis: The Influence of Preoperative Infliximab Use on Postoperative Complications of Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:261-269.
    PubMed     Abstract available


  865. DEEPAK P, Fowler KJ, Fletcher JG, Bruining DH, et al
    Novel Imaging Approaches in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2019;25:248-260.
    PubMed     Abstract available


  866. SHAFER LA, Walker JR, Restall G, Chhibba T, et al
    Association Between IBD Disability and Reduced Work Productivity (Presenteeism): A Population-Based Study in Manitoba, Canada.
    Inflamm Bowel Dis. 2019;25:352-359.
    PubMed     Abstract available


  867. RIVERA ED, Coffey JC, Walsh D, Ehrenpreis ED, et al
    The Mesentery, Systemic Inflammation, and Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:226-234.
    PubMed     Abstract available


  868. RENOUF MJ, Cho YH, McPhee JB
    Emergent Behavior of IBD-Associated Escherichia coli During Disease.
    Inflamm Bowel Dis. 2019;25:33-44.
    PubMed     Abstract available


  869. BUTTO LF, Jia LG, Arseneau KO, Tamagawa H, et al
    Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:14-26.
    PubMed     Abstract available


  870. ZHANG YG, Lu R, Xia Y, Zhou D, et al
    Lack of Vitamin D Receptor Leads to Hyperfunction of Claudin-2 in Intestinal Inflammatory Responses.
    Inflamm Bowel Dis. 2019;25:97-110.
    PubMed     Abstract available


  871. DELDAY M, Mulder I, Logan ET, Grant G, et al
    Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn's Disease.
    Inflamm Bowel Dis. 2019;25:85-96.
    PubMed     Abstract available


  872. STEINHART AH, Panaccione R, Targownik L, Bressler B, et al
    Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus.
    Inflamm Bowel Dis. 2019;25:1-13.
    PubMed     Abstract available


  873. CUSHING KC, Mclean R, McDonald KG, Gustafsson JK, et al
    Predicting Risk of Postoperative Disease Recurrence in Crohn's Disease: Patients With Indolent Crohn's Disease Have Distinct Whole Transcriptome Profiles at the Time of First Surgery.
    Inflamm Bowel Dis. 2019;25:180-193.
    PubMed     Abstract available


  874. SPENCER E, Norris E, Williams C, Dubinsky MC, et al
    The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD.
    Inflamm Bowel Dis. 2019;25:142-149.
    PubMed     Abstract available


  875. EL-MATARY W, Walters TD, Huynh HQ, deBruyn J, et al
    Higher Postinduction Infliximab Serum Trough Levels Are Associated With Healing of Fistulizing Perianal Crohn's Disease in Children.
    Inflamm Bowel Dis. 2019;25:150-155.
    PubMed     Abstract available


  876. SAROLI PALUMBO C, Restellini S, Chao CY, Aruljothy A, et al
    Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography.
    Inflamm Bowel Dis. 2019;25:124-133.
    PubMed     Abstract available


  877. LEGA S, Phan BL, Rosenthal CJ, Gordon J, et al
    Proactively Optimized Infliximab Monotherapy Is as Effective as Combination Therapy in IBD.
    Inflamm Bowel Dis. 2019;25:134-141.
    PubMed     Abstract available


  878. DOTSON JL, Kappelman MD, Bricker J, Andridge R, et al
    Multicenter Evaluation of Emergency Department Treatment for Children and Adolescents With Crohn's Disease According to Race/Ethnicity and Insurance Payor Status.
    Inflamm Bowel Dis. 2019;25:194-203.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: